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Abstract 
Bovine herpesvirus 4 (BoHV-4) is a virus with a worldwide distribution in cattle population that has been 
isolated from a lot of different tissues and samples from animal with various clinical manifestations, ranging 
from conjunctivitis, ocular discharge and genital diseases as post-partum metritis or abortion, but even in 
apparently healthy animal.  
Even if a clear correlation between BoHV-4 and any pathologies has never been demonstrated; BoHV-4 is 
most consistently associated with metritis, a very common postpartum disease of the uterus, in which the 
role of BoHV-4 as a secondary pathogen is well documented.  
BoHV-4 has a well known tropism for endometrial stromal and epithelial cells, in which causes non-
apoptotic cell death and de novo virus production associated with an increased prostaglandin-
endoperoxide synthase 2 protein, cyclo-ossigenase 2 (COX2) and prostaglandin E2 production and secretion 
from stromal cell. BoHV-4 activation and replication in the bovine endometrium is associated with the early 
transactivation of the BoHV-4 IE2 gene promoter from endometrial cells. BoHV-4 IE2 gene promoter 
transactivation and viral replication were associated also with extracellular stimuli belonging to the 
intrauterine microenvironment such as E. coli LPS and PGE. 
A model that fits well endometrial BoHV-4 disease is described in literature, involving a vicious circle 
comprising of bacterial endometritis leading to secretion of PGE, then PGE and LPS st imulating virus 
replication, which causes further endometrial tissue damage and inflammation. The existence of a virus 
patho-biotype causing uterine disease appears possible; virus strain adaptation to an organ, tissue or cell 
type is infact a very important issue for the study of pathology, even because the function of most of the 
viral genes remains still unknown.  
In this study a BoHV-4 strain was isolated from the uterus of a persistently infected cow affected with non-
responsive post-partum metritis and designated BoHV-4-U. After the characterization this uterine strain 
was cloned as a bacterial artificial chromosome (BAC) to easily manipulate and study the viral genome. 
The feasibility of using BoHV-4-U for mutagenesis was demonstrated using the BAC recombineering system, 
that allows to study single or multiple gene disruptions, opening the way to the clarification of the 
interactions between BoHV-4 infection and the host endometrial cells. 
After the generation of the BAC-BoHV-4-U the first gene we decided to investigate was the ORF50/Rta 
gene, that has been shown to be an essential gene for DNA replication and latency reactivation in many 
gammaherpesviruses. Although the BoHV-4 ORF50/Rta homolog, immediate early gene 2 (IE2), has been 
shown to activate several BoHV-4 early and late promoters in co-transfection assays, there is no direct 
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proof of its real indispensability for progression of the virus to the lytic replication cycle in the context of 
the viral genome. 
Through different strategies the ORF50 gene was interrupted generating before some mutants, replication 
defective BoHV-4-V.test /IE2 mutants, as a control viruses, and then some BoHV-4-U/IE2 mutants.  
The BoHV-4-V.test/IE2 mutants was efficiently rescued, with respect to the production of infectious virus 
and DNA replication, upon the expression of the BoHV-4 ORF50/Rta protein in trans by different 
complementing cell lines; the BoHV-4-U/IE2 mutants surprisingly were all able to growth, even in non-
complementing cell lines. The generation of a suitable probe led to discover that the IE2 gene is duplicated 
in the genome of BoHV-4-U. 
These data demonstrated that in BoHV-4, too, ORF50/Rta is the master replication switch gene and, that 
can be duplicated in some strains, as in our uterine strain.  
The deletion of the second gene copy of BoHV-4-U Rta unable the virus the capacity to replicate, and this 
inability was completely complemented by the in trans expression of ORF50/Rta. 
The generation of this completely replication un-competent virus maybe will provide a new powerful tool 
for recombinant vaccine production, even in respect to the rescue of the virus through the expression, 
under a strictly inducible promoter, of the Rta protein. 
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Riassunto 
Bovine herpesvirus 4 (BoHV-4) appartiene alla famiglia dei gammaherpesvirus ed è ampiamente 
distribuito nella popolazione bovina. Questo virus è  stato isolato da moltissimi tessuti  e campioni  
provenienti sia da animali apparentemente sani, che da animali che mostravano una varia 
sintomatologia clinica, che spaziava da problemi oculari,  come la congiuntivite, fino a problemi 
genitali, il più comune dei quali risulta essere la metrite post-parto.  
Non è stata tutt’ora dimostrata l’evidenza di una chiara correlazione di causa-effetto tra l’infezione da 
BoHV-4 e alcuna patologia, anche se, l’associazione tra BoHV -4 e la metrite post-parto, una patologia 
molto comune a carico dell’utero bovino in fase post-parto, è ben documentata e  ha suggerito come 
BoHV-4 possa essere considerato un patogeno secondario nell’insorgenza di  questa patologia.  
BOHV-4 mostra uno spiccato tropismo per le cellule endometriali stromali e epiteliali uterine, nelle 
quali causa morte cellulare per via non-apoptotica, insieme ad una produzione di virus strettamente 
associata con un’aumentata produzione di  COX2 (ciclo-ossigenasi  2)  e prostaglandina endoperossido 
sintasi 2, oltre che di un’aumentata secrezione di prostaglandina E2 da parte delle cellule stromali.  
La rapida attivazione di BoHV-4 e consequente replicazione nell’endometrio bovino risulta essere 
strettamente associata alla precoce transattivazione del promotore del gene Immediate early II (IE2) di 
BoHV-4 da parte delle cellule endometriali; che è inoltre associata anche con stmoli extracellulari come il 
Lipopolisaccaride (LPS) e PGE, rilasciati nell’micro-ambiente uterino, ad esempio in corso di infezione 
baterica. 
Sulla base dei risultati ottenuti in precedenza, è stato ipotizzato un modello che sembra ben 
descrivere le connessioni presenti tra BoHV-4 e  l’endometrio; questo modello svela l’esistenza di  un 
sistema che si  autoalimenta, sostenuto dalla secrezione di PGE da parte  di patogeni  batterici, PGE e  
LPS a loro volta stimolano la replicazione del virus, che causa così ulteriori  danni tissutali e  
infiammazione. Appare quindi possibile che esista un biotipo virale adattato all’utero e in grado di  
dare patologie uterine; la possibilità che i ceppi virali si adattino ad un organo, come anche ad un 
tessuto o a un tipo cellulare risulta essere molto importante nella comprensione della patologia, 
anche nell’ottica della prevenzione e della terapia.  
In questa tesi  è stato dapprima isolato un ceppo di BoHV-4 residente nell’utero di  una vacca affetta 
da una metrite post-parto non responsiva ai farmaci, che è stato designato BoHV -4-U; dopo la sua 
caratterizzazione questo ceppo è stato clonato come Cromosoma Artificiale Batterico (BAC), per 
poterlo studiare e  manipolare  agevolmente. Tramite un sistema di  Ricombinazione Omologa, è  stata 
testata la validità di questo BAC-BoHV-4-U, al  fine di  permettere  lo studio di  delezioni di geni singoli o 
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multipli, che saranno importanti  per comprendere le  interazioni  che si instaurano tra BoHV -4 e  le 
cellule ospiti uterine. 
Il primo gene sul quale si è concentrata la nostra attenzione, dopo la generazione de l BAC-BoHV-4-U è il 
gene codificato dall’ORF50 del virus, la proteina Rta, che è stata dimostrata essere essenziale per la 
replicazione del DNA e la riattivazione dalla latenza per molti altri gammaherpesviruses. 
Per quanto riguarda BoHV-4, studi precedenti hanno dimostrato come il gene Orf50/Rta sia in grado di 
trans-attivare alcuni promotori di geni precoci e tardivi di BoHV-4, in saggi di co-transfezione; tuttavia non è 
ancora disponibile alcuna prova diretta che questo gene sia responsabile della progre ssione del virus verso 
un ciclo litico nel contesto del genoma virale. 
Abbiamo quindi proceduto ad inattivare il gene tramite differenti strategie, generando dapprima un 
mutante di controllo, difettivo nel gene IE2, appartenente al ceppo di referenza V.test, per poi procedere 
con la delezione del gene nel nostro isolato uterino. 
Nel ceppo di referenza IE2 si è dimostrato essere indispensabile per la replicazione del virus, in effetti era 
possibile ricostituire il virus solo fornendo in trans la proteina Rta, tramite delle linee cellulari 
complementate; nel ceppo uterino abbiamo avuto risultati discordanti, in quanto la delezione del gene IE2 
non sembrava interferire con la replicazione virale, rendendo il virus capace di crescere anche in linee 
cellulari non complementate con Rta. Tramite la generazione di un’opportuna sonda, che ha permesso d i 
effettuare analisi approfondite, è emerso come nel nostro ceppo uterino, BoHV-4-U, il gene IE2 fosse 
duplicato. La delezione anche della seconda copia genica di IE2 ha evidenziato come anche in questo ceppo 
IE2 sia un gene essenziale per la replicazione del virus; anche in questo caso la capacità replicativa del virus 
veniva ristabilita fornendo in trans la proteina Rta. 
La generazione di un virus replicazione-incompetente, costituirà un nuovo e interessante mezzo per la 
produzione di vaccini ricombinanti, anche nell’ottica di poter ottenere il rescue del virus, attraverso 
l’espressione della proteina Rta, posta sotto il controllo di un promotore strettamente cellula o o rgano 
inducibile. 
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1.1. Herpesviridae family 
The Herpesviridae family comprises more than 120 viruses with linear double-stranded DNA genomes and 
common characteristics. According to their biological properties, host range, multiplication rate, 
cytopathology and latency site this family has been divided in three subfamilies, named Alpha-, Beta- and 
Gammaherpesvirinae. 
All members of this viral family share a common morphology based on an icosaedral capsid symmetry. 
Usually the spherical virion comprises core, capsid, tegument and envelope. The core consists of the viral 
genome packaged as a single, linear, double-stranded DNA molecule into preformed capsid. Capsid 
assembles by co- condensation around a protein scaffold to form a pro-capsid in which the subunities are 
weakly connected. Proteolitic cleavage of the scaffolding protein triggers the loss of the scaffold and the 
reorganization of the shell into the characteristic capsid form. The structure of  the tegument is poorly 
defined, with evidence of symmetry only in the region immediately surrounding the capsid; many proteins 
are contained in the tegument, not all required for virions formation. Enveloped tegument structure lacking 
capsids can be assembled and are released from cell along with virions. The envelope has a lipid bilayer 
structure and is strictly associated with the outer surface of the tegument; contains different integral viral 
glycoproteins.  
Herpesviruses are widely distributed in nature and have a wide range of vertebrate hosts, currently one 
herpesvirus, l’Ostreid Herpesvirus 1 (OsHV-1) can infect invertebrates (Roizman, 2001). As a general rule, 
the natural host range of individual viruses is highly restricted, and also co-evolution between 
herpesviruses and single host species occurs, through occasional transfer to other species in nature. Even if 
considering experimental animal and in vitro systems the host range varies remarkably, the same general 
rule holds true: members of the subfamily Alpha- often infect a wide variety of animal species and cell line 
from different species, whereas members of the subfamily Beta- and Gammaherpesvirinae exhibit a very 
narrowed experimental host range. 
These viruses produce lesions in man and animals ranging from localized vesicular eruptions of surface 
epithelia to diffuse wide spread damage in the mucosa of the respiratory, digestive and genitals tracts; 
from localized giant cell proliferation in glandular epithelium to necrosis of liver, lymphoid and other 
tissues; and from specific neuronal damage to diffuse meningoencephalitis. Infection of the fetus may lead 
to fetal death, abortion or in newborn diseases. Since the tissue tropism of various herpesviruses does not 
differ greatly, they tend to produce similar diseases in different animal species. Animal herpesviruses can 
thus cause disease such as bovine, feline, canine and equine rhinotracheitis. 
A variety of immune evasion mechanisms have been identified in different viruses, including the evasion of 
complement, antibody, MHC class I presentation and Natural Killer cells killing; however the ability  of these 
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viruses to survive to immune system is strictly connected to their ability to establish life-long latent 
infection; Alpha- in neuronal cells, Beta- in monocytes and Gammaherpesvirus in lymphocytes (Fauquet, 
2005). 
Alphaherpesvirinae 
Short replication cycle, wide host range, latency in sensorial ganglions and lysis of the infected cells are the 
hallmarks of this subfamily. Examples are Human Herpesvirus-I (HHV-1, also known as Herpes Simplex virus 
1), Human Herpesvirus-3 (HHV-3, also known as Varicella–zoster virus, VZV), Bovine Herpesvirus-1 (BoHV-1) 
and Caprine herpesvirus-1 (CaHV-1). 
Betaherpesvirinae 
This subfamily presents a slow replication cycle, narrow host range, and latency in monocytes, secretory 
glands, kidney and other tissues. The prototype virus of this subfamily is Human Herpesvirus-5 (HHV-5, or 
Human Cytomegalovirus, HCMV): has a high prevalence and cause severe and even fatal diseases in 
immunologically immature or compromised patients. HHV-5 has the largest genome among mammalian 
DNA viruses, with a 235 kb double-stranded DNA molecule; due to its genome size and its slow replicative 
cycle is extremely difficult to obtain HHV-5 mutants. 
Gammaherpesvirinae 
In this subfamily are grouped viruses that usually have a host range limited to the family or the order of the 
natural host, latency in lymphocytes or in lymphoid tissues and oncogenic properties; moreover many of 
them do not easily replicate in cultured cells, some of them seemingly not at all (Ackermann, 2006). 
This subfamily is divided in two genera: lymphocryptovirus (or gamma-1-herpesvirus) and rhadinovirus (or 
gamma-2 herpesvirus). The etiological agent of infective mononucleosis, Human Herpesvirus-4 (or Epstein 
Bar Virus, EBV) groups in the lymphocryptovirus genus and is associated with oncogenic potential in 
lymphoid tissues. 
Members of the Rhadinovirus genus have been isolated in many mammalian species, like Saimiriine 
Herpesvirus-2 (SaHV-2 or Herpesvirus Saimiri, HVS) in monkeys, Equid Herpesvirus-2 (EHV-2) in equines, 
Murid Herpesvirus-4 (MuHV-4 or Murine gammaherpesvirus-68, MuHV-68) in mice, Bovine herpesvirus-4 
(BoHV-4) in cattle and Human Herpesvirus-8 (HHV-8 or Kaposi’s sarcoma associated herpesvirus, KSHV) in 
man. 
Extensive studies have made apparent that, in the course of their evolution, herpesviruses have undergone 
considerable diversification with respect to their antigenic and biological properties and to composition, 
size and arrangement of DNA sequences. However the morphology of the virions has been preserved.  
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The genomes are composed of linear double-stranded DNA ranging from 125 to 240 Kb in size and from 32-
75% in G+C content. All herpesviruses share long regions with repeated sequences in their genome: the 
number, position and the sequence of these regions vary according to subfamily, genus and species which 
the virus belongs to; there is also a minor variability even among different strains of the same species. 
Roizman and Batterson (Roizman, 2001), presented a schematic arrangement of herpesvirus genomes; 
genomic organization is moreover used to classified herpesviruses, infact only five general genomic 
structures have been identified (Fig. 1). 
 
 
Fig. 1. Herpesvirus genomic organization (adapted from (Fauquet, 2005) 
 
Structure A shows a unique sequence flanked by a direct repeat that may be larger than 10kb (HHV-6) or as 
short as 30bp (MuHV-1); rhadinoviruses in general present a type B structure, with one unique long region 
flanked by direct terminal repeats variable in numbers; HHV-4 has a type C structure, with two unique 
region divided by a set of direct repeat and flanked by direct terminal repeats. HHV-3 exemplifies type D 
structure, that presents different elements at each terminus, which are present internally in inverted 
orientation and separate the two long unique regions; while viruses with a type E structure are HHV-1 and 
HHV-5, in which the terminal reiterations are also repeated in inverted orientations internally. 
A.
B.
C.
D.
E.
UL US
UL
UL
US
US
TRL IRL IRS TRS         
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As a matter of fact closely related herpesvirus tend to share the same genomic structure, even if exceptions 
can be found; HHV-1 and HHV-5 share the same genomic organization even if they are distantly related, 
reflecting probably that they have evolved independently into the same organization (Fauquet, 2005). 
 
1.2. Bovine Herpesvirus 4 (BOHV-4) 
The interest in bovine herpesviruses stems from their considerable economic importance rather than from 
their contribution to the biological understanding of Herpesviridae. All bovine herpesviruses conform to the 
other members of the family on the basis of morphology, uniqueness in using the nucleus for replication 
and maturation, and the ability to become latent in infected hosts (Roizman and Morse, 1978). Both 
domestic livestock and exotic ruminants are susceptible to herpesvirus infection, with a wide range of 
clinical manifestations (see Table 1). 
The term “Bovid” was introduced to accommodate viruses isolated from all members of Bovidae; cattle, 
sheep and goats. Bovid herpesviruses (BHV) were characterized on the basis of the serology and restriction-
enzyme analysis of DNA. 
 
Virus Natural host Disease Conditions 
BHV-1 Cattle 
Infectious pustular vulvovaginitis, infectious bovine rhinotracheitis, abortion, 
respiratory disease, conjunctivitis, meningoencephalitis 
BHV-2 Cattle Bovine herpesmammillitis, pseudo-lumpy skin disease 
BHV-3 Wildebeest Malignant catarrhal fever 
BHV-4 Cattle 
Unapparent infection, abortion, metritis, mammary pustular dermatitis, 
respiratory and enteric infection 
BHV-5 Sheep Pulmonary adenomatotis or Jaagsiekte 
BHV-6 Goat Latent infections, enteritis 
Table.1. Classification of bovine herpesviruses, adapted from (Ludwig, 1982) 
 
The BHV-4 group includes numerous herpesviruses isolates obtained from both diseased and apparently 
healthy cattle and buffaloes. 
This virus was isolated the first time in 1963 by Bartha et al. (prototype strain Movar 33-63) (Bartha et al., 
1966), in calves showing respiratory and conjunctival signs. It has been classified in the Herpesviridae family 
after the microscope observation of the viral particle. In the first times various isolates were observed with 
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worldwide distribution, and were called with different names, such as “orphan herpesvirus”, “Movar-type 
herpesvirus”, “Bovid cytomegalovirus” and “Bovid Herpesvirus-4”, generating confusion about the 
nomenclature, partly because of the specific acronyms used by various investigators in designating viral 
isolates. Bartha reviewed the nomenclature of all these isolates recommending for all “Movar-Type” the 
term “Bovine herpesvirus-4” (BHV-4) (Bartha et al., 1987). The international committee of viral Taxonomy 
decided then to adopt the official name of BoHV-4 in 2000 (Fauquet, 2005). 
BoHV-4 was firstly proposed to be a bovine cytomegalovirus because of its morphogenesis in infected cells 
(presence of inclusion body in cytoplasm and nucleus of infected cells and of giant cells) as well as its slow 
growth in cell culture (Storz et al., 1984). 
Studies on the genome organization and determination of first gene sequence revealed that BoHV -4 is a 
member of the Gammaherpesvirinae: (i) the virus has a B-type genome structure (Roizman, 2001) with a 
long unique genome region(LUR) flanked by poly-repetitive DNA (prDNA) elements, (ii) the genome 
contains a thymidine kinase gene (Kit et al., 1986), (iii) gene sequenced so far are strictly homologous to 
those of HHV-8 and SaHV-2, and (iv) the gene arrangement is collinear with those of other 
gammaherpesviruses (Bublot et al., 1992; Goltz et al., 1994). 
On the similarity of its biological properties and genome structure to those of SaHV-2, it has been 
proposed, lately in the Eighty’s, that BoHV-4 was included in the gammaherpesvirus, specifically in the 
gamma-2 genus, also called Rhadinovirus (Kit et al., 1986). In ruminants other four rhadinovirus have been 
identified: Alcelaphine herpesvirus 1(AlHV-1), Ovine herpesvirus 2 (OvHV-2), Bovine lymphotrophe 
herpesvirus (BLHV) and Caprine Herpesvirus 2 (CpHV-2); BoHV-4 seems not to be phylogenetically related 
to neither of them (McGeoch et al., 2005), so far its evolutive origin is still unclear (Dewals et al., 2006). 
Besides cattle, BoH-4 has been detected in a variety of ruminants. In particular BoHV-4seems to be highly 
prevalent among wild African Buffalo (Syncerus Caffer), which could be considered as the natural reservoir 
of the virus. Overall, more than 40 BoHV-4 strains have been isolated across the world; these can be 
classified in three groups: the European strain (or Movar 33-63 like strain), the American strain (or DN599-
like strain) and the African Buffalo strains (Dewals et al., 2006).  
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1.2.1. BOHV-4 genome 
BoHV-4 genome has been completely sequenced: in 2001 the sequence of BoHV-4 North American strain 
66-p-347 was completed (Broll et al., 1999; Zimmermann et al., 2001) and more recently, in 2011 that of 
BoHV-4 European strain V-test (Palmeira et al., 2011). 
BoHV-4 as a typical herpesvirus B genome organization; its linear, double-stranded DNA of 144±6 kb 
consists of a long central unique region (LUR~110 Kb) with a low G+C content which is flanked by two 
stretches of tandem repeats with high G+C content (Fig.2). These stretches have been designated 
polyrepetitive DNA (prDNA); it has been demonstrated that the frequency of prDNA units at both genomic 
termini is different between individual molecules of different strains; but the overall numbers is relatively 
constant (Ehlers et al., 1985). 
Fig. 2. BoHV-4 genomic organization (the orange bars represent the 5 conserved blocks within the LUR; V1-V4 the variable 
regions between strains). 
 
BoHV-4 prDNA size varies from 1450 to 2850 bp according to the strains; each unit is formed by a repeated 
sequence of approximately 200bp at the 3’ of each unit (repeated 3 times completely and 1 partially), and 
the other of 25 bp at the 3’of the unit (repeated 2 times); in strain 66-p-343 there are 15 unit of prDNA 
(Broll et al., 1999). prDNA does not contain any typical coding sequences (Chang and Van Santen, 1992), 
but are important during viral DNA replication; the cleavage/packaging site necessary to cleave the viral 
concatamers formed during rolling circle replication and involved also in viral incapsidation are infact 
located at the 5’ and 3’ termini of each repeated unit of prDNA. These site are called pac 1 and 2 and have 
been individuated in all herpesvirus; pac-1 consists in a T-A rich region located near the left end of the 
region and pac-2 in a T motif near the right end; a 443 bp region in the prDNA is sufficient for cleavage and 
packaging of BoHV-4 genome (Broll et al., 1999; Palmeira et al., 2011). 
prDNA acts as a genome-size buffer, ensuring the packaging of a complete copy of the LUR f lanked by 
prDNA (Broll et al., 1999; Ehlers et al., 1985); in other gammaherpesvirus it has been demonstrated that 
prDNA can have also other functions: during latency should be an anchorage point for viral episomes to 
v-Bcl-2 v-FLIP
V3 V1 V2V4
LUR
prDNA prDNA
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host chromosomes (Fejer et al., 2003); moreover could contain an oriP latency-associated origin of 
replication, like in SaHV-2 (Collins et al., 2002).  
 
The LUR of BoHV-4 strain 66-p-347 consists in 108.873 bp, with a 41.4% G+C content, as determined trough 
shotgun analysis by Zimmermann et al, in 2001. Only 1% of CpG dinucleotide frequency is described in this 
LUR, confirming data recorded in other Gammaherpesvirinae (Zimmermann et al., 2001). V-test strain 
sequencing revealed a 108.241 bp LUR with a average G+C content of 41.21%; the overall nucleotide 
identity between the two strain is high to 99.1%, but shows a large variability at the genome level (Palmeira 
et al., 2011). 
The conserved gene of gammaherpesviruses are arranged in a common block organization, but there are 
individual differences in number, position and orientation of subgroup-specific or individual ORFs 
(Zimmermann et al., 2001). These common blocks are arranged in 5 blocks (1 to 5 in 5’-3’ direction), within 
each of them ORFs tend to have the same organization and orientation (Bublot et al., 1992; Bublot et al., 
1990). Blocks 1, 2 and 4 group genes “core”, conserved in all Herpesviridae, involved in viral capsid 
formation, in viral replication and in DNA encapsidation, but al so in capsid release from the nucleus. 
Probably these genes have been inherited from an ancestor, common to all herpesvirus; otherwise ORFs in 
blocks 3 and 5 group gene proper of gammaherpesvirus. There are some region called “inter-block” (from A 
to F in 5’-3’ direction), coding gene unique to one or few phylogenetically related species; often they code 
for gene of cellular origin (Lomonte et al., 1995; Raftery et al., 2000). Two regions of multiple direct repeats 
have been identified within the LUR, called R1 and R2. R1 consists of several stretches of several complete 
and incomplete direct repeats of 23, 25 and 65 bp in length; its length and sequence differ between the 
strains; R2 consists of two different repeat stretches, R2a and R2b. R2a consists of 28 perfect and 3 
imperfect direct repeats of 22-23 bp and R2b contains several different repeats from 8 to 68 bp in length as 
well as one inverted repeat with an hairpin-loop predicted structure. Interestingly R2 is connected with a 
notably change in G+C content: whereas R2a has a high G+C content of 71%, a 750-bp sequence stretch 
directly upstream of R2 has only a 30% G+C content. Analysis of positional homology and the fine mapping 
of BoHV-4 sequence have led to the identification of a putative Ori Lyt, mapping downstream of the G+C- 
rich R2a stretch, in the R2b region with the predicted hairpin-loop structure, partially overlapping with the 
gene Bo11 and Bo12. The sequencing of these regions in the V-test strain showed a high divergence, up to 
more than 40% as well as large gaps. The palindromic region forming a perfect hairpin-loop structure is 
conserved in V-test genome; even if the R2 region shows a high divergence the palindromic motif essential 
for viral replication and present in putative Ori Lyt is conserved; therefore this structure can represent a 
common secondary one used by all herpesvirus and need to be tested as a candidate for an essential Ori Lyt 
motif (Palmeira et al., 2011). 
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The analysis of BoHV-4 sequence revealed the presence of at least 79 ORFs, 62 homologous to that of other 
rhadinovirus, 17 unique to BoHV-4 (Fig.3). ORFs homologous to other herpesviruses have been named from 
ORF1 to ORF 79; so ORFs homologous in SaHV-2 and in BoHV-4 have the same name; otherwise those 
peculiar of BoHV-4 have been named from Bo1 to Bo17, according to their position in the genome from 5’ 
to 3’ end. Only Bo5 has a corresponding gene in SaHV-2. The central part of the LUR contains a stretch of 54 
genes with the same orientation (ORFs 16 to 69), within it there are only two genes without genetic but 
with positional and orientational homology to SaHV-2 (Bo9 and Bo10). In all other herpesviruses sequenced 
till now. Differences in the presence and/or position of ORF 16 (v-Bcl-2) and in the number of individual or 
subgroup-specific genes between ORF50 and ORF69 are observed. 
BoHV-4 genome in respect to those of SaHV-2 seems to lack a lot of genes involved in modulation of the 
immune response, in cellular growth and survival and in nucleotide metabolism, the majority of them in 
SaHV-2 are located in genomic region outside the conserved gammaherpesvirus blocks (Lomonte et al., 
1995). BoHV-4 have no genes coding for cytokines or cytokines receptor (while SaHV-2, HHV-8 and EHV-2 
have), for interleukine receptors (while SaHV-2, HHV-8, MuHV-68 and EHV-2 have), for chemokines or viral 
macrophage inflammatory protein (while HHV-8 have) (Lomonte et al., 1995). In this respect BoHV-4 
appears most comparable to AlHV-1, more than HHV-8 or SaHV-2 (Markine-Goriaynoff et al., 2003a and b). 
BoHV-4 moreover has not a gene coding for cycline D or for a complement regulatory protein and is also 
absent the gene for dehydrofolate reductase and for thymidilate synthetase, while are present both in 
SaHV-2 and in HHV-8. 
To date BoHV-4 has never been associated with lympho-proliferative disorders or with transforming 
capability classically associated to other gammaherpesviruses like HHV-8 or MuHV-68. BoHV-4 genome 
codes for two ORFs with a potential involvement in cell survival: a v-Bcl-2 (ORF 16) and a v-FLIP (ORF17) 
have been identified, they should have a role in prevent apoptosis, one of the early stage of cellular 
transformation; but it has been demonstrated that the virus can induce apoptosis at a late stage of 
infection in permissive cells (Sciortino et al., 2000). 
BoHV-4 contains 17 unique ORFs, without positional and sequence homologous in others herpesviruses, 
except for Bo5, as described above. Among these ORFs are seven that have never been described in 
literature: Bo1, -3, -6, -7, -12, -13 and -15. 
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Fig. 3. BoHV-4 genomic organization, not to scale, adapted from (Zimmermann et al., 2001). In Red are represented the ORFs 
common to all herpesviruses, in Blue those to β and γ; in Pink those to α and γ; in Brown those peculiar to γ herpesviruses. In 
yellow are the ORFs of γ2 herpesviruses; in black are the gene unique for BoHV-4, designed from Bo1-17. (R1/2 are the repeated 
sequences R1 and R2,ori is the Ori of replication; DPOL:Dna polymerase; dUTPase:dUTP nucleotide hydrolase; exo: 
exonucleotide alkaline; FGARAT: α-N-formylglycineamide ribonucleotide aminotransferase; gB/H/L/M, glycoproteins B, H, L and 
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M; LTP:long Tegument protein;MCP:major capsid protein; MssDBP:major single strand DNA binding protein; PK:protein kinase; 
RRs and RR1: ribonucleotide reductase subunity; TK: timidina kinase; UDG: uracil DNA glicosidase; v -Bcl-2: viral B cell lymphoma 
gene; v-FLIP: viral Flice inhibitory protein.  
 
 
ORF Bo4 and the spliced Bo5 are part of the Major Immediate Early I transcript (IE1), as described by Van 
santen; they exhibit partial amminoacid homology and may be involved in differential splicing (van Santen, 
1991). ORF Bo8 overlaps partially with the 1.7kb late gene, described by Bermudez-cruz et al (Bermudez-
Cruz et al., 1997).  
Bo10 encodes a non essential viral envelope protein, gp180, that regulates viral tropism; recently it was 
demonstrated that gp180 interacts with glycosaminoglycans (GAGs), hiding a critical cell-binding epitope on 
virions until displaced by GAGs (Machiels et al., 2011a). Machiels et al., developed two Bo10 mutant viruses 
that showed that gp180 is dispensable for establishment and maintenance of latency in vivo, but drastically 
reduced the susceptibility of BoHV-4 to neutralization by immune serum on various cell line; gp180 seemed 
to hide partially several epitopes on gB, gH and gL, providing a O-glycan shield able to hide these epitopes 
(Machiels et al., 2011b).  
Bo11 is encoded by a previously described IE2-transactivated, spliced, 1.1kb RNA (Bermudez-Cruz et al., 
1998); Bo17 encodes a viral β-1,6-N-acetylglucosaminyltransferase (β-1,6GnT), that is 81,1% homologous 
with the human one, involved in cellular differentiation and in immunitary processes. Interestingly, BoHV-4 
is the only virus in which this gene has been identified (Vanderplasschen et al., 2000). 
RNAs of six genes were experimentally demonstrated to be spliced; besides Bo5, Bo10 and Bo11, these are 
ORF29, 50 and 57. ORF29 encodes a terminase, and is present and spliced in all herpesviruses sequenced 
till now. The ORF50 product is a putative R transactivator, coded by the spliced IE2; the intron of the IE2 
transcript contains the complete ORF49, coding for a product of 299aa, conserved in other herpesviruses 
(van Santen, 1991, 1993). ORF57 codes for a putative post-transcriptional transactivator; in HVS is 
responsible for redistribution of the spliceosome complex, modulating mRNA processing in infected cells 
(Cooper et al., 1999). 
BoHV-4, as all other herpesviruses, possesses a Thymidine Kinase gene (TK), involved in pyrimidine 
metabolism, more precisely in the salvage pathway of pyrimidine biosynthesis (Lomonte et al., 1992). TK is 
encoded by ORF21 and is transactivated by IE2 gene product (Zhang and van Santen, 1995); its disruption is 
not incompatible with virus replication (Kit et al., 1986), and TK gene has been chosen as a target site for 
foreign DNA insertion in vectorializing strategies (Donofrio et al., 2008c). 
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1.2.2. BOHV-4 glycoproteins 
BoHV-4 particle has an icosaedric capsid, which is composed by 150 hexamers and 12 pentamers; the 
nucleocapsid has a diameter of 90-100 nm, and is surrounded by an n envelope, that usually contains the 
viral glycoproteins involved in attachment, penetration, budding and diffusion of the viral particle.  
In herpesviruses there are 5 glycoproteins extremely conserved in all herpesviruses: gB, gH, gL, gM and gN. 
In BoHV-4 29 polypeptides were identified, all of them present in the envelope are glycosilated (Dubuisson 
et al., 1989).  
 
 
Fig. 4. BoHV-4 particle as appear at electronic microscope adapted from (Machiels et al., 2011b) 
 
Four major glycoprotein have been studied: the first is the complex formed by gp6/gp10/gp17 
(150kDa/120kDa/51kDa); gp10-gp17 are bounded by disulfides bonds and gp6 by non covalent bonds. The 
heterodimer gp10-gp17 derives from the proteolitical cleavage of BoHV-4 gB gene product, conserved in all 
herpesviruses and essential for host cell penetration (Dubuisson et al., 1989; Goltz et al., 1994). The 
disruption of this gene is not compatible with virus life and replication, and usually the complementation 
with gB from even others gammaherpesviruses is not able to rescue the virus (personal data). Another 
complex studied is that formed by gp11/VP24 (120kDa/16,5kDa), in which gp11, that is glycosilated, is 
bound to VP24, not glycosilated, through a non covalent bond, at least six neutralizing epitopes were 
identified in this complex (Dubuisson et al., 1989). The third major glycoprotein of BoHV-4 envelope is gp8 
(135kDa), involved in heparin-like molecules contacting at the cell surface; this protein is poorly glycosilated 
and is present at both the viral envelope and in the culture medium (Egyed, 2000; Vanderplasschen et al., 
1993). Gp8 is a late protein and its secreted form can interferes with the immune humoral response of the 
host (Dubuisson et al., 1992); a lot of studies have demonstrated that the protein identified as gp8 in reality 
is another form of gp6/gp10/gp17 protein. The last major protein characterized is gp1 (>300kDa), a strictly 
late protein as described by Dubuisson et al. (Dubuisson et al., 1991). 
envelope
nucleocapsid
capsid
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Other BoHV-4 glycoproteins have moreover been described: gp21 (26-27kDa), described in the sera of 
infected animals; gp110, corresponding to the gH glycoprotein of the other gammaherpesviruses and gp31-
35 or gp45-65, corresponding to gL protein. gH is important for viral envelope fusion with host cell 
membrane and propagation between cells; gL has not still a so clarified role, but is clear that can associate 
with gH. A recent paper demonstrated that a gL deficient virus displayed a growth deficit associated with a 
default in virus entry; it impaired endocytosis and endosome migration; moreover a deficit in gL altered 
also gH glycosilation, clearing that there is a strict correlation between gH and gL (Lete et al., 2011). 
gM and gN are not so studied in gammaherpesviruses, and their function has never been determined; they 
can complex and maybe act in budding of virions in vivo. 
Bo10, as described before, codes for a gp180 glycoprotein , that is expressed as a late gene, incorporated in 
the virion and function as a non-essential structural protein for BoHV-4 replication in vitro (Machiels et al., 
2011 a, b). 
BoHV-4 does not present gD or gE homologous; glycoprotein D is the major immunogen of BoHV -1 and gE 
is used as a marker in vaccine against BoHV-1. As a matter of fact there are any antigenic relationships 
between BoHV-1 and BoHV-4, even because they belong to different subfamilies; BoHV-1 to alpha- and 
BoHV-4 to gammaherpesviruses.  
BoHV-4 shares instead some epitopes with AlHV-1, a gammaherpesvirus with whom it can also be observed 
a cross reaction in serology, maybe protective (Osorio et al., 1985). 
 
1.2.3. BOHV-4 in vitro  infection 
1.2.3.1. In vitro  host range  
BoHV-4 replicates in primary and immortalized cultures of bovine cells: in kidney, tests, lungs, skin, 
mammary gland, nasal turbinate, endothelial cells, B-T lymphocytes, macrophage-derived cells, histiocytes, 
thyroid, embryo tracheal primary cells, fetal bovine bone marrow, in lymphosarcoma calf thymus; also in 
different kidney’s continuous lines (MDBK for Madin Darby Bovine Kidney, GBK for Georgia Bovine kidney 
and BEK for Bovine Embryonic cells) or lung’s derived (EBL for embryonic bovine lung). BoHV-4 can 
establish persistent infection in bovine macrophage cells (BoMac) (Donofrio and van Santen, 2001). 
BoHV-4 can also infect cells from different origins: buffalo, sheep, goat, swine, cat, dog, rabbit, mink, 
turkey, ferret, horse, chicken rat, mouse and hamster (Bartha et al., 1966; Egyed, 2000; Markine-
Goriaynoff, 2003b). 
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Recent studies have demonstrated that BoHV-4 can infect human cells and that some human cells lines are 
sensitive or even permissive to BoHV-4 (Donofrio et al., 2000b; Egyed and Bartha, 1998; Gillet et al., 2004). 
The replication of the virus in a primary cell line of glioblastoma and in human cell lines MRC-5 and WI-38, 
from embryonic lung was evidentiated. A recombinant BoHV-4 expressing a resistance gene for neomycin 
has established a persistent infection in RD4 (Rhabdomyosarcoma cells 4 line) cells, under the selective 
pressure of neomycin (Donofrio et al., 2000b). 
These observations led to the hypothesis that cross-species transmission of BoHV-4 could lead to human 
infection: BoHV-4 has infact a high prevalence in cattle population and no eradication scheme is directed 
against this virus; is frequently isolated from bovine serum as well as in the milk of cows affected by 
mastitis or apparently healthy, making possible the transmission of virus to human trough a lot of 
transmission route. To date there are no reported cases of human infection with BoHV -4. Scientists 
demonstrated that human serum neutralizes efficiently BoHV-4 through activation of complement by 
natural antibodies raised against host cell derived epitopes expressed on the virion surface , such as the 
Galα1-3Gal epitope (Machiels et al., 2007).  
The ability of BoHV-4 to infect human cells has also investigated to address the potential of BoHV-4 
recombinant strains for viro-oncolytic treatment of human cancer. BoHV-4 can induce apoptosis in vitro in 
some human carcinoma cell lines, A59 and OVCAR, through a pathway involving caspase 10 activity (Gillet 
et al., 2005b). Recently a work was published in which, a BoHV-4 vector armed with HSV-1 TK gene, was 
able to reduce glioma in mice and rats (Redaelli et al., 2011; Redaelli et al., 2010). 
The fact that BoHV-4 can infect such a broad host range, in contrast to other gammaherpesviruses, is 
probably related to the interaction of virus with host cell heparan-like structures as a first contact 
(Vanderplasschen et al., 1993). Heparan-like proteins are infact present on the surface of the majority of 
vertebrate’s cells, and this explains why BoHV-4 has a so wide host range. 
 
1.2.3.2. Viral replication in vitro   
Kinetics of virus production extra- and intracellular show that BoHV-4 is a cells-associated virus with a slow 
growth (Storz et al., 1984). Its replication and the synthesis of late protein is restricted by DNA Synthesis 
Dependence on the S phase of the cell cycle; moreover the slow replicative cycle could be due to its slow 
rate of thymidine kinase induction in infected cells (Kit et al., 1986); BoHV-4 does not induce a host cell 
shut-off, allowing cell to go through the S phase (Vanderplasschen et al., 1995).  
Cythopatic effect (CPE) appears usually in infected cells 48 to 72 hours after infection and is characterized 
by rounded cells, dispersed in the monolayers, without formation of classical plaques. 
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The expression of herpesvirus proteins is temporally regulated. The proteins are classified into three kinetic 
classes depending on the order of their synthesis during in vitro infection. They are chronologically 
expressed as immediate early (IE or alpha), early (E or beta) and late (L or gamma) proteins. Immediate 
early proteins are expressed directly after release of the viral genome from the capsid into the nucleus. 
While E protein expression occurs after synthesis of the IE protein, L protein expression depends on the 
expression of both IE ad E protein and viral DNA synthesis.  
Herpesvirus can establish two different types of infection: productive or latent infection. Typically cells 
infected by either alpha- r beta- herpesviruses support lytic replication, while only specific subsets of cells 
normally harbor latent virus. Gammaherpesviruses seem to initially favor the establishment of latency, 
while only  a subset of cells supports  lytic replication (Ackermann, 2006). 
 Productive infection: BoHV-4 binds to the host cellular surface through the weak interaction 
between gB and heparan sulfate-like structures; it is not clarified if are involved other interactions 
for a stable attachment to the host cell, and if there is a specific receptor for BoHV-4. 
Immediately after the attachment, the envelope fuses with the plasma membrane, and the 
nucleocapsid and the envelope protein are released in the cytoplasm and transported to the 
nucleus through the interaction with microtubules. Viral DNA is released into the nucleus passing 
through a nuclear pore; then circularized without synthesis of new DNA. Three classes of genes 
have been individuated, differentially expressed during the time: α or IE genes; β or E genes and γ 
or L genes (Chang and Van Santen, 1992). After the circularization of DNA in the nucleus some 
proteins of the envelope interact with the host cell transcriptional machinery to stimulate the 
transcription of IE genes by the host RNA polymerase II. IE1 and IE2 proteins are the two major 
immediately early proteins of BoHV-4, are produced in the cytoplasm and migrate to the nucleus 
where they block the expression of IE gene and activate the one of E and L genes. E genes are 
expressed at the major level from 4 to 8 hours after the infection; they work in the metabolism of 
nucleotides and in DNA replication. Between gene γ, we distinguish γ1, or partial late and γ2, real 
late. γ1 expression is amplified by viral DNA synthesis, and γ2 is totally dependent by viral DNA 
synthesis. γ proteins are produced in the cytoplasm and represent the majority of structural 
protein, which can migrate to the nucleus where they assemble in the new forming capsids.  
Viral DNA circularized in the nucleus and replication starts from the Ori of replication and proceeds 
with the rolling circle mechanism that produces a lot of viral concatamers, complex structure 
composed by genomic units disposed head to tail. These replication intermediates are cleaved and 
packaged in genomic unit in the new capsid. The new-formed capsids are then transported to the 
periphery of the nucleus, passed through the lumen of endoplasmic reticulum where they probably 
acquire some protein of the envelope but it is still not so clear how the capsid exit from the nucleus 
16 
 
and acquire the envelope. Two models have been proposed to clarify this process: the first is the 
luminal model, that hypotheses that full capsids embedded with viral DNA could acquire the 
envelope through passing the nuclear membrane and the ER; in this case the proteins composing 
the envelope will be the precursors of the final proteins. Enveloped capsids then arrive to the Golgi 
passing through the connection intra ER and Golgi or transport vesicles. The precursor proteins will 
then modified at the surface of the virion and the virions released by exocytose. The second model 
is based on the fusion of the virion envelope with the nuclear membrane and then to the ER 
membranes to release free capsids in the cytoplasm; then passing through the Golgi’s vesicles 
acquire the final envelope. 
Recently it was demonstrated that BoHV-1 capsids arrive to the cytoplasm through some nuclear 
pores, then reach the cellular surface passing in the Golgi’s vesicles (Wild et al., 2005). 
The lytic cycle in gammaherpesviruses is initiated only on rare occasion; the least contribution to 
pathogenicity has to be expected from this stage. In BoHV-4 are known three transactivating 
proteins, transcribed from immediate early genes that initiate the lytic cycle. Two of them are 
encoded by conserved open reading frames: ORF50 (Rta/IE2 protein) and ORF57 (Mta/IE1), and the 
third by a non conserved gene: Bo4/5. Promoter activation by these protein has also a strong effect 
on DNA synthesis from the Ori of lytic replication; as a result, virions are generated and released 
from the productively infected cells (Ackermann, 2006). The typical inclusion bodies appear in the 
cytoplasm 48 to 72 hours after the infection and are composed by viral particles at different stages 
of maturity, with capsids empty or full, enveloped or not; in the eighty’s that was considered a 
proof that BoHV-4 was a bovine cytomegalovirus, because of its similarity with HCMV (Storz et al., 
1984). 
 
 Latent infection: all the herpesviruses can give raise to latency state; apparently the default 
pathway used by the gammaherpesviruses will most often proceed with the establishment of 
latency instead of the lytic state (Ackermann, 2006). There is no common pattern of gene 
expression required for establishment, maintenance, and reactivation of latency. Some 
herpesviruses synthesize a lot of protein during latency, while others do not synthesize any. In 
rhadinoviruses the latency is characterized by the combination of viral sequences required for 
genome maintenance and genes that mediate cell survival by affecting signaling pathways and 
manipulation of the immune response (Field et al., 2003). Generally latency consists in the absence 
of virus replication or very low levels of it. The beginning of a latent infection is in common with 
lytic one; when the viral DNA arrive to the nucleus it does not start the classical amplification of 
signal through the transcription of alpha and beta gene; however it seems that a weak level or 
transcription of alpha and beta can occur, but it is not enough to start a lytic cycle. During latency 
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the viral genome persists in the nucleus as an episome, a circularized form of viral DNA. In 
rhadinoviruses during cell division episomes are distributed to the new formed cells thanks to the 
protein LANA (latency associated nuclear antigen, coded by ORF73) or its orthologues. LANA binds 
the cellular chromatin with its N-terminal and interacts with different sequences in prDNA with its 
C-terminal. In this way it starts the viral replication and is also permitted the anchorage of episome 
to cellular chromosomes. In BoHV-4 ORF73 deletion does not affect the virus replication in vitro, 
but affects virus persistence in vitro in cells persistently infected, and prevented latent infection in 
vivo in a rabbit model (Thirion et al., 2010). 
Recently Donofrio et al. have demonstrated that in RD4 and BoMac cell persistently infected with a 
recombinant BoHV-4 carrying the neomycin-resistance gene and drug selected with geneticin, the 
viral DNA can exist as an episome or can be integrated in the cellular DNA, at random sites. Further 
studies are required to corroborate if the integration occur also in vivo and to verify if it is random 
or in specific chromosome loci (Donofrio et al., 2010a). 
 Susceptibility and permissiveness: generally the host range of a virus is de termined by the 
susceptibility and permissiveness of the cells targeted; classically gammaherpesviruses are 
considered to have a very narrow host range. BoHV-4 is convenient to study because has the ability 
to replicate in vitro in a wide range of cultured cells of different origins. A cell is defined susceptible 
when possesses on its surface the receptor required for virus attachment and entry; a susceptible 
cell became a permissive one if support a complete cycle of productive infection. Two types of non-
productive infections have been described: the latent infection that can be reactivated from 
different exogenous stimuli in a productive infection; and the abortive one, in which the viral 
replication is irreversible blocked, that can evolve to cellular death or to a totally unapparent 
infection. Non permissive infection of human cells by BoHV-4 was indeed observed (Gillet et al., 
2004); and the overexpression of Immediate Early protein 2 (IE2) was able to induce virus 
replication in non-permissive cell lines (Donofrio et al., 2004a). 
 
1.2.4. BOHV-4 In vivo  infection 
1.2.4.1. In vivo  host range  
In contrast to other gammaherpesviruses, that have a restricted or preferential host, BoHV-4 has been 
isolated in several animals.  
The widespread distribution of BoHV-4 in cattle (Bos Taurus and Bos indicus) populations justified the fact 
that the bovines species is considered the natural hosts; hence the nomenclature of the virus. The virus has 
been isolated in a variety of ruminants, other than the cattle: in African buffalo (Syncerus caffer) has a high 
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prevalence (Rossiter et al., 1989), higher than that observed in cattle, suggesting that maybe the African 
buffalo can be the original host species for BoHV-4, and that other species, including domestic cattle, may 
have acquired the virus more recently (Dewals et al., 2006).  
BoHV-4 has also been isolated in the American bison (Bison bison) and in zebus (Bos indicus)(Moreno-Lopez 
et al., 1989); sheep and goat are sensitive to BoHV-4 infection, but there are not a lot of data about wild 
ruminant. 
The virus has been isolated in felines too: in lions (Egyed et al., 1997), and in a cat suffering from urolithiasis 
(Fabricant et al., 1971); felines are very far from phylogenetical point of view from cattle, but they feel to 
be sensitive to the virus. Experimental infection of cats with BoHV-4 gave different results depending on 
the strain used, maybe because of the adaptation that occurs between virus and host (Thiry et al., 1990). 
The same virus isolated from the lion was inoculated in new born cats and caused severe pathologies, 
varying from conjunctivitis to pneumonia , often with a lethal prognosis (Egyed et al., 1997). It is not clear 
how the virus can have infected for the first time felines: in reality there could be a strain circulating and 
adapted to felines or a contamination with infected biological materials. BoHV-4 has infact been isolated in 
fetal bovine serum, used as a supplement for culture medium and also in formulation of a lot of substances, 
opening the problem that contamination can be the leading trail for BoHV-4 infection in species not 
naturally susceptible, as felines or maybe humans. 
Simian herpesvirus aotus 2, isolated from the kidney of an apparently healthy owl monkey (Aotus 
trivirgatus), was proven to be a BoHV-4 strain (Bublot et al., 1991). In monkeys this virus is neither 
pathogen not oncogenic, and a high prevalence has been demonstrated, such as 42%, but it is not clear if 
this virus can give experimental infection and if these data are real or coming from a contamination or the 
circulation of a primate herpesvirus that is not yet identified. This monkey isolate replicated in different 
monkey’s cell lines from kidney, intestines and lung, as in rabbit cells and goat cells, where CPE and 
inclusion bodies were observed. No CPE was seen in a primary culture of whole embryo cells (Barahona et 
al., 1973). 
An herpesvirus related to BoHV-4 could circulate between exotic animals such as Asian elephants (Elephas 
maximus), that presented antibodies against BoHV-4 (Metzler et al., 1990) and in black rhinoceros (Diceros 
bicornis), in which a DNA polymerase strictly related to that of BoHV-4 was identified. 
Other species are susceptible to BoHV-4 infection, even if the virus has not been isolated in field conditions; 
these species are considered experimental animals to study this virus. A model studied was the lapin, 
considered a good model to study BoHV-4 biology (Egyed, 2000; Egyed and Baska, 2003; Egyed et al., 1997; 
Lin et al., 2000).  
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Experimental inoculations of BoHV-4 in hamster, rats and chicken have produced no clinical signs (Gibbs, 
1977). As a model to study BoHV-4 pathogenesis was chosen the rabbit, that successfully support the 
infection with BoHV-4; lymphoid organs were the site for viral replication and/or persistence; the virus was 
infact isolated from conjunctival swabs and spleen, but during latency also in bone marrow, lung, kidney, 
salivary glands and liver with a low titer (Osorio et al., 1982).  
Recently we reported the use of transgenic mice, like IFNAR -/- mice (knockout for IFN alpha and beta 
receptor) that showed no clinical signs of infection and support virus replication in  selected organ, as 
spleen and lymph nodes (Franceschi et al., 2011). 
 
1.2.4.2. Clinical  signs and pathologies  
BoHV-4 has been isolated from cattle suffering from a lot of different diseases and from healthy cattle. 
Although a possible role in respiratory and genital tracts infections has been reported and the virus has 
been isolated from several clinical conditions of cattle, experimental inoculation of most of the isolates of 
BoHV-4 in cattle and in laboratory animals do not produce clinical disease. The pathogenic role of this virus, 
therefore, is still not defined. 
Various conditions from which BoHV-4 has been isolated are: 
a) Ocular and respiratory diseases: the virus was firstly isolated in an animal suffering from 
keratoconjunctivitis (strain Movar 33/63) and from respiratory illness, characterized by nasal 
discharge, cough, dyspnoea and pulmonary lesions (Strain DN599) (Bartha et al., 1966; Mohanty et 
al., 1971). Intranasal and intratracheal inoculation of BoHV-4 reproduced the majority of symptoms 
and led to death some calves (Mohanty et al., 1972), the role of virus in this study remains unclear 
because even Pastorella multocida was isolated in some cases of this experiment. In other cases 
the inoculums of BoHV-4 resulted only in mild respiratory symptoms. 
 
b) Genital diseases (orchids, vaginitis, aborts, and metritis): since from the Eighty’s several BoHV-4 
strains were isolated in Africa in animals showing symptoms of the “epivag” syndrome : the bullets 
showed epididymitis and the calves vaginitis, post partum metritis and abortion. Inoculation of 
virus isolated from a metritis in fetuses caused the death of two fetuses at 3 and 4 month of 
gestation, showing lymphoreticular activation in the lung and in the lymph nodes (ParK and 
Kendrick, 1973). 
BoHV-4 has been also isolated in case of abortion, in association with Bovine Viral Diarrhea Virus 
(BVDV) (Reed et al., 1979). Association of BoHV-4 with other pathogens in cases of abortion has 
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been consistently reported in the past although the role of this association is not yet fully 
understood. BoHV-4 has been associated with metritis, especially post-partum metritis, with or 
without peritonitis. 
 
c) Mastitis: the virus has been isolated in case of mastitis and was detected in the cellular fraction of 
milk (Donofrio et al., 2000a). The experimental intranasal and intra-mammary inoculation has 
reproduced in several cases a subclinical mastitis (Wellenberg et al., 2002), but it is common 
though that BoHV-4 is not the causative agent of mastitis, but only a secondary pathogens. 
 
d) Skin lesions (lumpy skin disease, mammary pustular dermatitis): BoHV-4 has been isolated from 
skin lesions, ulcerative mammilitis, or mammary pustular dermatitis. When experimental infection 
was attempted with a BoHV-4 isolate recovered from a case of mammary pustular dermatitis, a 
febrile response was observed; in another study intradermal inoculation in the udder produced 
vesicular lesions but no definite role of BoHV-4 could be assessed (Osorio and Reed, 1983). 
 
e) Enteric diseases: DN599 strain was isolated from the feces of an adult cow with diarrhea, no other 
bacteria or parasites were found; however experimental inoculation failed to reproduce enteric 
symptoms in cattle (Eugster, 1978/1979). Another strain has been detected in samples from a 
tumors of the urinary bladder and rumen (Kaminjolo et al., 1972). 
 
f) Other pathologies: several strains of BoHV-4 have been isolated in animals with different 
pathologies and clinical signs: neoplastic diseases as lymphosarcoma, ocular carcinoma, T cell 
lymphoma and some others (Anson et al., 1982; Kaminjolo et al., 1972; Toho, 1985). 
 
1.2.4.3. BOHV-4 Pathogenesis  
The natural infection probably occurs by direct contact through the genital or the respiratory route and the 
respiratory and alimentary tracts, by inspired air or by the swallowing of virus aerosol or virus -infected 
cells. The virus replicates in epithelial cells of the intestines, larynx, trachea and bronchioles, causing slight 
catarrhal symptoms and fever. From the apparently healthy animals the virus is continuously detected from 
the blood leukocytes, spleen and lymph nodes for months (Osorio et al., 1982). BoHV-4 is normally isolated 
from upper respiratory tracts, and from genital tracts; if nasal transmission has been proven experimentally 
(Dubuisson et al., 1989), genital transmission is not yet totally understood. Recently a work by Egyed et al. 
demonstrated the intra-uterine transmission of virus between cows and fetus; viral genomes were 
recovered from semen cells and from spleen of stillborn calves (Egyed et al., 2011).  
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In general, the diseases that result from infection with BoHV-4 appear to be consequent of cell destruction 
resulting from virus replication in mononuclear blood cells. In immunologically weakened host BoHV-4 can 
cause an organ specific, lytic infection; it is possible that the virus enters the body via the oronasal route, 
multiplies in the mononuclear cells and disseminates in all the body via these cells. 
Primary multiplication of the virus usually occurs at the entry site, then virus multiplication occurs  in 
peripheral blood leukocytes, in the monocity/macrophage lineage, and the virus is disseminated in the host 
by these cells. The presence of viral DNA in blood of infected animal is detectable 10 to 30 days after the 
infection (Egyed et al., 1999), viremia is not always detectable and can re-appear at different times. Also 
endothelial cells are sensitive of BoHV-4 infection, probably the virus spread from the mononuclear blood 
cells to the endothelial cells, opening the route to infect tissues and organs. 
The virus preferentially replicates in conjunctiva, upper respiratory tract mucosa, and genital mucosa, 
resulting in ocular, nasal and vaginal excretions; these tissues can be considered the primary and secondary 
multiplication sites for BoHV-4.  
In experimentally infected rabbits BoHV-4 actively replicates in the spleen and also in the macrophages; 
splenic macrophages can be the site of both acute and latent infections; identification of BoHV-4 in non-T, 
non-B cells located in the marginal zone of the spleen of persistently infected cattle and rabbits have 
implied that cells of the monocytes/macrophage lineage are a site of persistent BoHV-4 infection (Osorio et 
al., 1982; Osorio et al., 1985). 
After the first infection BoHV-4 establishes a latent infection, as all the other herpesviruses. Different 
tissues have been proposed to be the site of latency: nervous system, lymph nodes, amygdale, upper 
respiratory tracts, lungs, bone marrow, conjunctives, bilious vesicles (Boerner et al., 1999). Splenic 
mononuclear cells (macrophages) could be the main site for viral persistence (Lopez et al., 1996); nervous 
tissues were also considered as sites of viral latency, although the rol e of the nervous system in acute and 
latent BoHV-4 infections is still questionable. Several studies have tried to verify if nervous system is a 
possible site of latency, but no clear data were acquired. Asano et al. recovered the viral genome in animals 
euthanized more than one year after the experimental infection; specifically in lymph nodes and medulla, 
spinal cord and trigeminal ganglion, supporting that even the nervous system may be a latency site (Asano 
et al., 2003). 
Lymphoid organs and mononuclear blood cells have been suggested as the sites of viral latency in cattle 
because the virus was recovered from co–cultures and organ explants of spleen from latently infected 
cattle (Castrucci et al., 1987a). The association of BoHV-4 with the lymphoid organs and a prolonged 
viremia associated with the mononuclear cells, with consequent permanent transport through lymphatic 
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and haematogenous routes for long periods of times, may explain the reason for the recovery of virus from 
diverse tissues and syndromes (Osorio and Reed, 1983). 
Donofrio et al. demonstrated that BoHV-4 can establish a persistent infection in vitro in a bovine 
macrophage cell line (BoMac) (Donofrio and van Santen, 2001). 
External stimuli, natural as the parturition, or experimental as dexamethasone treatment, can reactivate 
BoHV-4 from latency. Then the virus can be re-isolated from nasal secretion, mononuclear blood cells, and 
bone marrow cultures (Dubuisson et al., 1989). 
 
1.2.5. BoHV-4 correlates with post-partum metritis  
Half of all dairy cattle after parturition suffer from uterine microbial diseases often cause of infertility by 
disrupting uterine and ovarian function; metritis is defined how the uterine disease that appears usa lly 
within one week and 21 days after parturition, but is most common within 10 days, and is present in the 
40% of cows (Sheldon et al., 2009). Metritis is characterizedb by an enlarged uterus with a red-brown, 
watery and fetid fluid to viscous off-white purulent uterine discharge; grade 1 metritis show no systemic 
symptoms, while grade 2 experienced decrease in milk yeald, dullness anf fever; and grade 3 signs of 
toxemia such as inappetance, cold extremities, depression and/or collapse, with a poor prognisis. 
The most prevalent bacteria isolated from the uteus lumen of cattle suffering from uterine diseases, are 
Escherichia coli and Arcanobacterium pyogenes, followed by some anaerobic bacteria such as Prevotella 
species, Fusobacterium necrophorum and nucleatum. 
BoHV-4 was isolated for the first time in a metritis case in 1973 (ParK and Kendrick, 1973) and to date is the 
only virus usually associated with uterine diseases in the post-partum period in cattle (Ackermann, 2006; 
Thiry et al., 1992); Monge et al. reported that there is a clear association between BoHV-4 infections and 
acute post-partum metritis in dairy cows, and that BoHV-4 associated post-partum metritis appeared to be 
an emerging syndrome, even because often be refractory to antibiotic treatment (Monge et al., 2006). 
Wellemans et al. demonstrated the strict correlation between BoHV.4 and post-partum metritis: they 
inoculated several cattle with the virus and all cows developed ulcerative post-partum metritis (Wellemans 
et al., 1986); a recent paper reported that 15/22 cows affected by metritis were BoHV-4 positives, but that 
they recovered clinically and the course of metritis was not severe after a early and prolonged treatment 
with antibacterial and PGF2α (Nak et al., 2011). 
BoHV-4 is highly tropic for endometrial stromal and epithelial cells, led to non-apoptotic cell death and de 
novo viral production associated with increased cyclo-ossigenasi 2 synthesis (COX-2) and stromal cell 
prostaglandin-endoperoxide synthase 2 (PTGS2) protein and stimulated prostaglandin E2 (PGE) secretion 
(Donofrio et al., 2007a; Donofrio et al., 2008b). Post-entry events are responsible for BoHV-4 successfull 
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replication in bovine endometrial cells, with quick viral reconstitution following the electroporation of nude 
viral DNA into endometrial stromal and epithelial cells (Donofrio et al., 2007a; Donofrio et al., 2008b). 
The high efficiency of BoHV-4 replication in endometrial cells was associated with strong transactivation ot 
the IE2 gene; on IE2 promoter was also identified a putative endometrial specific TATA box; furthermore, 
BoHV-4 IE2 gene promoter transactivation and viral replication were associated with extracellular stimuli 
belonging to the intrauterine microenvironment such as E. coli, LPS and PGE (Donofrio et al., 2005). BoHV-4 
replication was also reactivated in latently infected macrophages by stromal cells in co-cultivation 
(Donofrio et al., 2007a; Donofrio et al., 2008b). A model for endometrial BoHV-4 disease was proposed, 
where viral particles infecting the endometrium, could stimulate PGE production and establish a positive 
feedback loop between PGE production and viral replication, which causes further endometrial tissue 
damage and inflammation (Donofrio et al., 2005; Donofrio et al., 2007a; Donofrio et al., 2008b). 
Bacterially induced metritis in cattle persistently infected with BoHV-4 could be exacerbated or become 
chronic after the recruitment of macrophages, that are the site for BoHV-4 latency, from the blood stream 
to the site of inflammation; because opportunistic infection can increase PGE production, it is supposed to 
have a correlation between opportunistic infection of the uterus, PGE2 production and BoHV-4 replication, 
with the generation of a loop system involved in generating and exacerbating uterine e diseases. 
The chemokine Interleukin 8 (IL-8) is involved in the recruitment of granulocytes, such as macrophages and 
neutrophils, in the site of Infection; it is stated that endometritis is associate with an increased IL8 mRNA 
expression in the endometrium, and that the intrauterine infusion of the chemokine, can reproduce the 
disease (Zerbe et al., 2003). A recent study confirmed that IL-8 is constitutively expressed and secreted in 
bovine endometrial stromal cells (BESC) and that the induction of IL-8 in BoHV-4 infected cells is mediated 
by Orf50/Rta at the transcriptional level, leading to the identification of a Rta responsive element on IL-8 
promoter (Donofrio et al., 2010b). These observations may represent an endometrial defence mechanism 
against viral infection or a virulence mechanism by which viral replication stimulates a chemokine to attract 
more susceptible host cells to the endometrium; targeting chemokines and/or their receptor might provide 
a successful therapeutic approach. 
Based on this in vitro knowledge, it appears evident that the existence of a patho-biotype of BoHV-4 
causing uterine disease, can not be ignored. 
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1.2.6. Immune response to BOHV-4  
After BoHV-4 infection in cattle a weak or null production of serum neutralizing antibodies can be 
observed; high titre of anti-BoHV-4 can be identified through indirect immuno-fluorescence test (IFI) 
(Castrucci et al., 1987a; Castrucci et al., 1987b; Storz et al., 1984). When a response is detectable, serum 
neutralizing antibodies (SNA) appeared from 22 to 34 days after the first infection; addiction of 
complement increases the titre and enables SNA to be detected earlier and with higher titles after 
infection. It is not clear if the weak humoral immune response is because of the strong cell association of 
BoHV-4 which may result in minimum exposure of the virus to the immune system.  
The role of BoHV-4 in cell-mediated immunity has not yet been investigated; Mohanty et al. reported the 
absence of antibodies in BoHV-4 infected calves but, when challenged with the virus 8 weeks after the 
primary infection, the surviving calves were found to be immune to the virus (Mohanty et al., 1972). 
Serum-neutralization test is not used to detect the virus in infected animal because has been demonstrated 
that the domains responsible for virus attachment and penetration are not so accessible to monoclonal 
antibodies. Instead other techniques as IFI or ELISA are able to detect a seroconversion from 14 to 20 days 
after the primary infection (Dubuisson, 1987; Osorio and Reed, 1983). 
Since the immune system plays a key role in protection against infection, viral damage to its components 
can exacerbate the severity of disease or predispose the animal to super-infection with other viral or non-
viral agents. Viral replication may lead to temporarily suppressed humoral and/or cell-mediated immune 
response. Some viruses have as preferential target the immune cells, as Marek’s disease and BVDV. 
Similarly, BoHV-4 is associated with mononuclear blood cells and lymphoid tissues both in acute and latent 
infections which may have implications for the regulation of humoral and cellular immune responses in 
cattle (Osorio et al., 1985). Similar information about BoHV-4 pathogenesis is not yet available. 
 
1.2.7. BoHV-4 Diagnosis and prophylaxis 
Not many tests are available for the detection of BoHV-4 or its antigen in fluids and tissues of infected 
animals. Several tests have been standardized to determine the level of BoHV-4 specific antibody in serum 
samples. Isolation of BoHV-4 has been successfully determined from different clinical specimen by using 
conventional cell culture inoculation and/or co-cultivation of infected cells with susceptible cells and organ 
explantation, and then analyzed by Immunofluorescence. 
Complement fixation, dot-immunoblotting assay, virus neutralization, Immunofluorescence (IFAT) and 
ELISA tests have been used for serological studies (Naeem and Goyal, 1990); IFAT and are used extensively 
and a good correlation between this two tests has been demonstrated; the seroconversion indicates that a 
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primary infection, a re-infection or a reactivation is in course. Later during the infection also the 
complement-dependent neutralization can be successfully used, even if the virus elicits a poor neutralizing 
antibody response. A recent study has demonstrated how a serum neutralization test can be very effective, 
in animal immunized with a recombinant BoHV-4, deleted in Bo10 gene, responsible for hiding the serum 
neutralizing epitopes of gB and gH/gL (Machiels et al., 2011b). 
The viral genome can be detected by specific PCR, with primers designed over BoHV -4 selective sequences 
as the gB (Boerner et al., 1999), the thymidine kinase (Egyed et al., 1996; Egyed and Bartha, 1998; 
Wellenberg et al., 2001); even the in situ ibridization, combined with PCR data was used to assess the 
presence of BoHV-4 genome (Egyed et al., 1997). 
Restriction analysis can also be utilized to characterize different BoHV-4 isolates for diagnostic or 
epidemiological purposes, is infact described a distinct difference between the patterns of different 
herpesviruses (Ludwig, 1982).  
Since the aetiopthologic role of BoHV-4 has not yet fully understood, no attempt has been made to develop 
a vaccine. Castrucci et al. observed a variation in the pathogenic potential of several isolates (Castrucci et 
al., 1987a; Castrucci et al., 1987b), indicating that it might be possible to develop a vaccine by using one of 
the non-pathogenic isolates as a vaccine. In America have been developed some vaccines against BoHV-4, 
but it is clear that control of BoHV-4 infection will be provided only by hygienic measures; trough the 
identification of latently infected animals and the physical separation with serum-negative animals. The 
serum-positive cows that are in the post-partum period have to be controlled in a particular way, because 
they can excrete a lot of virus, for long period in the uterine exudates (Thiry, 2000). 
 
1.2.8. BoHV-4 as a vector  
Several characteristics made BoHV-4 attractive as a vector: (i) its ability to establish a persistent infection, 
both in the natural host, the cattle, and in the experimental host, the rabbit, (ii) to maintain the viral 
genome as an episome in the cell host , (iii)  the lack of oncogenicity, (iv) the possibility to delete even the 
30% of the viral genome without consequence on the viral replication and so, (v) the huge capacity to 
transport exogenous DNA, (vi) the free access to the complete genome sequence of two different isolates 
types and (vii) the possibility to easily manipulate its genome as a Bacterial artificial chromosome (BAC). 
Moreover BoHV-4 has to date no clear disease correlation (an exception has to be done for the correlation 
as a secondary pathogen in uterine diseases) and can be isolated from a variety of samples and tissues from 
different species of animal; it is also able to replicate in vitro and cause CPE in a number of primary cell 
cultures and immortalized cell lines. 
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The possibility to manipulate BoHV-4 as a BAC has led the way to generate recombinant viruses able to 
target exogenous antigenic protein for vaccinal purposes or therapeutical agents for cancer treatment. 
For example the potential of BoHV-4 for the treatment of glioma has been investigated. The suitability of 
BoHV-4 as a vector was first evaluated in vitro, using the rat glioma F98 cell line and then in vivo, injecting 
the virus into rat brains. In F98 cells the virus was able to induce cell death by non-apoptotic way but, in 
vivo, showed a non permissive behavior, because the virus did not spread through the cerebral parenchyma 
and not cause clinical signs. The ability to establish permissive infection in cultures of glioma cells, and the 
absence of pathogenicity in the rat brain, make the virus an ideal candidate as a gene delivery or oncolityc 
vector for gliomas (Redaelli et al., 2008). BoHV-4 showed also the capability to infect selectively gliomas 
induced in the rat brain in vivo; a recombinant virus, expressing an enhanced green fluorescent protein 
(EGFP) was able to infect the glioma cells and was also confined to the tumor cells, being safe for the 
nervous system (Redaelli et al., 2010). 
Taking into account these data a new recombinant virus was generated, that expressed the thymidine 
kinase gene of HSV-1 (TK-HSV-1) and was used to target glioma cells growing in the brain of mice and rats. 
After the injection of the virus in the brain, the animal were treated with ganciclovir, that selectively targets 
the glioma cells because can be converted in a toxic agent by the thymidine kinase gene product. BoHV-4 
used as an oncolityc virus has led to a highly reduction of the gliomas in the mice, but especially in the rats, 
with no consequence on nervous system cells, implying that BoHV-4 is a good candidate to be used as a 
vector for cancer treatment in the nervous system (Redaelli et al., 2011). 
BoHV-4 has also been tested for vaccinal purposes: Donofrio et al., infact have explored the potential to 
target the antigenic protein of different viruses as BVDV (Bovine Viral Diarrhea Virus) or BoHV-1 (Bovine 
Herpesvirus 1), respectively gE2 and gD, to generate serum-neutralizing antibodies. A fusion peptide, 
obtained by the fusion of the ectodomain of the gE2 protein and the ectodomain of the gD protein, 
deprived of the signal peptide, but with the trans-membrane domain, was generated and tested in several 
different animal species, varying from rabbits, swine, goats and sheep; in every cases good title of serum-
neutralizing antibodies were obtained, against the two protein both. These data have to be supported and 
validated through challenge experiments that have to be planned (Donofrio et al., 2009b). 
Another study focused about the generation of a vector for Bluetongue vaccination: the VP2 protein of the 
serotype 8 of Bluetongue Virus (BTV-8) was used to create a recombinant BoHV-4, that was experimented 
to vaccinate transgenic mice IFNAR-/-, then exposed to a challenge with a lethal dose of BTV-8. Only the 17% 
of the animals survived the challenge, showing that a partial protection has been achieved, all the animals 
showed moreover a delay in the clinical signs and in the blood viremia; probably this vector have to be 
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hampered combining the expression of more than one antigenic protein, such as VP7 and NS1 (Franceschi 
et al., 2011). 
The feasibility of BoHV-4 as a vector for vaccination has also been tested in chicken; although the virus was 
able to replicate, leading to CPE effect in a chicken fibroblast cell line (DF-1) and can infect chorion allantoic 
membrane of embryonated eggs, it did not replicate and was not pathogenic, even at very high dose, in 
chickens, even if a good humoral immune response was achieved against the antigen carried on by the 
virus, suggesting that can be a good candidate for chicken vaccination (Donofrio et al., 2008a). 
 
1.3. BAC as a tool for herpesvirus genetics  
To date the complete sequence of the genome of many herpesviruses has been determined, but the 
precise function for many of the viral gene, both in vitro, and in particular in vivo, has not fully elucidated; 
this knowledge is important not only to understand their role in pathogenesis, but also to study them as 
potential therapeutic target, and even for the rational design of new vaccines. 
The disruption of herpesvirus genome is usually achieved by the integration of a marker gene into the viral 
genome through homologous recombination in permissive cells; this technique can not be applied to all 
type of viruses, especially viruses like HCMV that shows slow replication kinetics and is strictly cell 
associated, rendering the isolation of viral mutants very difficult. Conventional mutagenesis is usually 
followed by the phenotype analyses, both in vitro and in vivo; and is achieved through chemical 
mutagenesis, site-directed mutagenesis by homologous recombination in eukaryotic cells and manipulating 
virus genome using overlapping cosmid clones. All these methods are very useful to generate mutants, but 
often these procedure are inefficient, laborious and time consuming; they require to select the mutants 
from the parental virus, and this selection can be assessed only at the very end of the experimental 
procedure (Adler et al., 2003). 
Cosmids are basically plasmids with cos sequences (cohesive end site) derived from λ phage; the presence 
of this sites lead to an increase of insert size till to 35 kb, these sites can be also used to pack the plasmid in 
phage particles in vitro, that can transform with a high efficiency bacteria. 
Even the cloning of infectious viral genomes as a yeast artificial chromosome (YAC) has been described, for 
example for adenovirus (Ketner et al., 1994), but remains unclear if large herpesvirus genome can be 
cloned as YACs and whether these genomes are stable in yeast. YACs can accommodate up to 2Mb of DNA 
fragment, and include all the sequence necessary to maintain the vector as a chromosome: an origin of 
replication, a centromere, two telomeres (YAC are amplified as linear DNA molecules) and several 
selectable markers. The transformation in yeast is a process not so efficient as in bacteria, and YAC are very 
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difficult to isolate intact; they are also highly susceptible to shearing, since they are clone d as linear 
molecules; and genomic rearrangements and contamination with parental yeast DNA is however frequent. 
BACs are single copy cloning vectors derived from E.coli F plasmid; circular DNA molecules of about 100kb, 
able to persist as an episome or to integrate in bacterial chromosome; the high capacity vector derived 
from this plasmid contain the F replication and partitioning system that ensure low copy number and 
faithful segregation. 
BACs have been widely used thanks to their great capacity to accommodate large inserts (>300kb) and to 
be genetically stable in bacteria; viral BACs containing E.coli can infact be stored at -80°C, and new viruses 
can be quickly produced from them; the low and the controlled copy number of such vector has made 
them superior to cosmid and YAC (Shizuya et al., 1992). BACs are also suitable to clone viral genome, as first 
demonstrated by Luckow et al. (Luckow et al., 1993) with baculovirus. Exploiting bacterial genetics allowed 
the introduction of every type of mutation (deletion, insertion or point mutation) into the cloned viral 
genomes; manipulated genomes can moreover be characterized prior to the virus reconstitution. 
Ever since the creation of the first herpesvirus bacterial artificial chromosome (BAC) mutant, for murine 
cytomegalovirus, over a decade ago, mutagenesis using BAC technology has been proven to be an 
important tool to study herpesviruses pathogenesis. The availability of viral mutants would significantly 
contribute to the understanding of viral gene functions and to the evaluation of their role in pathogenesis. 
Since the cloning of the murine cytomegalovirus genome (MCMV) as the first herpesviral infectious BAC, a 
lot of DNA viruses have been cloned as BACs, including HCMV, HSV-1, EBV, HHV-8, Pseudorabies virus, 
Marek’s disease virus, MuHV-68, RRV, VZV, SaHV-2 and BoHV-4 (Adler et al., 2003; Borst et al., 1999; Gillet 
et al., 2005a; Messerle et al., 1997; Zhou et al., 2010).  
A typical BAC cassette is about 10 kb and must have an origin of replication, the genes necessary for BAC 
replication (such as redF and repE), and genes to control the rate of replication in order to limit the copy 
number per cell (such as parA and parB). Even an antibiotic resistance marker must also be contained in the 
BAC cassette; and must be flanked by 500-1000bp that are homologous to the target sequence where the 
BAC vector will be inserted. The insertion of a selectable marker, such as betagalactosidase or GFP, is 
necessary to isolate BAC-containing recombinant virus. 
It is desirable to reconstitute the complete wild type genome of the virus and so, to excise the BAC cassette 
from the virus, because the extra genetic materials might overcame the tolerable size limit of the viral 
genome, causing genomic instability and inefficient packaging. The excision of the BAC cassette can be 
achieved providing the BAC cassette of two loxP sites, exploiting the Cre-loxP system; or inserting a 
fragment of identical viral sequences on the opposite of BAC cassette; or inserting the cassette in the 
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tandem repeated area of the viral genome, that spontaneously tend to excise the cassette or exploiting the 
system of mini F-replicon (Zhou et al., 2010). 
The BAC cassette, flanked by viral sequences, is usually transfected in infected cells, resulting in the 
insertion of the BAC cassette in viral genomes by homologous recombination (Fig.5). During replication 
herpesviruses form circular intermediates that can be extracted from cells and used to transform E.coli; 
resulting in a shuttle vector containing the viral genome cloned as a BAC, and subsequently can be 
manipulated in bacteria cells, amplifying it. The so purified BAC clone can be transfected in eukaryotic 
permissive cells to reconstitute the recombinant virus; if the BAC cassette was provided of two loxP sites, 
the infection of permissive cell line expressing the recombinase cre, will lead to the reconstitution of a 
viable virus. 
 
 
Fig.5. Strategy for the construction of an infectious herpesvirus BAC clone , adapted from (Adler et al., 2003) 
 
30 
 
BoHV-4 was cloned as a BAC for the first time in 2005 by Gillet et al. (Gillet et al., 2005a), using an approach 
similar to those adopted by Messerle et al. to clone MCMV (Messerle et al., 1997). The BoHV-4 EcoRI 
fragment containing a XhoI site from the right end of the viral DNA was isolated and cloned in a plasmid to 
generate pGEM-T-EcoRI G. XhoI was then used to clone the BAC cassette in the plasmid; co-transfection 
with the linearized plasmid and purified viral DNA resulted in homologous recombination in MDBK cells 
(Madin Darby Bovine Kidney cells). The integration took place in a non-coding region at the junction of right 
prDNA and the unique central region ofBoHV-4 (Fig.6).The BAC cassette was flanked by two loxP sites to 
excise the BAC cassette, resulting in the removal of the BAC cassette after transfection in a permissive cell 
line expressing the cre recombinase (BEKfincre, Bovine embryo kidney cells expressing the cre 
recombinase). In the BAC vector is inserted moreover an expression cassette for the EGFP protein 
(enhanced green fluorescent protein), to easily visualize the cells infected by the recombinant BAC through 
fluorescence microscopy analysis. 
 
Fig.6.Diagram showing the insertion of a BAC cassette at the left end of the BoHV-4 genome, adapted from (Gillet et al., 2005a) 
 
There are two commonly used methods to mutate BAC DNA: random transposition and site direct 
mutagenesis. Site-direct mutagenesis exploits homologous recombination to create specific mutation in 
viral genes; transposition creates a diversity of BAC mutants, random mutated, and sequencing or PCR is 
required to determine the mutation site (Warden et al, 2011.). 
Homologous recombination is the process of exchanging DNA between two molecules through regions of 
identical sequences; the primary role of homologous recombination in the cell is almost certainly the repair 
of the DNA damage; most of the time occurring at the replication fork. In E.coli most recombination 
depends on RecA protein that binds to single stranded DNA, forming DNA-protein filaments that have the 
ability to look for other DNA molecules, showing sequence homology, leading the pairing between the 
strands. Then the RecBCD enzyme initiates the recombination at dsDNA generating 3’ single strand 
overhangs, helping RecA to promote strand exchange and recombination. The intermediate s formed are 
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resolved by the process of branch migration catalyzed by RuvAB or RecG, and the endonucleolytic cl eavage 
catalyzed by RuvC. 
Phage-mediated recombination systems can be provided in E.coli by the λ phage Red functions, Exo and 
Beta, that can also generate recombinants in the complete absence of RecA, through a process called single 
strand annealing. If two homologous DNAs both receive a double strand break, Exo can degrade the 
5’ended strands exposing 3’ overhangs, that can be bound by Beta, that anneals the two strands and 
generate recombinants. The third gene involved in recombination is Gam that encodes a RecBCD 
exonuclease inhibitor and protect linear DNA-targeting cassette from degradation by RecBCD. These three 
genes can be expressed from a stably integrated defective λ prophage, where exo, bet and gam are 
controlled by the strong phage promoter pL, under stringent control of the temperature-sensitive 
repressor,cI857. In this system exo, bet and gam are not expressed when the bacteria are kept at 32°C, the 
induction at 42°Cper 15 minutes, rapidly induce at high level these genes and homologous recombination is 
efficiently performed. Genetic engineering with phage-encoded recombination functions that utilizes short 
homologies sequences, till to 50 bp, has been named “Recombineering”, a conventional term to describe 
homology-dependant, recombination-mediated, genetic engineering (Court et al., 2002; Warming et al., 
2005). 
Warming et al., described the development of a novel Galk-based selection system for BACs manipulation 
in E.coli SW102. The E.coli galactose operon consists of 4 genes, GalE, GalT, Galk and GalM, necessary for 
the utilization of galactose as the unique carbon source. The Galk gene, codes for galactokinase, an enzyme 
able to convert the galactose in galactose-1-phosphate; is also able to catalyze the phosphorylation of a 
galactose analog, 2-deoxy-galactose (DOG) in a toxic compound. The E.coli SW102 strain is Galk- and is 
unable to use galactose as carbon source; leading to positive clone selection in galactose enriched minimal 
medium and the negative one in medium enriched with DOG (Warming et al., 2005). Donofrio et al., added 
another selection step, flanking the Galk cassette with the gene that confers resistance to Kanamicine; the 
addiction of a negative selection n kanamicine reduces the number of background colonies growing during 
the selection step (Donofrio et al., 2009b).  
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1.4. Gammaherpesviruses Immediate early 2 gene (IE2) 
Herpesviruses have large complex DNA genomes and transcription is strictly regulated during in vitro 
infection. Three phases occurs during infection and are sequentially regulated; genes are so divided into 
three classes: immediate early (IE), early (E) and late (L), on the basis of their time of expression. The 
temporal regulation of gene transcription is accomplished through transactivation of viral transcriptional 
promoters by viral genes specific products. IE proteins are usually considered as transactivator proteins; 
their expression does not require a prior viral DNA synthesis, and are also the only genes transcribed when 
cells are treated with cycloheximide, a protein synthesis inhibitor. Proteins encoded by the IE genes are 
necessary for the expression of E and L genes; L genes synthesis is restricted by viral DNA replication and 
infact are not expressed when DNA polymerase inhibitors are used (Hay and Hay, 1980). 
Herpesviruses lytic gene expression follows this temporal and sequential cascade, ultimately resulting in 
the production of progeny virions and destruction of and egress from the infected host cells.  
Immediate early genes define mRNAs that are transcribed in the presence of protein synthesis inhibitors, 
this applies both to herpesviruses genes after in vitro infection of permissive cells and to cellular genes 
after serum stimulation (Roizman, 1996). Herpesviruses immediate-early genes transcription is necessary 
and sufficient to initiate viral replication(McKnight et al., 1987).  
Rta/Orf50 is an immediate-early protein that is essential to initiate lytic replication of all studied 
gammaherpesviruses: Epstein Barr virus (EBV), Kaposi’s sarcoma associated herpesvirus ( HHV-8), rhesus 
rhadinovirus (RRV), herpesvirus saimiri (SaHV-2) and murid herpesvirus 68 (MuHV-68) (Staudt and Dittmer, 
2006). Ectopic expression of Rta/Orf50 will reactivate virus from latency; its deletion or inhibition by a 
dominant-negative mutant will prevent lytic and reactivation replication. There are other IE genes that are 
transcribed in presence of cycloheximide, but their presence is not enough to reactivate virus from latency.  
All gammaherpesviruses encode an Rta/Orf50 homologue, and each has been proven to play a pivotal role 
in the initiation of viral lytic gene expression and lytic reactivation from latency.  
Rta (replication and transcription activator) is the gene product of ORF50 gene and is the only 
demonstrated essential latent/lytic switch protein for the gamma-2-herpesviruses (rhadinoviruses); instead 
of gamma-1- or lymphocryptovirus, in which are present two IE protein, Zta and Rta, that independently 
can reactivate EBV from latency. The two groups of gammaherpesvi ruses can so have evolved different 
molecular mechanisms of virus-mediated lytic reactivation. 
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Fig. 7 . Classical architecture of Gammaherpesviruses Orf50 gene. 
 
The Orf50 transcripts from all gamma-2-herpesviruses share similarities in the genomic location, amino acid 
sequence and splicing patterns, and a typical architecture, essentially comprised of two exons, separated 
from an intron, that contains ORF49 gene, located in opposite orientation; its promoter is probably located 
within the Rta ORF. Splicing of the two exons and excision of the intron results in a single, major Rta 
transcripts, but differential splicing can also occur, for example in HHV-8 (Damania, 2004; Damania et al., 
2004). 
Amino acid sequence alignments of the Rta homologues revealed that the most conserved regions are at 
the N-terminus. This conserved portion of Rta in EBV is required for dimerization and DNA binding; another 
well conserved region is at the C-terminus and is rich in acidic residues, probably indicating a transcriptional 
putative activation domain. The Rta homologues of gammaherpesviruses share similar amino acid 
sequences and may also have similar functions in activating viral and possibly cellular promoters. It is not 
yet fully understood whether the Rta protein are capable of substituting for each other to transactivate 
virus-specific promoters; it has been shown that EBV Rta could not transactivate the viral promoters 
activated by SaHV-2 Rta or HHV-8 and vice versa (Damania, 2004; Damania et al., 2004). 
The exact mechanism whereby Rta/Orf50 activates expression are still not clear, but two possibilities can 
be supported by the existing data: (ì) Rta can transactivate by either binding directly to target gene 
promoters through specific RRE (Rta Responsive Element) target sequences to stimulate transcription, or 
(ìì) by interacting with cellular factor and or other viral factors to enhance transcription indirectly; for 
example HHV-8 Rta can interact with the RBP-Jk cellular protein, that can bind to promoter DNA in the RRE 
of Orf50 (Chang et al., 2005). 
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1.4.1. EBV Rta/Orf50 
The major viral lytic reactivation protein is considered to be Zta (or Zebra, BZLF-1 or Z protein), that is a 
bZIP-type (basic zipper) transcriptional transactivators (Cox et al., 1990). The EBV Orf50 homologue, the 
BRLF1 gene product Rta, is also a sequence specific DNA-binding protein, with transactivator’s functions. 
Independently Zta or Rta can both initiate lytic gene expression; Rta can act on E gene promoters in cell-
specific manner. The common thinking is that Zta and Rta act synergistically to induce viral reactivation 
from latently infected cells. Rta alone can activate a number of lytic promoters without Zta actions; and Zta 
alone can activate other that does not require Rta; Zta can moreover suppress the transactivation function 
of Rta. A deletion mutant of either Zta or Rta is defective for viral replication (Feederle et al., 2000). 
A recent study revealed that the expression of Zta and Rta substantially interfered with the cell cycle 
regulatory machinery in Raji (EBV-positive human Burkitt’s lymphoma –derived cells) cells, strongly 
inhibiting the expression of Rb and p53 and inducing that of E2F1; down regulation of Rb was further 
demonstrated to be mediated by proteosomal degradation, and p543 and op21 affected at transcription 
levels (Guo et al., 2010). 
A recombinant baculovirus was engineered to express a EBV Rta expression cassette and OriP and was 
specifically able to inhibits the growth of EBV-positive NPC (nasopharyngeal carcinoma) cells in vitro and in 
vivo, suggesting that may have potential application in NPC gene therapy (Wang et al., 2008). 
 
1.4.2. HHV-8 Rta/Orf50 
The HHV-8 ORF50 gene encodes for a 691 amino acid (aa) protein that is highly phosphorylated and 
localizes within the nucleus of mammalian cells, its expression can be detected as early as 1 hour after 
induction of viral replication and in the presence of the protein synthesis inhibitor (Lukac et al., 2001). 
Deletions of 160 aa in the C-terminal activation domain results in a stable but truncated form of Rta, that 
forms multimers with the wild type protein and functions as a dominant-negative inhibitors of Rta 
transactivation (Lukac et al., 1998). Expression of this truncated form leads to the suppression of both 
spontaneous and chemically induced viral reactivation. Viral reactivation can also be blocked by expression 
of human RNaseP (Wang et al., 2004). These data, taken together with a lot of other studies demonstrated 
that Rta is the switch protein involved in HHV-8 lytic reactivation. 
Also the BAC strategy was explorated; a mutant in which the ORF50 was deleted, was generated and tested 
in human cells; even these types of experiments demonstrated the role of Rta protein, because this virus 
was unable to reactivate on chemical studies; in trans expression of Rta was able to abolish both defects 
(Xu et al., 2005).  
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A recombinant BACmid with a deletion in bZIP ORF, a protein able to repress Rta transactivational activities 
for some promoters, was also generated and displayed an enhanced growth phenotype with respect to 
virus production and accumulation of virus encoded mRNA; bZIP can influence LANA localization and be 
involved in persistency state; this study also demonstrated that bZIP may facilitate the interaction of Rta 
with OryLyt (Kato-Noah et al., 2007; Lefort and Flamand, 2009). 
Extensive studies have demonstrated that HHV-8 Rta but not EBV Rta was able to induce MuHV-68 lytic 
viral proteins and DNA replication and processing and produce viable virions from infected cells; through 
the induction of MuHV-68 proper Rta; the species specificity of MHV-68 Rta respect to those of EBV or 
HHV-8 resides in the N-terminal DNA binding domain (Rickabaugh et al., 2005). 
HHV-8 Rta supports a lot of post-translational modifications, as phosphorylation in first attempt, that can 
regulate the function, and also the stability of the protein; Rta can infact modulate host gene transcription, 
as interleukine-6, or STAT3 transactivators activities; can also induce CD21 and CD23a and inhibits p53 
tumor suppressor protein (Gwack et al., 2003). 
HHV-8 Rta is a strong transactivators of many viral promoters, as demonstrated in transient transfection 
assays; 19 direct sites for Rta binding have been identified on different genes, including OryLyt (Chen J., 
2009) and Mta (ORF57), Kaposin, v-MIP-1, thymidine kinase, v-IL-6, LANA and a lot of other genes, as 
reported by Staut et al. (Staudt and Dittmer, 2006). Rta also acts on its own promoters through an Oct-1, 
Sp-1 mediated mechanism (Wang et al., 2003). 
Two RNAs antisense to HHV-8 Rta have been identified, seemingly they do not regulate Rta transcription 
but are mRNA encoding small peptides: these RNAs accumulate during lytic infection, were 5’ co-terminal, 
unspliced, and differentially poly-adenilated; they appear in polysomes in infected cells and internal AUG 
codons can be assessed by translating ribosomes, leading to the synthesis of small peptides of 17 to 48 
amino acids that can have a putative effect in vivo, maybe contributing to T cell epitope repertoire, 
generated in both infected and non infected cells (Xu and Ganem, 2010). 
Even two miRNAs (small single stranded non coding RNAs that post-transcriptionally regulate the 
expression of specific mRNAs by pairing to complementary target sequences within re lated mRNAs) were 
identified to directly target and inhibit HHV-8 Rta 3’ un-translated region, in a sequence-dependent 
manner, promoting the maintenance of the latent state by translationally regulating the Rta expression. 
These miRNAs can act suppressing viral lytic replication via activation of NF-kB, that is a strong negative Rta 
regulator through forming complex with RBP-Jk, one of the major co-activator of Rta (Lin et al., 2011). 
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1.4.3. MuHV-68 Rta/Orf50 
Wu et al. demonstrated that even the Rta protein encoded by MuHV-68 Orf50 is sufficient to induce lytic 
reactivation in latently infected cells (Wu et al., 2000), through the ectopic expression of the protein they 
verified that lytic protein were activated from Rta. They constructed also two mutants of MuHV-68 Rta, 
with deletions at the C-terminus and demonstrated that the mutants were no more able to transactivate 
some promoters as the Orf57 ones, and also that these mutants can function as dominant negative 
mutants, inhibiting trans-activation of wild type Rta, and the progression of a productive infection (Wu et 
al., 2001). 
A lot of studies have been published that clarified how Rta is necessary for viral reactivation, even studying 
the disruption of the ORF with BAC technologies (Pavlova et al., 2005; Pavlova et al., 2003) or by RNA 
interference knockout (Jia et al., 2004); definitively proving that Rta is essential for virus replication.  
A mutant called M50 was generated to express constitutively the protein, by insertion of a new promoter 
element in the 5’-UTR of the Orf50 promoter; this mutant was unable to establish the latency and, when 
used in immunization protocol in mice, conferred partial protection against wild type infection (Boname et 
al., 2004). 
A Rta/Orf50 null mutant established long-term latency in mice lung B cells, but failed to vaccinate against a 
wild type virus challenge, therefore implicating the necessity of lytic replication to generate a protective 
immune response (Moser et al., 2006). 
Assay studies on Rta transactivational activity showed that, if Rta is over-expressed, can up-regulate nearly 
every MuHV-68 gene, supporting the data that even in MuHV-68 Rta is the most important IE 
transactivators proteins (Martinez-Guzman et al., 2003). A recombinant virus over-expressing MuHV-68 Rta 
greatly accelerated the expression of specific lytic cycle ORFs and down-regulated transcription of the 
major latency gene, ORF73; also cellular genes were up-regulated, as FgF10, VEGFs and VCAM-1, important 
in cell growth, differentiation and cell adherence (Hair et al., 2007). 
Recently a recombinant virus deleted in Orf50 promoter was generated; it retained the ability to replicate 
in vitro, even with a slow growth rate, and revealed the presence of a distal upstream Orf50 promoter, it 
was able to establish latency in the spleen of infected mice, but unable to reactivate from latently infected 
splenocytes. This distal promoter is partially methylated in vivo and heavily in latently-infected cells, 
suggesting that DNA methylation may serve to silence the activity of this distal promoter during latency 
(Gray et al., 2009). Another study clarified better that MuHV-68 Rta promoter is hypomethylated during 
lytic infection in mice lung and that methylation level increases with virus latent infection in the spleen; 
histone acetylation, but not DNA demethylation, is sufficient to reactivate the virus from latency in cells 
(Yang et al., 2009). 
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Lee et al., clarified the role of Orf49, that resides adjacent to and in opposite direction from Rta; 
demonstrating that a mutant harboring a transposon at the Orf49 locus evidenced a highly attenuated in 
vitro growth; they generate also a FLAG-tagged protein and were able to state that this protein enhanced 
the Rta ability to transactivate downstream promoter, and also increased he level of auto-transcription of 
Rta; cooperating with Rta protein in regulating virus replication (Lee et al., 2007). 
To date it was demonstrated that MHV-68 Rta interacts with ORF57 promoters, ORF72 (v-Cyclin) (Pavlova 
et al., 2005) with MK3 promoter and ORF18 (trans-factor for late gene expression) (Hong et al., 2011). 
 
1.4.4. SaHV-2 Rta/Orf50 
The SaHV-2 R-transactivator protein is homologous to BRLF1 gene product (Rta) that is translated from a 
bicistronic mRNA which also encodes another IE product, BZLF1. The SaHV-2 R gene is proposed to be 
spliced with more than one exon; therefore it was clarified that two transcripts of ORF50 are expressed 
individually from a promoter 5’ to the exon 1 and an internal promoter within exon 2 and were called 
Orf50a and Orf50b, respectively. These transcripts are expressed at different phases during the lytic cycle; 
Orf50a as an IE gene and Orf50b as a E gene, supporting the idea that Orf50a is the real switch protein from 
latent to lytic replication, and Orf50b maybe a spliced form or a protein able to auto-regulate itself 
(Wellemans et al., 1986). 
Two isoforms of SaHV-2 Rta/Orf50 were isolated: Orf50a and Orf50b that show a high divergence in their 
sequence of about 30% in different strains. Orf50a protein efficiently activates early genes, and is able to 
reactivate lytic replication in persistently infected cells, whereas Orf50b shows contrasting activities in the 
different strains; maybe Orf50 may be involved in cell transformation and acts as an oncogene (Ensser et 
al., 2003). There is no evidence that Rta can transform cells in culture or can cooperate with other 
oncogene to do so; rather it seems that long term stable expression of Rta/Orf50 was i ncompatible with 
continued cell growth.  
The SaHV-2 Rta transactivates its own promoter, as well as the early ORF6, ORF57 and ORF9 viral 
promoters (Thurau et al., 2000). The Rta/Orf50 has an AT-hook DNA binding domain required to interact 
with ORF6 and ORF7 promoters. Rta/Orf50 was able to up-regulate its own promoter by use of a 36 bp RRE, 
that has no significant homology to previously reported RREs of any of others gammaherpesviruses; this 
sequence conferred a responsiveness to an enhancer-less than SV40 minimal promoter (Walters et al., 
2004). SaHV-2 Rta was shown to bind TATA-binding protein in vitro, and this provides another way to act of 
Rta (Hall et al., 1999). 
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1.4.5. RRV Rta/Orf50 
RRV has also been shown to transactivate a promoter-reporter constructs in transient transfection assays. 
The R8, ORF57 and gB promoters of RRV were highly activated and the vIRF promoter was slightly activated 
by Rta (DeWire et al., 2002). In contrast to HHV-8, RRV Rta does not auto-activate its own promoter. 
RRV ORF50 can be dramatically inhibited by the homologous to HHV-8 LANA protein, called R-LANA, 
through recruiting the histone deacetilase complexes; the repressive action of R-LANA on ORF50 may 
down-regulate the transcription of the early genes at late times during the lytic cycle and also help to 
maintain viral latency by preventing virus reactivation (DeWire and Damania, 2005). 
 
1.4.6. BOHV-4 Rta/Orf50 
Studies of RNAs transcribed from the BoHV-4 genome during lytic infection in MDBK (Madin Darby bovine 
kidney) cells led to the identification of the two major IE RNA and protein, by van Santen in 1991 (van 
Santen, 1991). The BoHV-4 major IE RNA is a spliced, 1.7kb RNA transcribed from right to left on BoHV-4 
restriction map. The nucleotide sequence of the DNA encoding the major IE early RNA, approximately 1.1kb 
5’ flanking sequences, and 0.15 kb 3’flanking sequences, contains 60% A+T and 40 G+C nucleotides. This 
5’flanking sequence does not contain multiple repeat motifs characteristic of the major IE promoter region 
of human, murine and simian cytomegalovirus (Thomsen et al., 1984). The nucleotide sequence of the DNA 
encoding the major IE RNA predicts that it encodes a protein of 284 amino acid and 33KDa, called E1.  
IE1 is a putative DNA binding protein and is infact similar to IE110 protein of HSV-1 and could be involved in 
zinc finger structures formation near its N-teminal.  
The other IE RNA, transcribed from left to right on BoHV-4 genome, is about 1.8-kDa, and encodes a 61 kDa 
protein that shows amino acid homology sequence with EBV transactivating protein R, Rta (van Santen, 
1991; van Santen and Chang, 1992) and also with SaHV-2 Rta. IE2 RNA has a short, mostly un-translated, 5’ 
exon, similar to the structure of the 5’portion of EBV R RNA and of those of SaHV -2. The initiation codon of 
BoHV-4 IE2 is contained in the first exon, while the remaining codons are in the second exon. BoHV-4 IE2 
does not transactivate promoters transactivated by SaHV-2 Rta and EBV Rta, and EBV Rta does not 
transactivate BoHV-4 or SaHV-2 targets; BoHV-4 IE2 moreover does not transactivate the homologous 
SaHV-2, that are not transactivate by the SaHV-2 homolog to BoHV-4 IE2 (Nicholas et al., 1991). 
Transactivation studies showed that the BoHV-4 IE2 gene product specifically transactivates the promoter-
regulatory region of the BoHV-4 early gene homologous to the major DNA-binding protein of HSV-1 (van 
Santen, 1993). Also the thymidine kinase gene was proven to be transactivated by IE2 protein in its 
promoter regulatory region within a 72 bp fragment 5’ to the start of transcription (Zhang and van Santen, 
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1995). Bermudez and Cruz identified another RNA that is transactivated from BoHV-4 IE2: the promoter of 
the 1.1kb poly-adenilated RNA, coded by BORFE1, is infact transactivated by IE2; even in this case a 
responsive element was identified, clarifying that IE2 functions as a promoter factor, rather than an 
enhancer factor (Bermudez-Cruz et al., 1998). 
Donofrio et al., were able to activate the lytic replication of the virus in a non-permissive cell line, RD4 
(human rhabdomyosarcoma cells) by overexpression of BoHV-4 IE2 gene, provided in trans by a plasmid 
vector; suggesting that in BoHV-4 too, Rta was the master switch protein involved in virus replication, not 
only during reactivation of latently infected non-permissive cells, but also in de novo infection of permissive 
cells (Donofrio et al., 2004a). 
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BoHV-4 is a virus widely distributed in cattle population. It shows a lot of attractive features as a vector for 
vaccinal and/or gene therapy purposes. A paper was recently published in which the generation of a 
mutant in ORF73, unable to establish latency in an animal model, is described; opening the way to generate 
replication or latency un-competent viruses. The feasibility to manipulate BoHV-4 as a BAC, described for 
the first time in 2005 by Gillet et al. (Gillet et al., 2005a), has led to the development of new strategies to 
generate viral mutants.  
BoHV-4 has been isolated, across the years, from a lot of different tissues and samples from animal with 
various clinical manifestations, ranging from conjunctivitis, ocular discharge and genital diseases as post -
partum metritis or abortion, but even in apparently healthy animal. The real correlation between BoHV-4 
as a causative agent of any pathologies, has never been clearly demonstrated, even if in case of post-
partum metritis, the role of BoHV-4 as a secondary pathogen is strictly defined (Donofrio et al., 2005; 
Donofrio et al., 2008b). BoHV-4 has a well known tropism for endometrial stromal and epithelial cells, in 
these cell types leads to non-apoptotic cell death and de novo viral production associated with an increased 
secretion of inflammatory proteins. The rapid activation of BoHV-4 replication in the bovine endometrium 
is associated with the transactivation of the BoHV-4 IE2 gene promoter from endometrial cells (Donofrio et 
al., 2008b); and BoHV-4 IE2 gene is supposed to be the master gene involved in the switch of viral 
replication, as for other herpesviruses (van Santen, 1991). BoHV-4 IE2 gene promoter transactivation and 
viral replication were associated also with extracellular stimuli belonging to the intrauterine 
microenvironment such as E. coli LPS and PGE (Donofrio et al., 2008b).  
Sheldon et al. proposed a model that describes well  endometrial BoHV-4 disease, involving a vicious circle 
comprising of bacterial endometritis leading to secretion of PGE, then PGE and LPS stimulating viral 
replication, which causes further endometrial tissue damage and inflammation (Sheldon et al., 2009).  
Even if BoHV-4 has been isolated from different lesions and from healthy animals, the existence of a patho-
biotype of BoHV-4 causing uterine disease, can not, consequentially, be ignored. 
The aim of this study was to generate a BAC from a uterine BoHV-4 isolate to characterize and study the 
interactions between the virus and the endometrium. The first part of this thesis describes how such a BAC 
was generated and characterized; the second lead to affirm that in BoHV-4 too, as for the other 
gammaherpesviruses, IE2 is the master gene switch and is necessary for viral replication. Surprisingly we 
found that in our uterine isolate IE2 gene is duplicated, providing information about the preferential 
tropism for endometrial cells, and we were able to disrupt all the two gene copies, generating a totally 
replication un-competent virus, complemented by in trans expression of Rta protein. This replication un-
competent virus would probably have some applications as oncolityc vector for gene therapy.  
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3.1 
 
 
 
 
 
Isolation and characterization of bovine herpesvirus 4 (BoHV-4) from a cow affected by post 
partum metritis and cloning of the genome as a Bacterial Artificial Chromosome: a versatile 
molecular tool to study interactions between BoHV-4 and the endometrium. 
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Abstract 
 
Bovine herpesvirus 4 (BoHV-4) is worldwide distributed in cattle and is the virus most consistently 
associated with metritis, a very common postpartum disease of the uterus. Virus strain adaptation to an 
organ, tissue or cell type is a very important issue for the study of pathology and the function of most of the 
viral genes remains unknown.  
A strain of the virus was isolated from the uterus of a persistently infected cow affected with non-
responsive post-partum metritis and designated BoHV-4-U. The isolate was studied by RFLP-PCR and 
sequencing using the TK locus as a genetic marker region for the BoHV-4 genome.  
To easily manipulate and study the viral genome the BoHV-4-U DNA was cloned as a bacterial artificial 
chromosome (BAC) and the stability of the pBAC-BoHV-4-U clone was confirmed over twenty passages, and 
viral growth was not affected compared with the wild type virus.  
The feasibility of using BoHV-4-U for mutagenesis was demonstrated using the BAC recombineering system, 
that allows to study single or multiple gene disruptions, clarifying the interactions between BoHV-4 
infection and the host endometrial cells. 
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Introduction 
 
Uterine infections are important because they disrupt not only the function of the uterus, but also the 
ovary and the overarching higher control centres in the hypothalamus and pituitary (Sheldon et al., 2009). 
The inflammatory and immune response to uterine infection compromises animal welfare as well as 
causing sub-fertility and infertility. Indeed, uterine disease causes infertility at the time the infection is 
present and sub-fertility even after successful resolution of the disease. Understanding the mechanisms 
underlying the effect of microbial infection and the associated immune response on bovine reproduction is 
important to develop new treatments and disease prevention strategies (Dobson et al., 2003).  
Abortion may follow infection with a variety of alpha-, beta- and gammaherpesvirus, but viral causes of 
uterine disease are seldom investigated in cattle. Although postpartum metritis affects up to 40% of cattle, 
it has been assumed that the majority of diseases are of bacterial origin and virus isolation or serology is 
rarely considered (Sheldon et al., 2009). However, bovine herpesvirus 4 (BoHV-4) has often been implicated 
in cases of bovine metritis. The first reported isolation of BoHV-4 from a case of bovine metritis was in 1973 
(ParK and Kendrick, 1973). Later several other isolates were obtained from cows with reproductive 
disorders from different countries, including Italy (Castrucci et al., 1986) and India (Mehrotra et al., 1986). 
In Belgium, BoHV-4 seroprevalence was associated with postpartum metritis, and chronic infertility of 
cattle (Czaplicki and Thiry, 1998). Postpartum metritis has also been associated with BoHV-4 in the USA 
(Frazier et al., 2001; Frazier et al., 2002), Spain (Monge et al., 2006) and Serbia (Nikolin et al., 2007).  
BoHV-4 is tropic for endometrial stromal and epithelial cells, leading to non-apoptotic cell death and de 
novo viral production associated with increased stromal cell prostaglandin-endoperoxide synthase 2 
(PTGS2) protein and stimulated prostaglandin E2 (PGE) secretion (Donofrio et al., 2007a; Donofrio et al., 
2008b). The successfull replication of BoHV-4 in bovine endometrial cells was shown to be attribuited to 
post-entry events, with rapid viral reconstitution following the electroporation of nude viral DNA into 
endometrial stromal and epithelial cells (Donofrio et al., 2007a; Donofrio et al., 2008b). A plausible 
mechanism underling this rapid activation of BoHV-4 replication in the bovine endometrium was associated 
with the capability of endometrial cells to transactivate the BoHV-4 immediate early 2 (IE2) gene promoter 
(Donofrio et al., 2008b), which is the molecular master swich gene for BoHV-4 replication (van Santen, 
1991). Furthermore, BoHV-4 IE2 gene promoter transactivation and viral replication were associated with 
extracellular stimuli belonging to the intrauterine microenvironment such as E. coli LPS and PGE (Donofrio 
et al., 2008b). BoHV-4 replication was also reactivated in latently infected macrophages by stromal cells in 
co-cultivation (Donofrio et al., 2007a; Donofrio et al., 2008b). Based on this knowledge, a model for 
endometrial BoHV-4 disease was proposed (Sheldon et al., 2009), involving a vicious circle comprising of 
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bacterial endometritis leading to secretion of PGE, then PGE and LPS stimulating viral replication, which 
causes further endometrial tissue damage and inflammation.  
Although BoHV-4 has been isolated from different lesions and from healthy animals, the existence of a 
patho-biotype of BoHV-4 causing uterine disease can not be ignored. Thus, in the present study, BoHV-4 
was isolated from a cow affected with non-responsive post-partum metritis, characterized and the genome 
cloned as bacterial artificial chromosome (BAC). This new uterine BAC-BoHV-4 clone represents a versatile 
molecular tool for functional genomic study of BoHV-4 genes adapted to the endometrium, which will lead 
to new insights into the relationship between BoHV-4 and postpartum metritis. 
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Materials and Methods 
 
Herd screening and isolation of BoHV-4  
A dairy herd comprising of 73 cows that had a high incidence of postpartum metritis, abortion, and 
infertility was screened by indirect fluorescent antibody test (IFAT) for BoHV-4 antibodies. Briefly, IFAT was 
performed as follow: BoHV-4 infected and uninfected BEK cells were seeded onto 18-wells glass slides fixed 
in cold acetone and stored a -20 °C until used. Sera were serially diluted in phosphate buffered saline (PBS) 
and 30 l added to the infected and uninfected cells. For each slide a negative and a positive serum was 
introduced, as well as a control made by treating a slide well containing BoHV-4 infected and a one 
containing uninfected cells only with the secondary antibody. After 1 h incubation at 37 °C, the slides were 
washed three times in PBS and incubated 1 h at 37 °C with fluorescein isothiocyanate conjugated anti -
bovine immunoglobulin G. At the same time, cells were counterstained with Evans Blue Dye (EBD; Sigma, 
St. Louis, USA). Fluorescence was detected using a Zeiss Axiovert epifluorescent microscope and images 
acquired with the Axiocam Zeiss system. Sera were considered positive for BoHV-4 antibody when green 
fluorescence was detected at a dilution ≥ 1:40, with no fluorescence for uninfected cells at 1: 20.  
 
Endometrial cells collection by uterine trypsin flushing  
A cow identified by IFAT as persistently infected with BoHV-4 and with a history of metritis, was treated 
with prostaglandin F2α (PGF2α, Estrumate, SCHERING PLOUGH) and 4 days later endometrial cells were 
collected by flushing the uterus. Briefly, a Foley catheter was introduced through the cervix into the uterine 
lumen guided by rectal palpation and 50 ml of a trypsin EDTA solution (0,25% trypsin, 1 mM EDTA in PBS) 
infused and the uterus gently massaged for 2 min before aspiration into a 50 ml tube. After collection, 1 ml 
FBS was added and endometrial cells collected by centrifugation at 2,000 RPM for 5 min. The cells were 
washed twice with 10 ml medium comprising of Dulbecco’s modified essential medium (D-MEM; Sigma), 
10% FBS (Sigma), 50 IU/ml penicillin (Sigma), 50 μg/ml streptomycin (Sigma) and 2.5 μg/ml Amphotericin B 
(Sigma), re-suspended in 2 ml of medium and stored at -80°C.  
 
BoHV-4-U isolation 
The following BoHV-4-sensitive cell lines were obtained: bovine arterial endothelial (BAE-7372) from Prof. 
S. Grolli (Veterinary Biochemistry Institute, Parma University, Italy); Madin Derby Bovine Kidney (MDBK 
CCL-22) from ATCC (ATCC American Type Culture Collection, Manassas, USA); and bovine embryo kidney 
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(BEK) and bovine embryo lung (BEL) cells from M. Ferrari (Istituto Zooprofilattico Sperimentale, Brescia, 
Italy). All cells were cultured in D-MEM (Sigma) containing 10% FBS, 2 mM of l-glutamine, 100 IU/ml of 
penicillin, 100 μg/ml of streptomycin and 2.5 μg/ml of Amphotericin B. The uterine endometrial cells were 
co-cultured with BAE-7372, MDBK, BEL and BEK cells in culture flasks until plaques characteristic of a 
cytopathic effect (CPE) developed. Single plaques were purified using 0.2% agarose gel three times. Flasks 
containing plaques were frozen in liquid nitrogen and thawed, the medium containing cell plaques 
centrifuged at low speed and the supernatant filtered through a 0.2 μm syringe filter (Minisart, Sartorius) 
and stored at -80°C. 
 
BoHV-4-U plaque immuno-peroxidase staining 
The cell plaques were washed three times with PBS, fixed with 4% paraformaldehyde for 10 min at 37°C, 
washed twice with PBS, 0.1% BSA, and incubated 5 min at 20°C with the same solution. Cells were then 
incubated 5 min at 20°C with PBS, 0.3% Triton X-100, washed three times with PBS, and incubated 10 min 
at 37°C with 0.15% H2O2 in PBS. Rabbit anti-BoHV-4 hyper-immune serum, diluted 1:500 in PBS, was 
incubated with the cells for 2 h at 37°C. After three washes with PBS, cells were incubated with peroxidase-
conjugated secondary antibody, diluted 1:500 in PBS, for 1 h at 37°C, and washed three times with PBS. 
Secondary antibody was detected by development in 250 μg/ml DAB (Sigma), 0.015% H2O2, 50 mM Tris pH 
7.4, for 10 min at 20°C. 
 
BoHV-4-U characterization 
Viral infected cells were lysed overnight in TEL (10 mM Tris–HCl, pH 7.5, 1 mM EDTA) buffer containing 
0.5% sodium dodecyl sulphate (SDS) and 100 μg of proteinase K per ml at 37 °C. Nucleic acids were 
extracted by treatment with phenol–chloroform and precipitated with ethanol. Treatment with 100 μg/ml 
of RNAse A (Sigma) was performed for 1 h, after which the DNA was extracted with phenol and precipitated 
with ethanol again. The samples were kept at −20 °C. One microgram sample DNA was amplified over 30 
cycles, each cycle consisting of denaturation at 94 °C for 1 min, primer annealing at 55 °C for 1 min, and 
chain elongation with 1 U of Taq polymerase (Roche) at 72 °C for 2 min. PCR amplification was carried out 
in a final volume of 50 μl of 10 mM Tris–hydrochloride pH 8.3 containing 0.2 mM deoxynucleotide 
triphosphates, 3 mM MgCl2, 50 mM KCl and 0.25 μM of each primer. In the first cycle, the samples were 
denatured at 94 °C for 5 min, and in the last cycle the extension step was increased to 7 min. The primers 
used for amplification were selected from the published sequence of BoHV-4 genome (Zimmermann et al., 
2001) (sense primer:5′-cgaattctagtctaaagtcatcctc-3′; antisense primer: 5′-cgaattccattggcttcatcccaca-3′. 
Accession number: NC002665). The PCR products were electrophoresed in 1% agarose gel and visualized 
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after ethidium bromide staining. The amplified 2538-bp TK fragment was extracted from the agarose gel, 
digested with HindIII restriction endonuclease, and analyzed on 1.5% agarose gel in 1× TAE buffer (40 mM 
Tris–acetate, 1 mM EDTA) containing ethidium bromide for DNA staining. The specificity of the PCR product 
was determined by sequencing. 
 
RNA extraction and RT-PCR 
Total RNA from infected and uninfected cells was extracted with TriPure reagent (Roche) and 2 μg of total 
RNA were reverse transcribed using Ready-To-Go, T-Primed First-Strand Kit (Amersham Biosciences). Three 
microliters of reverse transcribed RNA were amplified over 30 cycles, each cycle consisting of denaturation 
at 94 °C for 1 min, primer annealing at 55 °C for 1 min, and chain elongation with 1 U of Taq polymerase 
(Boehringer-Diagnostics) at 72 °C for 2 min. PCR amplification was carried out in a final volume of 50 μl of 
10 mM Tris–hydrochloride, pH 8.3, containing 0.2 mM deoxynucleotide triphosphates, 3 mM MgCl2, 50 mM 
KCl and 0.25 μM of each primer (sense primer: 5′-acaaacacacagaccagtca-3′; antisense primer: 5′-
gtttcacaacagattgagca -3′. Accession Number NC002665). Primers were selected from the published 
sequence of BoHV-4 genome (Zimmermann et al., 2001).  
 
BAC-BoHV-4-U generation 
For BAC cloning BoHV-4-U genome, a strategy employed to BAC clone BoHV-4-A genome was used 
(Donofrio et al., 2008c). The intergenic region between the ORF2 and ORF3, previously shown to be suitable 
for the introduction of the BAC cassette was chosen. pSP72Bo2-loxGFP-BAClox-Bo3 was excised out from 
pSP72Bo2-loxGFP-BAClox-Bo3 (Donofrio et al., 2008c) with PvuII/ClaI restriction digestion and the gel-
purified fragment was co-electroporated with 1 μg of purified BoHV-4-U DNA, obtained by sucrose purified 
viral particles, in BEK cells. GFP positive plaques were under agar isolated and transferred onto newly 
prepared BEK cells. After several rounds of isolation, circular viral DNAs intermediates were isolated from 
infected cells by the Hirt isolation method (Hirt, 1967) and transferred into Escherichia coli DH10B. The 
transformants were plated on agar containing 17 μg/ml chloramphenicol. DNA was extracted from each 
positive clone and was restriction enzyme digested and analyzed by electrophoresis on 1% agarose gel. 
DNA fragments were visualized with a UV trans-illuminator.  
 
Cell culture electroporation and recombinant virus reconstitution 
BEK or BEKcre cells were maintained as a monolayer with complete medium containing 90% D-MEM, 10% 
FBS, 2 mM l-glutamine, 100 IU/ml penicillin and 10 μg/ml streptomycin. Cells were sub-cultured to a fresh 
culture vessel when growth reached 70–90% confluence (i.e., every 3–5 days) and were incubated at 37 °C 
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in a humidified atmosphere of 95% air–5% CO2. BAC-BoHV-4 plasmid DNA (5 μg) in 500 μl D-MEM without 
serum was electroporated (Equibio apparatus, 270 V, 960 μF, 4-mm gap cuvettes) into BEK or BEKcre cells 
from a confluent 25-cm2 flask. Electroporated cells were returned to the flask, fed the next day, and split 
1:2 when they reached confluence at 2 days post-electroporation. Cells were left to grow until CPE 
appeared. Recombinant viruses were propagated by infecting confluent monolayers of BEK or MDBK cells 
at a m.o.i. of 0.5 TCID50 per cell and maintaining them in MEM with 10% FBS for 2 h. The medium was then 
removed and replaced by fresh MEM containing 10% FBS. When approximately 90% of the cell monolayer 
exhibited CPE (approximately 72 h post-infection), the virus was prepared by freezing and thawing cells 
three times and pelleting virions through 30% sucrose. Virus pellets were resuspended in ice cold D-MEM 
without FBS. TCID50 were determined on MDBK cells by limiting dilution. 
 
BAC-BoHV-4-U genome modification by recombineering 
Recombineering was performed as described by Warming et al., (Warming et al., 2005) with some 
modifications: Five hundreds μl of a 32°C overnight culture of SW102 containing BAC-BoHV-4-U, were 
diluted in 25 ml Luria-Bertani (LB) medium with or without chloramphenicol (SIGMA) selection (12.5 μg/ml) 
in a 50 ml baffled conical flask and grown at 32°C in a shaking water bath to an OD600 of 0.6. Then, 10 ml 
were transferred to another baffled 50 ml conical flask and heat-shocked at 42°C for exactly 15 min in a 
shaking water bath. The remaining culture was left at 32°C as the un-induced control. After 15 min the two 
samples, induced and un-induced, were briefly cooled in ice/water bath slurry and then transferred to two 
15 ml Falcon tubes and pelleted using 5000 r.p.m. (eppendorf centrifuge) at 0°C for 5 min. The supernatant 
was poured off and the pellet was resuspended in 1 ml ice -cold ddH2O by gently swirling the tubes in 
ice/water bath slurry. Subsequently, 9 ml ice-cold ddH2O were added and the samples pelleted again. This 
step was repeated once more, the supernatant was removed and the pellet (50 μl each) was kept on ice 
until electroporated with gel-purified ~4.3 kb fragment (TK-KanaGalK-TK) obtained by cutting pTK-
KanaGalK-TK with XhoI/EcoRI (ROCHE). An aliquot of 25 μl was used for each electroporation in a 0.1 cm 
cuvette at 25 μF, 2.5 kV and 201 Ω.  After electroporation, the bacteria were recovered in 1 ml LB (15 ml 
Falcon tube) for 1 h in a 32°C shaking water bath. For the counter selection step (see below), the bacteria 
were recovered in 10 ml LB in a 50 ml baffled conical flask and incubated for 4.5 h in a 32°C shaking water 
bath. 
After the recovery period, the bacteria were washed twice in sterile 1× M9 salts (6 g/l Na2HPO4, 3 g/l 
KH2PO4, 1 g/l NH4Cl and 0.5 g/l NaCl,) (SIGMA) as follows: 1 ml culture was pelleted in an eppendorf tube at 
13,200 r.p.m. for 15" and the supernatant was removed with a pipette. The pellet was resuspended in 1 ml 
of 1× M9 salts, and pelleted again. This washing step was repeated once more. After the second wash, the 
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supernatant was removed and the pellet was resuspended in 1 ml of 1× M9 salts before plating serial 
dilutions (100 μl each of 1:10, 1:100 and 1:1000 dilutions) on M63 minimal medium plates (agar 15 g/l; 
(DIFCO, BD Biosciences), 0.2% D-galactose (SIGMA), 1 mg/l D-biotin (SIGMA), 45 mg/l L-leucine (SIGMA) and 
50 mg/l kanamycin (SIGMA)). Washing in M9 salts is necessary to remove any rich media from the bacteria 
prior to selection on minimal medium plates. Plates were incubated 3–5 days at 32°C. Several selected 
colonies were picked up, streaked on McConkey agar indicator plates (DIFCO, BD Biosciences) containing 50 
μg/ml of kanamycin and incubated at 32°C for 3 days until red colonies appeared. Red colonies were grown 
over night in 5 ml of LB containing 50 μg/ml of kanamycin and BAC-BoHV-4-U was purified and analyzed 
through HindIII restriction enzyme digestion for TK-KanaGalK-TK fragment targeted integration into the 
BoHV-4 TK locus. 
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Results 
 
BoHV-4 isolation from the uterus of an infected animal 
A cow was identified from a herd with a high incidence of metritis; the animal had with a history of 2 years 
of reproductive failure, was affected by post partum metritis and was BoHV-4 IFAT positive twice at 6-
month interval (Fig. 8).  
 
Fig. 8. Representative microscopic (10X) IFAT images of sera from the cow which was used to isolate BoHV-4-U. The presence of  
anti-BoHV-4 antibodies in the first and second sample (6 months following the first) are detectable by green cells when observed 
with a FITC filter and the negative controls appears brown due to the Evans blue dye. Counterstaining with Evans blue dye 
observed with a TRITC/filter (red pictures) was used to monitor the integrity of the cell substrate. The merged pictures  
(FITC/TRITC) allow co-localization of the anti-BoHV-4 antibody staining with the cellular substrate.  
 
Uterine cells were collected from this animal and co-cultivated with BoHV-4 permissive cell lines. Ten days 
after co-culture and one cell passage, a CPE typical of BoHV-4 appeared in the BEK cells (Fig. 9A). The 
presence of BoHV-4 was confirmed by immuno-peroxidase staining of the plaques with anti-BoHV-4 
antibodies (Fig. 9B). 
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Fig 9. A) Representative phase contrast microscopic images (10X) of BoHV-4-U cytopathic effect generating plaques immuno-
peroxidase stained with anti-BoHV-4 antibodies (B). 
 
 
BoHV-4 isolate characterization 
To confirm the specificity of the BoHV-4 isolate, single-plaque purified virus was analyzed by RFLP-PCR of 
the TK locus (Fig. 10A) and RT-PCR for the spliced form of the Immediate Early 2 (IE2) gene (Fig. 10B), which 
is a specific marker for BoHV-4 immediate early gene expression (van Santen, 1991). Both methods 
confirmed the specificity of the uterine isolate, which was called BoHV-4-U. A restriction profile comparing 
the BoHV-4-U viral genome with reference strains (LVR, DN 599 and Movar), classified the isolate as Movar-
like (data not shown), which was in agreement with the geographical distribution of the Movar strain in the 
north of Italy (Donofrio et al., 2000a). 
CPE Immunoperoxidase stained CPE
A) B)
54 
 
 
Fig.10A) Predicted location of HindIII restriction sites and respective expected restriction fragment sizes (not shown to scale). 
Ethidium bromide stained agarose gel electrophoresis of specific amplification of BoHV-4 DNA fragment from LVR, DN599 
reference strains and the BoHV-4-U isolate. PCR amplified 2,538-bp fragment (Uncut) and digested with HindIII restriction 
enzyme (Cut). Lanes (-) corresponds to negative controls and La to 1 kb ladder molecular size marker. 
 
Fig. 10B) Diagram showing the genomic region containing the BoHV-4 IE2 gene (not to scale), where the exon II contains most of  
the IE2 ORF, except the translation initiation codon contained into the exon I. During splicing, an intron is removed and the two 
exon (I and II) are joined together to generate the IE2 ORF. The positions of the primers used to amplify the region containing IE2 
are shown by arrows. The selected primers generate an amplicon of 1400 bp from the viral IE2 genomic region, while the 
amplicon is only 386 bp in length from the spliced product of IE2 transcript, thus allowing distinction between viral genomic DNA 
and the reverse transcribed IE2 RNA. Ethidium bromide stained agarose gel electrophoresis of RT-PCR or PCR of RNA and DNA 
from LVR, DN599 reference strains and the new isolate BoHV-4-U infected cells.  
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Cloning of BoHV-4-U as a bacterial artificial chromosome 
To facilitate further characterization and manipulation of BoHV-4-U, the genome was cloned as a bacterial 
artificial chromosome. The intergenic region located between Bo2 and Bo3 ORFs (situated to the left end of 
the viral genome, Fig. 11A) (Zimmermann et al., 2001)  was selected as a target site to introduce the BAC 
cassette. The plasmid pBo2-EGFP-BAC-Bo3, containing homologous regions flanking the floxed BAC cassette 
for cre excision and an EGFP expression cassette, was linearized and co-transfected with BoHV-4-U purified 
genome into BEK cells. Recombinant virus was isolated from single plaques expressing EGFP and the 
structure of the recombinant virus was assessed by HindIII restriction profiling, PCR and sequencing. 
Circular intermediates of the recombinant BoHV-4-U were isolated from newly infected BEK cells and 
electroporated into E. coli DH 10B to generate pBAC-BoHV-4-U (Fig. 11B). HindIII restriction profile (Fig. 
11C), Southern blotting, PCR and partial sequencing (data not shown) confirmed the integrity of the clone. 
 
Clone stability and viral reconstitution 
The stability of the pBAC-BoHV-4-U clone in bacteria was confirmed over twenty passages (Fig. 12A). 
Electroporation of the pBAC-BoHV-4-U plasmid into BEK cells, allowed infectious virus reconstitution as 
observed by plaques expressing green fluorescent protein formation and CPE spreading through the cell 
monolayer over time (Fig. 12B). The BAC cassette was successfully excised from the BAC-BoHV-4-U, as 
monitored by the lost of GFP expression, when BAC-BoHV-4-U virus was growth on BEK cells expressing cre 
or pBAC-BoHV-4-U plasmid was electroporated into BEK cells expressing cre (Fig. 12C). No difference in 
growth characteristics between BoHV-4-U, BAC-BoHV-4-U and BoHV-4-UΔBAC was observed (Fig. 13). 
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Fig. 11) Representative flow chart of the strategy used to generate pBAC-BoHV-4-U. A) Through classical homologous 
recombination in eukaryotic cells obtained by co-transfection, the floxed (loxP sites indicated by triangles) CMV-GFP BAC 
cassette containing F1 plasmids elements (chloramphenicol resistant gene, Cam; F1 origin of replication, Ori2; partitioning  
protein genes, repE, parA, parB and parC), flanked by two homologous BoHV-4-U regions, Bo2 and Bo3, was introduced into the 
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intergenic region of the BoHV-4-U genome [Numbers indicates sequence location in BoHV-4 genome based on the 
Zimmermann’s sequence (Zimmermann et al., 2001)]. B) Diagram of the recombinant BoHV-4-U and images of a single plaque 
expressing GFP (Fluorescence and phase contrast merged on fluorescence. 10X). C) Ethidium bromide stained agarose gel of 
three (1, 2, 3) representative HindIII digested pBAC-BoHV-4-U clones. 
 
 
Fig. 12) A) Stability of the pBAC-BoHV-4-U plasmid in E. coli DH10B. DH10B containing the pBAC-BoHV-4-U were passaged for 21 
consecutive days, BAC DNA from the culture was prepared on the indicated days (3, 6, 9, 12, 15, 18 and 21), HindIII digested and 
analyzed on ethidium bromide stained agarose gel. B) BEK or C) BEK expressing cre cells (BEK/cre) at 3 and 5 days post 
electroporation with pBAC-BoHV-4-U, where BAC-BoHV-4-U virus is reconstituted causing CPE and spreading through the cellular 
monolayer as shown by both phase contrast and fluorescence images (in B). Whereas, due to the expression of cre and the BAC 
cassette containing GFP is removed from the BAC-BoHV-4-U reconstituted, CPE is appreciable in phase contrast images but not in 
fluorescence (in C).  
 
 
Fig.13. Replication kinetics of BoHV-4-A-U reconstituted virus in BEK/cre cells (the BAC cassette has been removed by cre), 
compared with those of the parental BAC-BoHV-4-U (virus reconstituted on un-expressing cre BEK cells) still containing the BAC 
cassette and the BoHV-4-U isolate. The data presented are the means ± standard errors of triplicate measurements, P>0,05 for 
all time points as measured by Student’s t test. 
3     6     9    12  15   18    21La
d
d
er Passages
Phase contrast Fluorescence
3
d
ay
s
P
.E
.
5
d
ay
s
P
.E
.
3
d
ay
s
P
.E
.
5
d
ay
s
P
.E
.
B
EK
B
EK
/c
re
A) B)
C)
1
10
100
1000
10000
100000
1000000
BoHV-4-UΔBAC
BAC-BoHV-4-U
BoHV-4-U
0 2 4 6
P.
F.
U
./
m
l
days
58 
 
Insertional mutagenesis into BoHV-4-U genome cloned as Bacterial Artificial Chromosome. 
To test the feasibility of BoHV-4-U for mutagenesis, the BAC recombineering system approach (Warming et 
al., 2005), modified by the introduction of a kanamycin selection step, was used for this purpose. 
Accordingly, the galactokinase cassette (GalK) along with a kanamycin resistance cassette, both under the 
control of constitutively active prokaryotic promoters, were subcloned in pINT2 (Donofrio et al., 2002) to 
be flanked by the BoHV-4 TK gene and adjacent sequences. The generated targeting vector (TK-KanaGalK-
TK) was excised out from the plasmid backbone and used for heat-inducible homologous recombination in 
SW102 E.coli containing the BAC BoHV-4 genome (Fig. 14).  
 
 
Fig. 14. Kanamycin resistant cassette (Kana) adjacent to the galactokinase cassette (GalK) and flanked by BoHV-4 thymidine 
Kinase gene and adjacent sequences (TK), are introduced into the TK gene of BoHV-4-U genome cloned as bacterial artificial 
chromosome (BAC-BoHV-4-U) via heat inducible homologous recombination in SW 102 E.coli .  
 
Following a positive selection in minimal medium containing galactose (on solid agar plate) and a second 
positive selection with medium containing kanamycin (liquid medium), all the clones analyzed displayed the 
correct targeting (Fig.15). 
 
Kana
TK
GalK
~ ~
Kana GalKTK TK
~~
TKTK
59 
 
 
Fig.15. HindIII restriction enzyme analysis of 2 clones out of hundreds, displaying the right targeting, where a new 2.6 kb band 
(indicated by arrow) corresponding to the insertion of the Kana/GalK cassettes is present but missing in the untargeted control. 
Southern hybridization with a Kanamycin specific probe confirms the specific targeting. 
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Discussion  
 
BoHV-4 is a herpesvirus belonging to the gammaherpesvirus family, genus Rhadinovirus (Zimmermann et 
al., 2001). Although BoHV-4 has been isolated from animals with various clinical symptoms and also from 
apparently healthy animals, BoHV-4 isolation from animals with disease of the female genital tract is the 
best documented and one of the few cases where disease could be reproduced (Wellemans et al., 1986). 
Wellemans et al, (1986) reproduced metritis by infecting cows at various times before parturition; no 
clinical signs were seen after primary infection but metritis was observed after parturition. It is likely that 
BoHV-4 causes post-partum metritis along with other microbes such as the bacteria E. coli and A. pyogenes 
(Donofrio et al., 2008b).  
In the present study a BoHV-4 strain (BoHV-4-U) was isolated from the uterus of a persistently infected 
cow, affected by postpartum metritis. Restriction pattern analyses by RFLP-PCR and sequencing using a 
large 2,538 bp conserved region (TK locus) as a genetic marker region for the BoHV-4 genome, (Lomonte et 
al., 1996), including the 3' end of ORF1 (homologous to the EBV BVRF1 gene), ORF2 (homologous to the 
EBV BXRF1 gene), ORF3 (TK gene) and ORF4 (gH gene) 5' end, confirmed that the isolate was a BoHV-4 
strain 
Even the spliced form of the Immediate Early 2 (IE2) gene, a specific marker for BoHV-4 immediate early 
expression (van Santen, 1993) was analyzed by RT-PCR and sequencing.  
The BoHV-4-U genome was cloned as a bacterial artificial chromosome (BAC) and the stability of the pBAC-
BoHV-4-U clone was confirmed over twenty passages, and viral growth was not affecte d compared with the 
wild type virus. The feasibility of using BoHV-4-U for mutagenesis was demonstrated using the BAC 
recombineering system. 
Virus strain adaptation to an organ, tissue or cell type is a very important issue for pathology. Differences 
observed in the disease potential of BoHV-4, as is the case of post-partum metritis, may constitute an 
adaptation of the virus to different selection pressures that may increase the frequency of the most 
efficient genetic variants. These selection pressures might include the different endometrial cells and their 
endocrine functions, physical and chemical conditions. To understand the effects of BoHV-4 on uterine 
function it is therefore important to use a specific BoHV-4 isolate from a case of post-partum metritis. 
Nuget et al. (2006) (Nugent et al., 2006), for example, found that non-neuro-pathogenic EHV-1 strains 
encode A in the position 2,254 (amino acid N752) of the genome corresponding the viral DNA polymerase 
(pol) ORF. Whereas, neuro-pathogenic EHV-1 strains encode G in that position (amino acid D752). This 
suggested that the ancestral EHV-1 virus probably encoded D752 and the variants expressing N 752 arose 
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subsequently, possibly due to selective advantage. The relationship between polymorphism in EHV -1 pol 
and neuro-pathogenicity was verified by targeted mutagenesis of a single nucleotide in the DNA genome of 
the virus cloned as bacterial artificial chromosome (Goodman et al., 2007), confirming the functionality of 
such single nucleotide polymorphism. Starting from the assumption that the uterine isolate of BoHV-4 
genome could be cloned as bacterial artificial chromosome, the viral genome could then be modified by 
homologous recombination and the virus reconstituted in eukaryotic cells following transfection.  
The primary method for investigating the function of individual herpesvirus genes is mutagenesis. Mutated 
viruses are usually constructed by homologous recombination following the co-transfection of viral 
genomic DNA and a mutated allele on a separate DNA fragment (Roizman, 1996). Recombinant viruses are 
either screened or selected during several sequential rounds of plaque purification. However, if the 
mutation results in growth defects relative to wild-type parental virus, the mutant virus may be difficult or 
impossible to purify. Lethal mutations are often detected only indirectly by the unsuccessful isolation of the 
desired mutant virus. Such mutants can be isolated and confirmed as le thal only by the construction of a 
complementary cell line expressing the wild-type allele. To overcome these limitations, many herpesviruses 
have been cloned as an infectious bacterial artificial chromosome (BAC). 
Although the genome of BoHV-4 has been sequenced completely (Zimmermann et al., 2001) the function of 
most of the gene remains unknown. Fewer than 75 ORFs have been characterized in BoHV-4, based on 
amino acids homology and genome co-location with the other gammaherpesviruses. While most of the 
genes have no apparent homology to known viral or cellular genes, some are known to be important for 
virus–host interaction. For example, IE2 gene, is the molecular master switch for BoHV-4 replication, and 
the capability of endometrial cells to transactivate the IE2 promoter was previously investigated by 
transient transfection assay using a reporter construct containing the IE2 promoter electroporated into 
endometrial stromal and epithelial cells (Donofrio et al., 2008b). Therefore the mutation of the IE2 gene in 
BoHV-4-U would be of great interest, to understand its function in the context of the interaction between a 
specific uterine strain (BoHV-4-U) and uterine cells.  
The functional analysis of BoHV-4-U genes in endometrial cells is a fundamental prerequisite for regulatory 
region discovery. Gene trap technology (Zambrowicz et al., 1997) in combination with transposition 
technology, site direct mutagenesis and homologous recombination on BAC-BoHV-4-U genome, will 
provide an important tool to carry out a large-scale search and analysis of BoHV-4-U regulatory regions, in 
the context of which, factors belonging to the uterus microenvironment, like hormones, cytokines, 
prostaglandins and others, can be tested. Targeting genes and regions of gene expression regulation and 
the phenotypic analysis of the BoHV-4-U mutants represents a powerful tool to study the direct and 
indirect interactions of genes and genomic elements in a biological context as the uterus in this particular 
case. The classification of equivalent phenotypes carrying different types of mutations will provide insight 
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into functional networks and their constituting elements. A classification of mutants into functional clusters 
will contribute to identifying uncharacterized genes responsible for BoHV-4 strain adaptation to the uterine 
microenvironment. The established BoHV-4-U mutant’s library together with different endometrial cell 
types will cover a substantial amount of biological information of intrinsic value concerning the functional 
relationship of the targeted genes and the host background. The results obtained in the large-scale gene 
mutation analysis will be investigated as a whole for their functional relationship. 
The uterine adapted BoHV-4-U genome cloned as bacterial artificial chromosome, represents an important 
tool to understand the complex interactions between BoHV-4-U and uterine host cells and the effect of 
viral infection on endometrial metabolic and endocrine function, and antigen-processing pathways.  
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Bovine herpesvirus 4 immediate early 2 (Rta) gene is an essential gene and is duplicated in 
bovine herpesvirus 4 isolate U  
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Abstract 
 
The ORF50/Rta gene has been shown to be an essential gene for DNA replication and latency reactivation 
in many gammaherpesviruses. Although the BoHV-4 ORF50/Rta homolog, immediate early gene 2 (IE2), has 
been shown to activate several BoHV-4 early and late promoters in co-transfection assays, there is no direct 
proof of its real indispensability for progression of the virus to the lytic replication cycle in the context of 
the viral genome. 
In this study, a replication defective BoHV-4-V.test IE2 mutant was efficiently rescued, with respect to the 
production of infectious virus and DNA replication, upon the expression of BoHV-4 ORF50/Rta in trans. 
This mutant was able to normally growth and replicate only if Rta was provided in trans, demonstrating 
that even in BoHV-4, ORF50/Rta is the master replication switch gene.  
Surprisingly, in the course of our studies, we discovered that the IE2 gene is duplicated in the genome of 
BoHV-4-U.  
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Introduction 
 
Herpesvirus immediate early (IE) genes are expressed “immediately“ during cell infection without requiring 
any prior viral protein synthesis  for their expression; they are infact activated by host cell transcription 
factors, already present at the moment of infection(Staudt and Dittmer, 2007). BoHV-4 IE2 protein 
(homologous to Epstein-Barr virus replication and transcription activator, Rta, and thus designated BoHV-4 
Rta) encoded by open reading frame 50 (ORF 50) is well conserved among gammaherpesviruses 
(Zimmermann et al., 2001). BoHV-4 IE2 RNA is a spliced, 1.8 kb RNA, which is transcribed from left to right 
on the restriction map of the BoHV-4 genome from DNA contained in the 8.3 kb HindIII fragment F, and is 
the less abundant of two IE RNAs encoded by BoHV-4 (van Santen, 1991, 1993). The predicted amino acid 
sequence of the protein encoded by IE2 RNA reveals that it could encode a 61-kDa protein with amino acid 
sequence homology to the Epstein-Barr virus (EBV) transactivator R and its homolog’s in other 
gammaherpesviruses, including herpesvirus saimiri (SaHV-2), equine herpesvirus 2 (EHV-2), murine 
herpesvirus 68 (MuHV-68), rhesus rhadinovirus (RRV) and Kaposi’s sarcoma-associated herpesvirus (HHV-
8). Studies of HHV-8, MuHV68 and RRV demonstrated that the expression of ORF50/Rta is essential for viral 
replication; several recombinant viruses with deletion or inactivation by a premature stop codon insertion 
within its open reading frame were generated and were all replication-defective; but were efficiently 
rescued, with respect to production of viable virus and DNA replication, upon the expression of ORF50/Rta 
in trans (Pavlova et al., 2003; Xu et al., 2005; Zhou et al., 2010).  
Transactivation studies have shown that BoHV-4 Rta specifically transactivates expression of reporter genes 
linked to the promoter regulatory regions of all BoHV-4 early (E) and late (L) genes examined, including 
those encoding thymidine kinase and the BoHV-4 homologue of the herpes simplex virus type 1 (HSV-1) 
major DNA binding protein (Bermudez-Cruz et al., 1997; Bermudez-Cruz et al., 1998; van Santen, 1993; 
Zhang and van Santen, 1995). BoHV-4 Rta expression plays a pivotal role in initiating viral lytic replication, 
not only during reactivation of latently infected non-permissive cells but also during de novo infection of 
permissive cells (Donofrio et al., 2004a; Donofrio et al., 2004b; Donofrio et al., 2004c; van Santen, 1993). 
These results indicate that ORF50/Rta is essential for lytic viral reactivation and transactivation of viral 
genes contributing to DNA replication. Although the BoHV-4 IE2 gene has been well characterized in terms 
of gene structure, transcription and RNA post transcriptional processing (van Santen, 1993), it has not been 
demonstrated that the expression of ORF50/Rta is required for progression to the lytic replication cycle in 
the context of the viral genome. 
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We have demonstrated previously the activation of BoHV-4 lytic replication in a non-permissive cell line by 
over-expression of ORF50/Rta (Donofrio et al., 2004a), beginning to demonstrate the direct role of BoHV-4 
ORF50/Rta for the progression of the virus into the lytic cycle.  
The cloning of different isolates of BoHV-4 genome as bacterial artificial chromosomes (BAC) (Donofrio et 
al., 2009a; Donofrio et al., 2008c; Gillet et al., 2005a) allowed, in the present work, the generation of viral 
mutants targeting specific parts of the IE2 locus within the BoHV-4 genome, which provided further 
evidence that BoHV-4 ORF50/Rta is necessary to initiate and allow progression of BoHV-4 lytic replication. 
67 
 
Materials and Methods 
 
 
Cells and Stable cell  l ines generation 
Bovine Embryo Kidney [(BEK) from M. Ferrari, Istituto Zooprofilattico Sperimentale, Brescia, Italy], and 
BEK/cre cell lines (Donofrio et al., 2008c) were cultured in Eagle’s Minimal Essential Medium (EMEM) 
(Lonza) containing 10% fetal bovine serum (FBS), 2 mM l-glutamine, 100 IU/ml penicillin (SIGMA) and 
100 μg/ml streptomycin (SIGMA). BEK/IE2 were cultured in Eagle’s minimal essential medium (EMEM) 
(Lonza) containing 10% fetal bovine serum (FBS), 2 mM l-glutamine, and 100 IU/ml penicillin (SIGMA). For 
establishment of stable IE2-expressing cell lines, confluent BEK cells in a 75 cm2 flask were detached with 
trypsin, washed with Dulbecco’s modified essential medium/high (D-MEM/high), and transfected with 
p2xCMVeIE2neo, pCMV-ORF50-IRES-neo, or pCMV-ORF50-IRES-hygro. DNA plasmids (15 μg) in 500 μl D-
MEM/high without serum were electroporated (Equibio apparatus, 270 V, 960 μF, 4-mm gap cuvettes) into 
BEK cells; electroporated cells were immediately returned to a 25 cm2 flask in complete EMEM with FBS. A 
control BEK 25 cm2 flask was also seeded with un-transfected cells for every transfection. Cells were 
incubated at 37 °C in a humidified atmosphere of 95% air–5% CO2. Six hours after electroporation cells 
were subjected to selection by specific antibiotics: BEK transfected with p2xCMVeIE2neo were selected in 
700 µg/ml of G418, BEK transfected with pCMV-ORF50-IRES-neo with 900 µg/ml of G418, and BEK 
transfected with pCMV-ORF50-IRES-hygro with 200 µg/ml of Hygromicin B; control un-transfected BEK 
were subjected to the same selection as the transfected ones. These concentrations of selective antibiotics 
resulted in death of all the control cells. Cells were sub-cultured to a fresh culture vessel when growth 
reached 70–90% confluence (i.e., after 15 days) and seeded in a new flask; single colonies were recovered 
and screened by RT-PCR for the presence of IE2 gene. Stable cell lines containing p2xCMVeIE2neo were 
named BEK/IE2, and those containing pCMV-ORF50-IRES-hygro or neo were named BEK/ORF50 (hygro or 
neo). They were maintained in complete EMEM complemented with the same concentrations of antibiotics 
used for selection. 
 
Viruses 
BoHV-4-U, BoHV-4-U/IE2pr, BoHV-4-UΔORF50, BoHV-4-LVR, BAC-BoHV-4-LVR/IE2pr, and BAC-BoHV-4-
LVRΔORF50 and BAC BoHV-4 U ΔORF50 IgKE2VP2
2800gD106 and BAC BoHV-4 U ΔORF50-double mutants 
were propagated by infecting confluent monolayers of BEK, BEK/IE2 or MDBK cells at a multiplicity of 
infection (m.o.i.) of 0.5 50% tissue culture infectious doses (TCID50) per cell and maintained in Eagle’s 
minimal essential medium (EMEM) (Lonza) with 2% FBS for 2 h. The medium was then removed and 
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replaced by fresh EMEM containing 10% FBS. When approximately 90% of the cell monolayer exhibited CPE 
(approximately 72 h post-infection), the virus was prepared by freezing and thawing cells three times and 
pelleting the virions through 30% sucrose, as described previously (Donofrio et al., 2009b) . Virus pellets 
were resuspended in cold MEM without FBS. TCID50 were determined with BEK, BEK/IE2, and BEK/ORF50 
cells by limiting dilution. 
 
Plasmid Constructs 
pCMV-ORF50-IRES-neo or hygro were obtained by subcloning a 1669 bp NheI/BamHI fragment, amplified 
by PCR from BoHV-4 DNA using a forward primer containing an atg translational initiation codon and 
matching the beginning of the ORF 50 second exon (Full-IE2-sense-NheI, Table 2), and a reverse primer 
matching the end of the second exon including the stop codon (Full -IE2-anti-BamHI, Table 2), into the 
Multiple Cloning Site (MCS) of bicistronic vectors pIREShyg2 or pIRESneo2 (Clontech). 
pIE2neo was obtained by subcloning the 3442 bp EcoRI/PstI fragment of BoHV-4 IE2 (van Santen, 1993) in 
pEGFP-C1, used as a vector backbone containing a neo resistant cassette for G418 drug selection, cut with 
EcoRI and PstI. 
p2xCMVeIE2neo was obtained by subcloning first the 231 bp NdeI/BglII fragment of hCMV enhancer 
promoter generated from pEGFP-C1 by PCR, using the primer pair NdeI-hCMV-sense/ BglII-hCMV-anti 
(Table 2), then the 438 bp BglII/HindIII fragment of hCMV enhancer promoter generated from pEGFP-C1 by 
PCR, using the primer pair BglII-hCMV-sense/ HindIII-hCMV-anti, in pIE2neo (Table 2).  
pIE2prKanaGalKIE2pr was obtained by subcloning first a 593 bp EcoRI/PstI fragment of BoHV-4 IE2 (TargI-
sense/Anti I amplicon, Table2, Accession number: NC002665) in pTZΔlinker KanaGalk vector, cut with EcoRI 
and PstI, and then a 932 bp KpnI/HindIII fragment (Sense II amplicon/Anti II amplicon, Table 2), into the 
vector, cut with KpnI and HindIII. 
pTZKanaGalK was obtained by subcloning the 2231 bp galactokinase prokaryotic expression cassette (GalK), 
along with the kanamycin resistant expression cassette (KanaGalK) by PCR from pINT2KanaGalK (Donofrio 
et al., 2007b), into pTZ57R cut by KpnI and PstI. pTZKanaGalK was cut with EcoRI/KpnI to insert the first  IE2 
1001 bp amplicon (Delta ExonII A/Delta Exon II B, Table 2), amplified by PCR and cut with the same 
enzymes; in this intermediate construct, cut with PstI/HindIII, was sub-cloned the second IE2 1038 bp 
amplicon, amplified by PCR (Delta Exon II C/Delta Exon II D, Table 2) and cut with PstI/HindIII to generate 
pORF50KanaGalK. 
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pTK-KanaGalK-TK, was generated by sub-cloning the galactokinase prokaryotic expression cassette (GalK), 
along with the kanamycin resistant expression cassette into the pINT2 shuttle vector (Donofrio et al., 
2007b). 
The AseI/MluI fragment from p IgKE2VP2
280 0gD106  (Capocefalo et al , 2010.)  was sub-cloned in 
pORF50KanaGalK  after a KpnI/PstI double digestion and by a blunt-end reaction, to obtain 
PORF50LEFT/IGKE2VP2
20 70 -20 83
GD106 /ORF50RIGHT. 
pORF50KanaGalK was further modified through the insertion firstly of the 273bp X-amplicon (EcoRI-X-
sense, KpnI-X anti), restricted with EcoRI/KpnI, in the vector backbone, restricted with the same enzyme; 
and then of the 261bp Y-amplicon (PstI-Y-sense, HindIII-Y-anti), cut with PstI/HindIII and inserted in the 
vector cut with the same enzyme, to generate pORF50-X-KanaGalK-ORF50-Y. X and Y have been designed to 
amplify the IE2 region of the II exon, deleted during the first step of targeting. 
 
Transient Transfection 
Confluent BEK cells in twenty four-well plates were co-transfected with 0.5 g of pIE2prom-Luc (containing 
137, 337, 537 or 1122 nt of the IE2 promoter region ) or 0.5 g pGL3 empty vector, as a negative control 
and 0.05 g of pRK-Renilla to normalize the efficiency of transfection, using LTX transfection reagent 
(Invitrogen, UK) as suggested by the manufacturer. Transfection mixture was prepared in DMEM/high 
without serum and antibiotics and left on the cells for 6 h at 37oC, 5% CO2 in air, in a humidified incubator. 
After 6 h, the transfection mixture was replaced with complete medium (EMEM, 10% FBS, 50 IU/ml 
penicillin, 50 g/ml streptomycin and 2.5 g/ml Amphotericin B) and left to recover for 18 h at 37oC, 5% 
CO2 in air, in a humidified incubator. 24 h post transfection, cells were treated with different reagents to 
perform luciferase assay. 
 
Luciferase reporter assay 
Luciferase reporter assay was performed with a Dual Luciferase Reporter Assay System kit (Promega) with 
minor modifications. Following treatments, cells were washed with PBS, lysed with 100 l of lysis passive 
buffer by freeze-thawing at -80 °C. 10 l of the cell lysate was added to 50 l of Luciferase Assay Reagent 
(LAR) and Luciferase activity was determined with a PerkinElmer Victor3 Multilabel Counter, according to 
the manufacturer’s specifications. Individual assays were normalized for Renilla luciferase activity with a 
second reading, adding 50 l of Stop & Glo substrate. 
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Experiments were performed with 4 replicates and each experiment repeated three times and statistical 
differences were tested by Student’s t test 
 
RNA extraction and RT-PCR 
Total RNA from BEK/IE2 and BEK/ORF50 cells was extracted with TriPure reagent (Roche) and 2 μg of total 
RNA were reverse transcribed using Ready-To-Go, T-Primed First-Strand Kit (Amersham Biosciences). Two 
microliters of resulting cDNA were amplified in a final volume of 50 μl of 10 mM Tris–hydrochloride, pH 8.3, 
containing 0.2 mM deoxynucleotide triphosphates, 3 mM MgCl2, 50 mM KCl, 1 U of Taq polymerase 
(Invitrogen) and 0.25 μM of each primer (IE2-A-sense/IE2-B-antisense, Accession Number NC002665, Table 
2). Primers were selected from the published sequence of BoHV-4 genome (Zimmermann et al., 2001). The 
amplification program was 30 cycles, each cycle consisting of denaturation at 94 °C for 1 min, primer 
annealing at 55 °C for 1 min, and chain elongation with at 72 °C for 2 min.  
 
BAC BoHV-4-A recombineering and selection 
Recombineering was performed as previously described (Donofrio et al., 2009a; Donofrio et al., 2008c) with 
some modifications. SW102 bacteria containing BAC-BoHV-4-U and BAC-BoHV-4-LVR were grown, heat 
induced and electroporated with a gel-purified 3146 bp fragment (IE2prKanaGalKIE2pr) obtained by cutting 
pIE2prKanaGalKIE2pr (pTZΔlinker I-II amplicon IE2) with EcoRI (Fermentas). After recovery of 1 h in a 32°C 
shaking water bath, bacterial serial dilutions were plated on M63 minimal medium plates (agar 15 g/l; 
(DIFCO, BD Biosciences), 0.2% D-galactose (SIGMA), 1 mg/l D-biotin (SIGMA), 45 mg/l L-leucine (SIGMA) and 
50 mg/l kanamycin (SIGMA). Plates were incubated 3–5 days at 32 °C. Several selected colonies were 
picked, streaked on McConkey agar indicator plates (DIFCO, BD Biosciences) containing 12.5 μg/ml of 
chloramphenicol and incubated at 32 °C for 3 days until white colonies appeared. White colonies were 
grown in duplicate for 5–8 h in 0.5 ml of LB containing 50 μg/ml of kanamycin or LB containing 12.5 μg/ml 
of chloramphenicol. Only those colonies growing on chloramphenicol and on kanamycin were kept and 
grown overnight in 5 ml of LB containing 12.5 μg/ml of chloramphenicol. BAC-BoHV-4-U/IE2pr and BAC-
BoHV-4-LVR/IE2pr were purified and analyzed through EcoRI restriction enzyme digestion for 
pIE2prKanaGalKIE2pr fragment targeted integration. 
To delete IE2 Exon II, SW102 bacteria containing BAC-BoHV-4-U/IE2pr and BAC-BoHV-4-LVR/IE2pr were 
grown, heat induced and electroporated with a ~4.2 kb gel purified fragment (pORF50KanaGalkORF50) 
obtained by cutting pORF50KanaGalK with HindIII/EcoRI (FERMENTAS). Selection step, plating of dilutions, 
and selection of clones were performed as above. BAC-BoHV-4-UΔORF50 and BAC-BoHV-4-LVRΔORF50 
were purified and analyzed through PstI or BamHI restriction enzyme digestion for pORF50KanaGalKORF50 
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fragment targeted integration. Retargeting in BAC-BoHV-4-UΔORF50 was done electroporating the 
≈4428bp PvuII fragment excised out from pORF50LEFT/ IgKE2VP2
2070-2883gD106/ORF50RIGHT in SW102 
bacteria containing BAC-BoHV-4-UΔORF50 and heat induced. After a recovery step of 4 hours bacteri a 
serial dilution were plated on M63 minimal medium plates (agar 15 g/l; (DIFCO, BD Biosciences), 0.2% 
Deoxy-2-galactose (DOG)(SIGMA), 1 mg/l D-biotin (SIGMA), 45 mg/l L-leucine (SIGMA) and 12.5 mg/l 
chloramphenicol (SIGMA) and incubated at 32 °C for 5 days until white colonies appeared. White colonies 
were grown in duplicate for 5–8 h in 0.5 ml of LB containing 50 μg/ml of kanamycin or LB containing 
12.5 μg/ml of chloramphenicol. Only those colonies growing on chloramphenicol but not on kanamycin 
were kept and grown overnight in 5 ml of LB containing 12.5 μg/ml of chloramphenicol. BAC-BoHV-4 U 
ΔORF50-IgKE2VP2
2070-2883gD106were purified and analyzed through BamHI restriction enzyme digestion for -
IgKE2VP2
2070-2883gD106 fragment targeted integration. 
To delete the second copy of IE2 Exon II, SW102 bacteria containing BAC-BoHV-4 U ΔORF50-IgKE2VP2
2070-
2883gD106 were grown, heat induced and electroporated with a ~2.74 kb gel purified fragment (pORF50X-
KanaGalkORF50-Y) obtained by cutting pORF50-X-KanaGalK-y with HindIII/EcoRI (FERMENTAS). Selection 
step, plating of dilutions, and selection of clones were performed as above, for the description of BAC-
BoHV-4-UΔORF50 generation. 
Original detailed protocols for recombineering can also be found at the recombineering website 
(http://recombineering.ncifcrf.gov). 
 
Restriction enzyme analysis and non-isotopic Southern hybridization 
BAC-BoHV-4-U, BAC-BoHV-4-U/IE2pr, BAC-BoHV-4-UΔORF50, BAC-BoHV-4-LVR, BAC-BoHV-4-LVR/IE2pr, 
BAC-BoHV-4-LVRΔORF50, BAC-BoHV-4 U ΔORF50-IgKE2VP2
2070-2883gD106  and BAC-BoHV-4-UΔORF50-double 
mutant recombinants were characterized as previously described (Donofrio et al., 2009b). Fifteen 
microliters of DNA prepared from bacteria containing pBAC-BoHV-4-U and pBAC-BoHV-4-LVR and 
derivatives, were restriction enzyme digested, separated by electrophoresis overnight in a 0.8% agarose 
gel, stained with ethidium bromide, capillary transferred to a positively charged nylon membrane (Roche), 
and cross-linked by UV irradiation by standard procedures. The membrane was pre -hybridized in 50 ml of 
hybridization solution (7% SDS, 0.5 M phosphate, pH 7.2, 1 mM EDTA) for 2 h at 65 °C in a rotating 
hybridization oven (Techna instruments). Probe preparation and digoxigenin non-isotopic labelling was 
performed by PCR (Donofrio et al., 2009a), using ORF50-del-sense and ORF50-del-antisense primers or 
Kana primers (SmaI-AseI-kana sense: 5’-aac ccc cgg gat taa tcc gga att gcc agc tgg gg-3’; SmaI-MluI-Kana 
anti: 5’-cca acc cgg gac gcg tga aat tgt aag cgt taa taa t-3’). Five microliters of the probe were added to 
100 μl of ddH2O, denatured in boiling water for 5 min, and cooled on ice for another 2 min. Denatured 
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probe was added to hybridization solution and membrane hybridized overnight at 65 °C in a rotating 
hybridization oven (Techna Instruments). Following hybridization, the membrane was washed and blocked 
in 50 ml of blocking solution. Anti-digoxigenin Fab fragment (150 U/200 μl [Roche]), diluted 1:15,000 in 
50 ml of blocking solution, was applied to the membrane and detection was performed following 
equilibration of the membrane in detection buffer for 2 min at room temperature. Chemiluminescent 
substrate (CSPD, Roche) was added by scattering the drops over the surface of the membrane after 
placement of the membrane between two plastic sheets, and any bubbles present under the sheet were 
eliminated with a damp lab tissue to create a liquid seal around the membrane. Signal detection was 
obtained by exposing the membrane to X-ray film. The exposure time was adjusted with the intensity of the 
signal. 
 
Cell  culture electroporation and recombinant virus reconstitution  
BEK and BEK/cre cells were cultured and transfected as previously described (Donofrio et al., 2009b). BEK or 
BEK/cre cells were maintained as a monolayer with complete medium containing 90% EMEM, 10% FBS, 
2 mM l-glutamine, 100 IU/ml penicillin and 10 μg/ml streptomycin. Cells were sub-cultured to a fresh 
culture vessel when growth reached 70–90% confluence (i.e., every 3–5 days) and were incubated at 37 °C 
in a humidified atmosphere of 95% air–5% CO2.  
BAC-BoHV-4-U, BAC-BoHV-4-LVR, BAC-BoHV-4-U/IE2pr, BAC-BoHV-4-LVR/IE2pr, BAC-BoHV-4-UΔORF50, 
BAC-BoHV-4-LVRΔORF50, BAC-BoHV-4 U ΔORF50-IgKE2VP2
2070-2883gD106,BAC-BoHV-4-UΔORF50-double 
mutant, BAC-BoHV-4-UΔTK and BAC-BoHV-4-LVRΔTK DNA plasmid (5 μg) in 500 μl D-MEM/high without 
serum were electroporated (Equibio apparatus, 270 V, 960 μF, 4-mm gap cuvettes) into BEK or BEKcre cells 
from a confluent 25-cm2 flask. Electroporated cells were returned to the flask, fed the next day, and split 
1:2 when they reached confluence at 2 days post-electroporation. Cells were left to grow until CPE 
appeared. Recombinant viruses were propagated by infecting confluent monolayers of BEK cells at a m.o.i. 
of 0.5 TCID50 per cell and maintaining them in EMEM with 10% FBS for 2 h. The medium was then removed 
and replaced by fresh EMEM containing 10% FBS. When approximately 90% of the cell monolayer exhibited 
CPE (approximately 72 h post-infection), the virus was prepared by freezing and thawing cells three times 
and pelleting virions through 30% sucrose. Virus pellets were resuspended in ice cold EMEM without FBS. 
TCID50 were determined on BEK or MDBK cells by limiting dilution. 
5 μg of BAC-BoHV-4-UΔORF50, BAC-BoHV-4-LVRΔORF50, BAC-BoHV-4 U ΔORF50-IgKE2VP2
2070-2883gD106  and 
BAC-BoHV-4-UΔORF50-double mutant in 500 μl DMEM/high without serum were also electroporated 
(Equibio apparatus, 270 V, 960 μF, 4-mm gap cuvettes) into BEK/IE2 or BEK/ORF50 cells from a confluent 
25-cm2 flask. Following electroporation,  cells were recovered in a new 75-cm2 flask with 25 ml of EMEM and 
10% fetal bovine serum to allow cells to attach. Cells were left to grow until CPE appeared. Recombinant 
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viruses were propagated by infecting confluent monolayers of BEK/IE2 or BEK/ORF50 cells at a m.o.i. of 0.5 
TCID50 per cell. When complete CPE appeared, the virus was prepared as described before. TCID50 were 
determined on BEK/IE2 or BEK/ORF50 cells by limiting dilution. 
 
Viral growth curves 
BEK/IE2 and BEK/ORF50 cells were infected with BAC-BoHV-4-LVR and BAC-BoHV-4-LVRΔORF50 at a MOI of 
1 TCID50/cell and incubated at 37 °C for 4 hours. Infected cells were washed
 with serum free EMEM and 
then overlaid with EMEM containing 10% fetal bovine serum (FBS), 2 mM l-glutamine, 100 IU/ml penicillin 
(SIGMA), 100 μg/ml streptomycin (SIGMA) and 2.5 μg/ml Amphotericin B. The supernatants of infected 
cultures were harvested after 12 hours and then every 24 hours, and the amount of infectious  virus was 
determined by limiting dilution on BEK/IE2 or BEK/ORF50 cells. 
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Results  
 
Firstly, based on the hypothesis that the IE2 gene is essential for initiation and progression of BoHV -4 lytic 
replication, IE2 expressing cell lines were generated to rescue IE2-defective BoHV-4 in trans. 
A cell line, BEK/IE2, was created, which contains a 3442-bp EcoRI/PstI BoHV-4 genome fragment including 
the full BoHV-4 IE2 gene and its promoter-regulatory region (van Santen, 1993) (Fig. 16A).  
 
Fig. 16. A) BoHV-4 IE2 (ORF 50) genomic locus schematic diagram (not to scale) based on the BoHV-4-66p347 complete genome 
published sequence (GenBank accession number AF318573). ORF 50 is formed by splicing of Exon I, beginning at the 
transcriptional start site (+1, 62523) indicated by an arrow and containing the atg (62591), to Exon II. ORFs 48 and 49 are l ocated 
on the opposite strand as ORF50; ORF 49 is contained within the ORF 50 intron, below, the EcoRI/PstI fragment containing the 
minimal promoter (dashed line) and employed to generate pIE2neo construct (in C).  
 
The transcriptional activity of the IE2 promoter region was evaluated by Luciferase assay, by subcloning 
different region of the promoter: 137 bp, 337 bp, 537 bp and 1122 bp containing the TATA box, the 
transcriptional start site and the first 15 non-coding nucleotides (UTR) of the first exon  were obtained by 
PCR and sub-cloned in front of the Luciferase ORF (Luc) in the pGL3 basic vector. Constructs were 
transiently co-transfected with pTK-Renilla for data normalization, into Human Embryo Kidney cells (ATCC, 
CRL-1573, USA) and Luciferase reporter assay was performed with a Dual Luciferase Reporter Assay System 
kit.  
537 bp 5’ to the IE2 transcription start site in the 3442-bp EcoRI/PstI fragment were shown to comprise the 
minimal IE2 promoter-regulatory region giving the maximal signal in a Luciferase reporter assay (Fig. 16B).  
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Fig.16.B) Transcriptional activity of different IE2 promoter region sub-cloned in front of the Luciferase ORF (Luc.) in the pGL3 
basic vector. Each reaction was done in quadruplicate, and each point represents the average ± standard deviation (±S.D.) from 
three experiments ( P<0.001). 
 
To increase IE2 expression, two copies of a 427-bp sequence containing the hCMV enhancer but lacking the 
basal promoter (TATA box and transcriptional start site) were inserted in front of the 3442-bp EcoRI/PstI 
BoHV-4 genome fragment and subcloned into a vector backbone containing a neo resistant cassette for 
G418 drug selection (p2xCMVeIE2neo) (Fig. 16C and D). IE2 mRNA was expressed at higher levels from 
p2xCMVeIE2neo than from the un-enhanced expression construct, pIE2neo (Fig. 16C), containing only the 
3442-bp EcoRI/PstI BoHV-4 genome fragment, when tested by transient transfection assay and RT-PCR (Fig. 
16E). p2xCMVeIE2neo was used to generate BEK/IE2, stably expressing IE2. 
 
 
Fig.16.C) pIE2neo vector diagram (not to scale) showing the EcoRI/PstI fragment (in A, bottom), sub-cloned into a vector 
containing a neo expression cassette for G418 selection. D) p2xCMVeIE2 vector diagram (not to scale) where the human 
cytomegalovirus enhancer (CMVe), obtained from pEGFP-C1 vector (Clontech), has been inserted in duplicate upstream of the 
EcoRI/PstI fragment into pIE2neo. 
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Fig.16. E) Semi-quantitative differential expression between pIE2neo and p2xCMVeIE2neo tested by RT-PCR. The primers  
employed generate an amplicon of 386-bp in length from the spliced product of IE2 transcripts. The experiment was repeated 
three times giving similar results. RT-PCR detecting RNA transcribed from GAPDH house-keeping gene is shown as a control.  
 
BoHV-4 IE2 gene contains even the ORF49 within its intron, which is transcribed in the opposite direction of 
ORF50 (Fig. 16A) so, to exclude the possibility that a defect in the expression of ORF 49 expression could be 
responsible for or contribute to a replication defective phenotype; a cell line (BEK/ORF50) expressing only 
the ORF50 was generated. The complete ORF 50 that encodes only the complete Rta protein was generated 
by PCR using a forward primer containing an atg translational initiation codon and the rest of the primer 
sequence matching the beginning of the ORF 50 second exon, and a reverse primer matching the end of the 
second exon including the stop codon. The amplicon was cloned into a bi-cistronic vector containing an 
internal ribosomal entry site (IRES) followed by a selectable marker (neo or Hygromycin) (pCMV-ORF50-
IRES-neo and pCMV-ORF50-IRES-Hygromicin; Fig. 16F) and used to generate a stable cell line expressing 
only ORF50/Rta (BEK/ORF50). Both BEK/IE2 and BEK/ORF50 stably expressed ORF50 through at least six 
passages when tested by RT-PCR (Fig. 16G). Furthermore, a morphological change characterized by 
increased cell sprouting and shrinking, although completely compatible with cell survival and replication, 
was observed for BEK/IE2 and BEK/ORF50 cell lines (data not shown).  
 
Fig.16. F) Diagram (not to scale) of the bi-cistronic expression vector, pCMV-ORF50-IRES-neo or Hygro, made by sub-cloning the 
ORF50 coding region obtained by PCR, into pIRES-neo or pIRES-Hygro (Clontech, Mountain View, USA). G) RT-PCR analysis of ORF 
50 mRNA expression in BEK cells stably transfected with p2xCMVeIE2 neo (BEK/IE2) and pCMV-ORF50-IRES-neo (BEK/ORF50) at 
passages 1, 3 and 6. 
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To investigate the role of ORF50/Rta expression in initiating the BoHV-4 transcriptional/replication cycle, 
the BoHV-4 IE2 gene was interrupted in its 5’ untranslated region by site specific insertional mutagenesis 
mediated by heat inducible homologous recombination into the genome of two strains of BoHV -4 cloned as 
bacterial artificial chromosome (BAC): the BAC-BoHV-4-U genome, cloned from a BoHV-4 uterine isolate 
(Donofrio et al., 2009a) and the BAC-BoHV-4-V.test genome, cloned from the BoHV-4-V.test reference 
strain (Gillet et al., 2005a), respectively. A targeting construct, pIE2prKanaGalKIE2pr, containing the 2004-
bp KanaGalK DNA stuffer double selecting cassette (Donofrio et al., 2007b) flanked by two BoHV-4 IE2 gene 
homologous regions, was inserted between the putative IE2 transcriptional start site [based on the IE2 
transcriptional start site identified in the BoHV-4 DN-599 isolate (van Santen, 1993)] and the IE2 
translational start site (ATG) positioned in the IE2 gene first exon (Fig. 17A).  
 
 
Fig.17. A) The 2204-bp Kana/GalK selectable DNA stuffer, flanked by IE2 homologous regions, was introduced at position 62582, 
between the IE2 gene transcriptional start site and the first atg of the BoHV-4-U and BoHV-4-V.test strains cloned as BAC. The 
expected IE2 targeted locus (A, bottom) has an increased size of the EcoRI fragment (3119 bp instead of 915 bp), generated by 
EcoRI restriction enzyme digestion (diagrams are not to scale). 
 
Then, the targeting cassette was electroporated into SW102 E. coli containing BAC-BoHV-4-U and BAC-
BoHV-4-V.test genomes, to produce BAC-BoHV-4-U/IE2pr and BAC-BoHV-4-V.test/IE2pr. Selected targeted 
clones were analyzed by PCR and sequencing, EcoRI restriction enzyme digestion, and Southern 
hybridization. All the clones analyzed displayed the expected targeting (Fig. 15B).  
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Fig.17. B) EcoRI restriction profile and Southern blotting of 4 representative targeted clones compared to the untargeted control. 
The expected targeting, shows a new 3119 bp band (indicated by arrow) that misses in the untargeted control, Southern blotting  
with a probe (indicated in Fig.15.A) matching the Kana/GalK sequence, confirmed the data. 
Two control mutant viruses, constructed by the insertion of the same DNA stuffer into the BAC-BoHV-4-U 
(BAC-BoHV-4-UΔTK) (Donofrio et al., 2009a) and BAC-BoHV-4-V.test (BAC-BoHV-4-V.testΔTK) (Gillet et al., 
2005a)TK ORF were employed as controls in a viral reconstitution assay to test the competence of BAC-
BoHV-4-U/IE2pr and BAC-BoHV-4-V.test/IE2pr DNA to reconstitute infectious replicating viral particles 
(Infectious Replicating Viral Particles, IRVPs). BEK cells or BEK expressing cre, to excise the floxed BAC 
cassette (Donofrio et al., 2008c), were electroporated with BAC-BoHV-4-U, BAC-BoHV-4-V.test, BAC-BoHV-
4-UΔTK, BAC-BoHV-4-V.testΔTK, BAC-BoHV-4-U/IE2pr and BAC-BoHV-4-V.test/IE2pr DNA. As expected, the 
BAC-BoHV-4-V.test/IE2pr genome could not reconstitute IRVPs when electroporated into either BEK or 
BEK/Cre cells.  
Although a phenotype identical to BAC-BoHV-4-V.test/IE2pr was expected for BAC-BoHV-4-U/IE2pr, to the 
contrary, BAC-BoHV-4-U/IE2pr could reconstitute IRVPs efficiently as well as control BAC-BoHV-4-UΔTK, 
BAC-BoHV-4-V.testΔTK, BAC-BoHV-4-U and BAC-BoHV-4-V.test DNA, as shown by forming plaques on the 
cell monolayer and the spreading of the cytopathic effect (CPE) over time (Fig. 18.A). 
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Fig. 18. A) Representative images (10X) of BEK and BEK expressing cre (BEK/cre) electroporated with BAC-BoHV-4-U, BAC-BoHV-
4-V.test, BAC-BoHV-4-UΔTK, BAC-BoHV-4-V.testΔTK, BAC-BoHV-4-U/IE2pr and BAC-BoHV-4-V.test/IE2pr DNA. CPE induced by  
reconstitution of IRVPs is recognizable only for BAC-BoHV-4-U, BAC-BoHV-4-V.test, BAC-BoHV-4-UΔTK, BAC-BoHV-4-V.testΔTK, 
BAC-BoHV-4-U/IE2pr and not for BAC-BoHV-4-V.test/IE2pr The test was repeated three times always giving identical results. 
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BoHV-4-U/IE2pr reconstituted progeny viruses could still transcribe the IE2 gene, while BAC-BoHV-4-
V.test/IE2pr could not, as expected (data not shown). When BAC-BoHV-4-V.test/IE2pr DNA was 
electroporated into BEK/IE2 (Fig. 18.B) and BEK/ORF50 (not shown) complemented cells, IRVPs were 
reconstituted efficiently, thus linking BoHV-4-V.test viral reconstitution and replication with IE2 expression. 
 
Fig.18 B) Representative images (10X) of CPE induced by reconstitution of IRVPs, rescued in cells expressing ORF50 (BEK/IE2 
cells) are shown. Similar results were obtained in BEK/ORF50 cells). 
 
An alternative approach to disrupt the IE2 gene was then employed. BAC-BoHV-4-U and BAC-BoHV-4-V.test 
genomes were generated that contained a 488-bp deletion in the second exon of IE2; through the insertion 
of the 2204-bp Kana/GalK selectable DNA stuffer between positions 63905 and 64393 of the BoHV -4-U and 
BoHV-4-V.test strains cloned as BAC (Fig. 19A). Selected targeted clones were carefully analyzed by 
restriction enzyme digestion, Southern hybridization (Fig. 19B), PCR and sequencing (data not shown). 
 
Fig. 19. A) Overall strategy to delete a 488-bp sequence from the IE2 gene Exon II, via heat inducible homologous recombination.  
The expected IE2 targeted locus (A, bottom) has an increased size of the PstI fragment (8710 bp instead of 8005 bp), generated 
by PstI restriction enzyme digestion (diagrams are not to scale). 
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Fig.19.B) PstI restriction profile and corresponding Southern blotting of representative targeted clones compared to the 
untargeted controls. The targeted clones display the expected targeting, where a new 8710-bp band (indicated by arrow) is 
present but missing in the untargeted control and confirmed by Southern blotting with a probe (indicated in Fig.17.A) matching  
the Kana/GalK sequence. 
 
Representative targeted clones were finally electroporated into BEK cells expressing or not expressing cre. 
As before, BAC-BoHV-4-UΔORF50 but not BAC-BoHV-4-V.testΔORF50, maintained the capability to 
reconstitute IRVPs (Fig. 20A). Again, when BAC-BoHV-4-V.testΔORF50 DNA was electroporated into BEK/IE2 
and BEK/ORF50 complementing cells, IRVPs were reconstituted efficiently (Fig. 20B), as well as control BAC-
BoHV-4-U, BAC-BoHV-4-V.test, BAC-BoHV-4-UΔTK, BAC-BoHV-4-V.testΔTK DNA (data not shown). 
BAC-BoHV-4-V.testΔORF50 replication characteristics were identical to BAC-BoHV-4-V.test ones, when the 
replication curve was performed in BEK/IE2 cells (Fig. 20C), whereas, an accelerated replication phenotype 
of the BAC-BoHV-4-V.test was observed when replicated in BEK/IE2 cells compared to replication in BEK 
cells.  
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Fig. 20. A) Representative images (10X) of BEK and BEK expressing cre (BEK/cre),electroporated with BAC-BoHV-4-UΔORF50 and 
BAC-BoHV-4-V.testΔORF50 DNA. CPE induced by reconstitution of IRVPs is recognizable only for BAC-BoHV-4-UΔORF50 and not 
for BAC-BoHV-4-V.testΔORF50. The test was repeated three times, giving always identical results; and B) Representative images 
(10X) of CPE induced by reconstitution of IRVPs, rescued in cells expressing ORF50 (BEK/IE2 cells are shown. Similar results were 
obtained in BEK/ORF50 cells). 
 
 
Fig.20. C) Replication kinetics of BAC-BoHV-4-V.test in BEK cells (white squares), BAC-BoHV-4-V.test in BEK/IE2 cells (black 
squares), BAC-BoHV-4-V.testΔORF50 in BEK cells (black triangles) and BAC-BoHV-4-V.testΔORF50 in BEK/IE2 (white triangles). 
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RT-PCR revealed that mRNA containing the full-length 1659 bp ORF50 was still expressed in BAC-BoHV-4-
U/IE2pr and BAC-BoHV-4-UΔORF50 but not in BAC-BoHV-4-V.test/IE2pr and BAC-BoHV-4-V.testΔORF50 
(results not shown). Therefore, a possible duplication of IE2 gene in the BoHV -4-U genome was 
hypothesized. To determine whether the BoHV-4-U genome contains duplicate IE2 genes, a probe was 
generated that hybridizes to Exon II and thus to the fragment containing the BoHV -4 IE2 locus when cut 
with PstI and BamHI restriction enzymes (Fig. 21A). 
 
 
Fig. 21. A) BoHV-4 IE2 genomic locus schematic diagram (not to scale) with PstI and BamHI restriction site positions. The 
predicted sizes of the restriction fragments (8005 bp for PstI and 7154 bp for BamHI) are based on the BoHV-4-66p347 complete 
genome published sequence (accession number AF318573). 
 
 
 
When analyzed by PstI and BamHI restriction digestion and Southern blotting both the BoHV-4-U isolate 
and the BAC-BoHV-4-U genome showed the presence of two bands (Fig. 21B); such duplication was absent 
in the BoHV-4-V.test genome, where just a single band appeared. 
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Fig.21.B) Southern blotting of BAC-BoHV-4U (Lanes 1 and 2), BoHV-4-U isolate (Lanes 3 and 4) and control BAC-BoHV-4-V.test 
(Lane 5) DNA, cut with BamHI and PstI and hybridized with the IE2 exon II-specific probe indicated in Fig.19.A).  
 
 
To delete even the second gene copy of IE2 gene, a re-targeting construct, pORF50LEFT/IgKE2VP2
2070-
2083gD106/ORF50RIGHT, in which IgKE2VP2
2070-2883gD106 expression cassette (Capocefalo et al., 2010) is flanked 
by two BoHV-4 IE2 gene homologous region sequences, was generated. 
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The 2204-bp Kana/GalK DNA stuffer between positions 63905 and 64393 of the BAC-BoHV-4-UΔORF50 (Fig. 
22) was replaced by the IgKE2VP2
2070-2883gD106 expression cassette. Selected targeted clones were carefully 
analyzed by restriction enzyme digestion, Southern hybridization (Fig. 22B), PCR and sequencing (data not 
shown). 
 
 
Fig. 22. A) Overall strategy to replace the KanaGalk stuffer inserted in the IE2 gene Exon II, via heat inducible homologous  
recombination (diagrams are not to scale). 
 
 
When pBACBoHV-4 U ΔORF50-IgKE2VP2
2070-2883gD106 was electroporated into BEK or BEKcre cells viable virus 
was obtained in both case and the depletion of the floxed BAC cassette in the progeny virus was assessed 
by loss of the green fluorescence in the viral  plaques in consequence of the excision of the CMV-GFP 
expression cassette contained in the BAC plasmid backbone (data not shown).  
The duplicated IE2 gene was deleted via homologous recombination trough the insertion of a 220 6 bp 
KanaGalk cassette stuffer between position 63.905 and 64.393, that is the region already deleted in the IE2 
first copy gene (Fig.23A). 
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Fig.22.B) BamHI restriction profile and corresponding Southern blotting of representative targeted clones compared to the 
untargeted controls. The targeted clones display the expected targeting, where a new 6832-bp band (indicated by arrow) is 
present but missing in the untargeted control and confirmed by Southern blotting with a probe (indicated in Fig.20.A) matching  
the GalK sequence.  
Fig. 23.A) Overall strategy to insert the kanaGalk stuffer in the second gene copy of IE2 gene Exon II, via heat inducible 
homologous recombination (diagrams are not to scale).  
Selected targeted clones were carefully analyzed by restriction enzyme digestion, Southe rn hybridization 
(Fig. 23B), PCR and sequencing (data not shown). 
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Fig.23.B) EcoRI restriction profile and corresponding Southern blotting of representative targeted clones compared to the 
untargeted controls. The targeted clones display the expected targeting, where a new 3461bp band (indicated by arrow) is 
present but missing in the untargeted control and confirmed by Southern blotting with a probe matching the GalK sequence.  
 
Only the electroporation of pBACBoHV-4 U ΔORF50-double mutant in BEK/IE2 and BEK/ORF50 cells was 
able to rescue a viable virus from the BAC clones; as supposed it was not able to growth neither in BEK cells 
nor in BEK fincre cells (data not shown). 
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Discussion 
 
BoHV-4 IE2 protein (Rta) is encoded by ORF 50 and is well conserved among -herpesviruses (Zimmermann 
et al., 2001); studies from closely related viruses, as MuHV68, HHV-8 and RRV demonstrated that the 
expression of ORF50/Rta was essential for viral replication and lytic reactivation. Transactivation studies 
have shown that BoHV-4 Rta specifically transactivates expression of a reporter gene linked to the 
promoter regulatory region of the BoHV-4 early (E) gene encoding the BoHV-4 homologue of herpes 
simplex virus type 1 (HSV-1) major DNA binding protein. BoHV-4 Rta expression plays a primary role  in 
initiating viral lytic replication, not only during reactivation of latently infected non-permissive cells but also 
during de novo infection of permissive cells (Donofrio et al., 2004b; van Santen, 1993). Although BoHV-4 IE2 
gene was well characterized in terms of gene structure, transcription and RNA post transcriptional 
processing (van Santen, 1993), it has not been yet demonstrated that the expression of ORF50/Rta is 
required for progression to the lytic replication cycle in the context of the viral genome. 
A prior study focused on the results of exogenous expression of BoHV-4 ORF50/Rta, that lead the activation 
of BoHV-4 lytic replication in a non-permissive cell line by over-expression of ORF50/Rta (Donofrio et al., 
2004a), this study was the first attempt to demonstrate the direct role of BoHV-4 ORF50/Rta for the 
progression of the virus into the lytic cycle.  
BoHV-4 IE2 promoter was previously shown to be transcriptionally up-regulated in bovine endometrial 
stromal cells (Donofrio et al., 2007a; Donofrio et al., 2008b). To better understand the importance of such 
promoter in the context of viral replication on the endometrial cellular substrate we generate pBAC-BoHV-
4-U, starting from a uterine virus isolated from a cow affected by post-partum metritis (Donofrio et al., 
2009a). 
In the present work, we generated several viral mutants targeting specific parts of the IE2 locus within the 
BoHV-4 genome, demonstrating that ORF50/Rta has a direct role in initiating and progressing BoHV-4 lytic 
replication. 
Based on the hypothesis that IE2 gene is essential for initiation and progression of the BoHV-4 lytic 
replication, before to attempt the generation of BoHV-4 mutants un-expressing or lacking IE2 gene 
products, IE2 complemented cell lines were generated to rescue in trans the defect in IE2 gene. A cell line, 
BEK/IE2, was created with a 3442 bp EcoRI/PstI BoHV-4 genome fragment containing the full BoHV-4 IE2 
gene (van Santen, 1993) and expressing its ORF50 splicing product; to force IE2 expression a 427 bp 
sequence containing the hCMV enhancer promoter but lacking the basic transcriptional apparatus 
(TATAbox and transcriptional start site) was dimerized in front of the BoHV-4 537 bp IE2 promoter, which 
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was shown to be the minimal promoter size giving the maximal signal in a Dual Luciferase reporter assay, 
and present at the 5’ end of the 3442 bp EcoRI/PstI BoHV-4 genome fragment and subcloned into a vector 
backbone containing a neo resistant cassette for G418 drug selection (p2xCMVeIE2neo). 
p2xCMVeIE2neo was much better expressed then the un-enhanced version, pIE2neo containing only the 
3442 bp EcoRI/PstI BoHV-4 genome fragment when tested by transient transfection assay and RT-PCR. 
Because the BoHV-4 IE2 gene contains the ORF49 within its intron, which is transcribed on the opposite 
direction of the ORF50, it is theoretically possible that BEK/IE2 cells express both  ORF49 and ORF50 
products. Therefore, to exclude the possibility that defect in the expression of other genes present into the 
IE2 gene locus, specifically the ORF 49, which could be responsible or contribute for a replicating defective 
phenotype, as shown for MHV-68 (Lee et al., 2007), a cell line (BEK/ORF50) expressing only the ORF50 was 
generated. The ORF 50 spliced transcript that encodes the only and complete Rta protein was amplified by 
PCR and subcloned into a bi-cistronic vector generating pCMV-ORF50-IRES-neo that was used to generate a 
stable cell line expressing only the ORF50/Rta. Both these two cell lines, BEK/IE2 and BEK/ORF50/Rta stably 
expressed ORF50 through the passages when tested by RT-PCR and moreover, a morphological change, 
characterized by an increased cell sprouting and shrinking, but completely compatible with cell survival and 
replication, was observed for BEK/IE2 and BEK/ORF50 cell lines; such morphological change was probably 
due to IE2 over-expression, as previously observed for MHV-68 ORF50 (Staudt and Dittmer, 2007), but it 
requires further investigated to be fully stated. 
As a first step toward understanding the pivotal role of ORF50/Rrta expression in initiating BoHV-4 
transcriptional/replication cycle, BoHV-4 IE2 gene promoter was interrupted by site specific insertional 
mutagenesis mediated by heat inducible homologous recombination into the genome of two strains of 
BoHV-4 cloned as bacterial artificial chromosome (BAC) (Warming et al., 2005).The first targeting construct, 
pIE2prKanaGalKIE2pr, containing the KanaGalK 2004 bp DNA staffer double selecting cassette (Donofrio et 
al., 2007b) flanked by two BoHV-4 IE2 gene homologous regions, was inserted between the putative IE2 
transcriptional start site and the IE2 translational start site (ATG) positioned into the IE2 gene first exon 
(van Santen, 1993)  
The functionality of the targeting construct, in terms of transcriptional blocking was initially tested by 
transient transfection assay and RT-PCR and no ORF50/RTA spliced transcript could be detected (data not 
shown). BAC recombineering of the targeting cassette in the BAC-BoHV-4-U and BAC-BoHV-4-LVR genome, 
get BAC-BoHV-4-U/IE2pr and BAC-BoHV-4-LVR/IE2pr. Because the introduction of a 2004 bp staffer into the 
viral genome could impairs the viral replication due to the enlargement of the viral genome size, thus 
confusing the phenotypic effect induced by the inactivation of the IE2 promoter, two control parental 
mutant viruses, built by the insertion of the same 2004 bp staffer into the BAC-BoHV-4-U (BAC-BoHV-4-
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UΔTK) (Donofrio et al., 2009a) and BAC-BoHV-4-LVR (BAC-BoHV-4-LVRΔTK) (Donofrio et al., 2007b) TK ORF, 
which was already shown to be a BoHV-4 not dispensable gene (Donofrio et al., 2002), were employed as a 
control in a viral reconstitution assay to test the competence of the recombinant viruses. After 
electroporation in BEK cells or BEK expressing cre, BAC-BoHV-4-LVR/IE2pr genome could not reconstitute 
IRVPs, as expected. Although an identical phenotype to BAC-BoHV-4-LVR/IE2pr was expected for BAC-
BoHV-4-U/IE2pr, to the contrary, BAC-BoHV-4-U/IE2pr cold well reconstitute IRVPs, as well as control BAC-
BoHV-4-UΔTK, BAC-BoHV-4-LVRΔTK, BAC-BoHV-4-U and BAC-BoHV-4-LVR DNA. Furthermore still 
unexpectedly, BoHV-4-U/IE2pr reconstituted progeny virus could still transcribe IE2 gene, rather BAC-
BoHV-4-LVR/IE2pr could not and when BAC-BoHV-4-LVR/IE2pr DNA was electroporated into BEK/IE2 and 
BEK/ORF50 complemented cells, IRVPs were well reconstituted, linking BoHV-4-LVR viral reconstitution and 
replication with IE2 expression. 
For some reasons, the IE2 promoter abrogation strategy gave a non replicating competent phenotype just 
for BAC-BoHV-4-LVR but not for BAC-BoHV-4-U. Such reasons could be differently explained: ì) merely for a 
technical problem or badly designed strategy and experiments, but those did not seem to be the case 
because the targeting construct as well as the targeted viral genomes were finely checked by PCR, 
sequencing, restriction enzyme analysis and southern hybridization and not mistakes were found. ìì) for 
strain variations in terms of IE2 product requirement, where IE2 expression is dispensable for BAC-BoHV-4-
LVR strain but not for BAC-BoHV-4-U. 
Taking into account the later hypothesis, a forward approach to the problem was employed. The IE2 second 
exon containing most of the IE2 ORF was 488 bp deleted both in BAC-BoHV-4-U and BAC-BoHV-4-LVR 
genome. As before, the so generated BAC-BoHV-4-UΔORF50 but not BAC-BoHV-4-LVRΔORF50, maintained 
the capability to reconstitute IRVPs; and also when BAC-BoHV-4-LVRΔORF50 DNA was electroporated into 
BEK/IE2 and BEK/ORF50 complemented cells, IRVPs were well reconstituted, as well as control BAC-BoHV-
4-U, BAC-BoHV-4-LVR, BAC-BoHV-4-UΔTK, BAC-BoHV-4-LVRΔTK DNA. Even the, growth characteristics were 
identical to the LVR ones when growth curve was performed on BEK/IE2 cells. These growth kinetics data 
were completely in agreement with those of a MHV-68 mutant transcribing ORF50 at high level and 
showing more rapid lytic spread in permissive fibroblast cultures (May et al., 2004).  
Although with a different strategy, the necessity of IE2 gene integrity was shown only for BoHV -4-LVR but 
not for BoHV-4-U. Because the full length 1659 bp ORF50 mRNA was still expressed in BAC-BoHV-4-U/IE2pr 
and BAC-BoHV-4-UΔORF50 but not in BAC-BoHV-4-LVR/IE2pr and BAC-BoHV-4-LVRΔORF50; therefore, a 
possible duplication of IE2 gene in BoHV-4-U genome was hypothesized. 
This hypothesis was confirmed by generating a probe spanning the deleted region within the IE2 exon 2, 
and, as expected, was absent into BoHV-4-LVR genome. 
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The deletion of the other gene copy unable the replication competence of the virus; infact the recombinant 
virus was able to growth only in the lines complemented in trans with Rta protein. 
Although the full BoHV-4-U genome sequence would be necessary to finely allocate and define such 
duplication in the contest of the entire genome, this work represent the final proof on the essentiality of 
IE2 gene for BoHV-4, in agreement with what was found for other gamma herpesviruses like MuHV-68 
(Pavlova et al., 2003), HHV-8 (Xu et al., 2005) and RRV (Zhou et al., 2010). 
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Appendix 1:  
 
Table 2. List of primers used in this work.  
 
      Primer name                             Sequence 
Full-IE2-sense-NheI 5’-gct agc tag cca cca tga agg gga tta ttt atc cc-3’ 
Full-IE2-anti-BamHI 5’-gcg gga tcc tta cac aaa caa atc gag ggg gtt-3’ 
NdeI-hCMV-sense 5’-ggt gga gta ttt acg gta aac tgc cca-3’ 
BglII-hCMV-anti 5’-gga aga tct gca gtt acc ctc aaa caa aac-3’ 
BglII-hCMV-sense 5’-gga aga tct cat agc cca tat atg gag ttc-3’ 
HindIII-hCMV-anti 5’-gca gtt acc ctc aaa caa aac aag ctt ggg-3’ 
TargI-sense   5’-atg tgc ctg aca aac ttt ttt gtg gga-3’ 
Anti I amplicon 5’-aat ttg ctg cag tgt gtt tgt ttc ttg tgg ctg-3’ 
Sense II amplicon 5’-ttg tat ggt acc cag acc agt cat ggt aag aat-3’ 
Antisense II amplicon 5’-acc cag aag ctt gat acc aat atg aat aca ggt-3’ 
Delta ExonII A 5’-gtt gtc cag aaa att gct tga ttg aaa aac-3’ 
Delta ExonII B 5’-gcc ggt acc ttt ctg tga gat gtt tca caa cag-3’ 
Delta ExonII C 5‘-caa act gca gtc tga acc aca gac cat tct caa ac-3’ 
Delta ExonII D 5’-ggc caa gct ttt agt cag ttg aaa ggt gca gag g-3’ 
IE2-A-sense 5’-aca aac aca cag acc agt ca-3’ 
IE2-B-antisense 5’-gtt tca caa cag att gag ca-3’ 
ORF50-del-sense 5’-tgt att gca ctg aca agt ttt tta taa act-3’ 
ORF50-del-antisense 5’-cag ttt ctc cag atc tgg tcc ttt gtt tgc-3’ 
EcoRI-X-sense 5’-ccc gaa ttc gaa tgg tgt att gca ctg aca agt ttt ta-3’ 
KpnI-X-anti 5’-ccc ggt acc ctt tat aaa tgc ctt aca ttt gtc atc aat-3’ 
PstI-Y-sense 5’-ccc ctg cag ctc acc ttt cct tac ctt aat ctt gag act-3’ 
HindIII-Y-anti 5’-gcc caa gct tta aca gtt tct cca gat ctg gtc ctt tgt t-3’ 
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Fig.24. Schematic representation (not to scale) of two constructs used in this work. 
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The present doctoral thesis covers researches lead to underline the relationship between BoHV-4 and the 
uterine microenvironment, involved in the generation of pathologies, such as post-partum metritis and 
others uterine diseases. 
In the first study we characterized a uterine BoHV-4 isolate, thanks to RFLP and PCR analysis and we cloned 
this strain as a Bacterial Artificial Chromosome (BAC), to easily manipulate the viral genome; in the second 
study we demonstrated that this BAC, called BAC-U, can be further studied through the knock-out of viral 
specific genes. Infact we successfully interrupted the Immediate Early II gene (IE2) of BAC-U, demonstrating 
that this gene is the real master switch of the virus replication; moreover in this uterine strain the IE2 gene 
was surprisingly duplicated, suggesting that gene duplication may provide a selective gain for the virus to 
persist in the uterine microenvironment. 
BoHV-4 is an herpesvirus belonging to the gammaherpesvirus family, genus Rhadinovirus (Zimmermann et 
al., 2001), as HHV-8, MuHV-68 and SaHV-2, that are extensively studied even because of their oncogenic 
potential; BoHV-4 as the same genome structure and gene co-linearity and homology with these viruses 
have been described (Zimmermann et al., 2001a), but its absence of oncogenicity and of a clear correlation 
of pathologies, has prompted the attention on BoHV-4, as a model for human viruses and for vaccinal 
purposes (Donofrio et al., 2006; Donofrio et al., 2009b). 
Although BoHV-4 has been isolated from animals with various clinical symptoms and also from apparently 
healthy animals, BoHV-4 isolation from animals with disease of the female genital tract is the best 
documented and one of the few cases where disease could be reproduced (Wellemans et al., 1986); the 
pathogenic role of BoHV-4 remains otherwise still unclear, and the correlation of the virus with pathologies 
is at the time unresolved, even by experimental infections. 
A study by Wellemans et al., (Wellemans et al., 1986) were able to reproduce metritis by infecting cows at 
various times before parturition; no clinical signs were seen after primary infection but metritis appeared 
after parturition. BoHV-4 has often been implicated in cases of bovine metritis; the first reported isolation 
of this virus from a case of bovine metritis was in 1973 (ParK and Kendrick, 1973). Later several other 
isolates were obtained from cows with reproductive disorders from different countries, including Italy 
(Castrucci et al., 1986), India (Mehrotra et al., 1986), in the USA (Frazier et al., 2001; Frazier et al., 2002), in 
Spain (Monge et al., 2006) and Serbia (Nikolin et al., 2007). It is the common thinking that BoHV-4 was not 
the primary cause of metritis, but can have a secondary pathogenic role, causing post-partum metritis 
along with other microbes such as the bacteria E. coli and A. pyogenes (Donofrio et al., 2008b), that are the 
most prevalent bacteria isolated from the uterus of cattle suffering from uterine diseases, followed by a 
range of anaerobic bacteria, such as Prevotella species, Fusobacterium necrophorum and nucleatum 
(Sheldon 2009). 
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The infections of the uterine microenvironment alter not only the function of the uterus, but also the ovary 
and the overarching higher control centres in the hypothalamus and pituitary glands (Sheldon et al., 2009). 
Sub-fertility and infertility follow often the inflammatory and immune response to uterine infection and 
compromise even animal welfare. Infertility is caused at the time during the course of the infection; and 
sub-fertility often after successful resolution of the disease.  
Uterine diseases, such as metritis, can cause infertility that is strictly associated to financial losses; failure to 
conceive, reduced milk production and the costs for treatments increased the amount of losses (Sheldon 
2009). The clarification of the mechanisms involving the effect of microbial infection and the associated 
immune response on bovine reproduction is necessary to develop new treatments and prevention 
strategies (Dobson et al., 2003).  
Abortion may follow infection with a variety of alpha-, beta- and gammaherpesvirus, but viral causes of 
uterine disease are seldom investigated in cattle. Although postpartum metri tis affects up to 40% of cattle, 
it has been assumed that the majority of diseases are of bacterial origin and virus isolation or serology is 
rarely considered (Sheldon et al., 2009).   
BoHV-4 has a strictly tropism for endometrial cells, infact can infect purified population of bovine 
endometrial stromal and epithelial cells, leading to non-apoptotic cell death and de novo viral production 
that is also associated with an increased production of COX-2 and prostaglandin-endoperoxide synthase 2 
(PTGS2) protein from stromal cells and with prostaglandin E2 (PGE) secretion (Donofrio et al., 2007a; 
Donofrio et al., 2008b).  
Post-entry events are responsible of the succesfull replication of BoHV-4 in bovine endometrial cells as 
demonstrated by the rapid viral reconstitution following the electroporation of nude viral DNA into 
endometrial stromal and epithelial cells (Donofrio et al., 2007a; Donofrio et al., 2008b); the tropism should 
not infact be determined only by the receptor has never been identified.  
In a precedent study a construct containing the Immediate Early II gene (IE2) of BoHV-4, labelled with an 
EGFP, was used to transfect endometrial stromal and epithelial cells; in 24 hours, the EGFP robustly 
accumulated in the cytoplasm of both cells type (Donofrio et al., 2007a), suggesting that a mechanism 
underling the rapid activation of BoHV-4 replication in the bovine endometrium was associated with the 
capability of endometrial cells to transactivate the BoHV-4 IE2 gene promoter (Donofrio et al., 2008b), 
which is supposed to be the molecular master swich gene for BoHV-4 replication (van Santen, 1991).  
BoHV-4 IE2 gene promoter transactivation and viral replication are moreover associated with extracellular 
stimuli belonging to the intrauterine microenvironment such as E. coli LPS and PGE (Donofrio et al., 2008b) 
and BoHV-4 replication is also reactivated in latently infected macrophages by a co-cultivation with stromal 
cells (Donofrio et al., 2007a; Donofrio et al., 2008b); but is also stimulated by the addiction of exogenous 
PGE (Donofrio et al., 2005). 
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All these data led to the description of a model that fits well BoHV-4 replication and uterine diseases, 
involving the secretion of PGE from bacteria causing endometritis, then PGE and LPS can stimulate viral 
replication or re-activation from the latency site, the macrophages, in the site of infection; with further 
endometrial tissue damage and inflammation (Sheldon et al., 2009).  
Starting from this model, the evidence of the existence of a patho-biotype of BoHV-4 causing uterine 
disease can not be ignored, although BoHV-4 has been isolated from different lesions and from healthy 
animals.  
Thus, in the first study here presented, BoHV-4 was isolated from a cow affected with non-responsive post-
partum metritis, and after the characterization, its genome was cloned as bacterial artificial chromosome 
(BAC). The so generated BAC-BoHV-4-U clone could be a useful molecular tool to study the functional 
genomic of BoHV-4 genes adapted to the endometrium, which will be used to clarify the relationship 
between BoHV-4 and postpartum metritis. 
In the first study a BoHV-4 strain (BoHV-4-U) was isolated from the uterus of a BoHV-4 persistently infected 
cow, with a history of postpartum metritis. This isolate was confirmed to be a BoHV-4 strain after 
restriction pattern analyses by RFLP-PCR and sequencing using a large 2,538 bp conserved region (TK locus) 
including the 3' end of ORF1 (homologous to the EBV BVRF1 gene), ORF2 (homologous to the EBV BXRF1 
gene), ORF3 (TK gene) and ORF4 (gH gene) 5' end (Lomonte et al., 1996). 
Also the IE2 gene was analyzed by RT-PCR and sequencing, specifically for its spliced form, that is a specific 
marker for BoHV-4 immediate early expression (van Santen, 1993), confirming that this uterine isolates 
belongs really to BoHV-4.  
After the so described characterization, the BoHV-4-U genome was cloned as a bacterial artificial 
chromosome (BAC) and the stability of the pBAC-BoHV-4-U clone was assessed over twenty passages, and 
also the viral growth was not affected compared with the wild type virus.  
The use of a specifical BoHV-4 uterine isolate is necessary to well understand and underline the effects of 
the virus on the uterine environment and functions. In pathology is otherwise a very important issue the 
virus strain adaptation to an organ, tissue or cell type for the knowledge and description of the disease. The 
fact that BoHV-4 has not clearly fully correlated with a pathology, even in case of post-partum metritis, 
suggests that maybe the virus can be adapted to uterine stimuli and micro-environmental selective 
pressures given by endometrial cells and also from external or chemical, physical conditions; that may 
increase the frequency of the most efficient genetic variants.  
An important tool to study viral genome, even in attempt to characterize gene mutation or polymorphism, 
is the possibility to clone the genome of herpesvirus as bacterial artificial chromosome, and then to modify 
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the viral genome by homologous recombination , being than possible to reconstitute a viable virus in 
eukaryotic cells following transfection (Messerle et al., 1997).  
The disruption of herpesvirus genome is usually achieved by mutagenesis through the integration of a 
marker gene into the viral genome through homologous recombination of co-transfected viral genomic 
DNA and a mutated allele on a separate DNA fragment in permissive cells; this technique could be applied 
to all type of viruses, especially viruses showing a slow replication kinetics and that are strictly cell 
associated, rendering the isolation of viral mutants very difficult. Recombinant viruses are either screened 
or selected with sequential rounds of plaque purification but, if the case that mutation results in growth 
defects relative to wild-type parental virus, the mutant virus may be difficult or impossible to purify. Lethal 
mutations are often detected only indirectly by the unsuccessful isolation of the desired mutant virus; 
these mutants can be successfully isolated and confirmed to be lethal only after the construction of a 
complementary cell line expressing the wild-type allele. 
Conventional mutagenesis is usually followed by the phenotype analyses, both in vitro and in vivo; that is 
achieved through chemical mutagenesis, site-directed mutagenesis by homologous recombination in 
eukaryotic cells and manipulating virus genome using overlapping cosmid clones. All these methods are 
very useful to generate mutants, but often these procedure are inefficient, laborious and time consuming; 
even because they require to select the mutants from the parental virus, and this selection can be assessed 
only at the very end of the experimental procedure (Adler et al., 2003). 
To overcome these limitations, many herpesviruses have been cloned as an infectious bacterial artificial 
chromosome (BAC) (Adler et al., 2003; Borst et al., 1999; Gillet et al., 2005a; Messerle et al., 1997; Zhou et 
al., 2010). 
The genome of BoHV-4 has been sequenced completely (Palmeira et al., 2011; Zimmermann et al., 2001)  
but the function of most of the gene remains still unknown; the generation of a BAC even for BoHV-4, was 
firstly described by Gillet et al., in 2005, targeting the homologous recombination of an engineered cassette 
expressing EGFP with the non-coding region at the junction of right prDNA and the unique central region 
ofBoHV-4 (Gillet et al., 2005a). 
To date the analysis of BoHV-4 sequence has revealed the presence of at least 79 ORFs, 62 homologous to 
that of other rhadinovirus, 17 unique to BoHV-4, based on amino acids homology and genome co-location 
with the other gammaherpesviruses. Homology data with others rhadinoviruses and precedent work has 
led to the hypothesis that IE2 gene could be the molecular master switch protein for BoHV-4 replication. 
Endometrial cells can rapidly transactivate the IE2 promoter as previously stated by transient transfection 
assay using a reporter construct containing the IE2 promoter (Donofrio et al., 2008b). Therefore the 
mutational analysis of the IE2 gene in BoHV-4-U would be of great interest, to understand its functions in 
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the context of the interaction between uterine cells and a virus specifically adapted to the uterus, as a 
BoHV-4-U.  
The analysis of the functionality of BoHV-4-U genes in endometrial cells would be of great interest to 
discover regulatory regions; transposition technology, site direct mutagenesis and homologous 
recombination on BAC-BoHV-4-U genome will provide an important tool to carry out a large-scale research 
and analysis of BoHV-4-U regulatory regions, analysing even the effect of factors belonging to the uterus 
microenvironment, like hormones, cytokines, prostaglandins and others.  
The classification of mutants into functional clusters will contribute to identify uncharacterized genes 
possibly responsible for BoHV-4 strain adaptation to the uterine microenvironment. The so established 
BoHV-4-U mutant’s library together with different endometrial cell types will cover a substantial amount of 
biological information of intrinsic value concerning the functional relationship of the targeted genes and 
the host background. The results obtained in the large-scale gene mutation analysis will be investigated as 
a whole for their functional relationship. 
The uterine adapted BoHV-4-U genome cloned as bacterial artificial chromosome, represents indeed a very 
useful tool to understand the complex interactions existing between BoHV-4-U and uterine host cells and 
microenvironment, and to study the effect of viral infection on endometrial metabolic and endocrine 
function, and also on antigen-processing pathways.  
After the cloning of BoHV-4-U as a Bacterial as a Bacterial artificial chromosome and the assessment of its 
potential to study BoHV-4 genome and the relationships between the uterine microenvironment and an 
adapted virus strain, we started to analyse single genes, in order to demonstrate their role in the emerging 
of uterine diseases. 
The first gene we decided to submit to an extensive study was the Immediate Early II gene; previously we 
infact demonstrated the activation of BoHV-4 lytic replication in a non-permissive cell line by over-
expression of ORF50/Rta (Donofrio et al., 2004a), beginning to demonstrate the direct role of BoHV-4 
ORF50/Rta for the progression of the virus into the lytic cycle.  
In the second study several viral mutants were generated targeting specific parts of the IE2 locus within the 
BoHV-4 genome, which provided further evidence that BoHV-4 ORF50/Rta is necessary to initiate and allow 
progression of BoHV-4 lytic replication. 
Herpesvirus immediate early (IE) genes are expressed “immediately“ during cell infection without the 
requirement of prior viral protein synthesis  for their expression; host cell transcription factors, already 
present at the moment of infection, are able to activate them (Staudt and Dittmer, 2007).  
The Open Reading Frame 50 (Orf50) gene product, also known as Rta, Replication and Transcription 
Activator, is an Immediate Early gene that is extremely conserved in functions but not always in sequence, 
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in all Rhadinoviruses (Zimmermann et al., 2001). BoHV-4 IE2 RNA is a spliced, 1.8 kb RNA, which is 
transcribed from left to right on the restriction map of the BoHV-4 genome from DNA contained in the 
8.3 kb HindIII fragment F, and is the less abundant of two IE RNAs encoded by BoHV-4 (van Santen, 1991, 
1993). The predicted amino acid sequence of the protein encoded by IE2 RNA reveals that it could encode a 
61-kDa protein with amino acid sequence homology to the Epstein-Barr virus (EBV) transactivator R and its 
homolog in other gammaherpesviruses, including herpesvirus saimiri (SaHV-2), equine herpesvirus 2 (EHV-
2), murine herpesvirus 68 (MuHV-68), rhesus rhadinovirus (RRV) and Kaposi’s sarcoma-associated 
herpesvirus (HHV-8).  
Studies on several Rhadinoviruses, closely related to BoHV-4, have demonstrated that the expression of 
ORF50/Rta is essential for viral replication; recombinant viruses with deletion or inactivation by a 
premature stop codon insertion within its open reading frame were generated and were all replication-
defective; but were efficiently rescued, with respect to production of viable virus and DNA replication, upon 
the expression of ORF50/Rta in trans (Pavlova et al., 2003; Xu et al., 2005; Zhou et al., 2010).  
Precedent transactivation studies have shown that BoHV-4 Rta specifically transactivates expression of 
reporter genes linked to the promoter regulatory regions of all BoHV-4 early (E) and late (L) genes 
examined, including those encoding thymidine kinase and the BoHV-4 homologue of the herpes simplex 
virus type 1 (HSV-1) major DNA binding protein (Bermudez-Cruz et al., 1997; Bermudez-Cruz et al., 1998; 
van Santen, 1993; Zhang and van Santen, 1995) supporting the idea that BoHV-4 Rta expression could play 
a pivotal role in initiating viral lytic replication, not only during reactivation  of latently infected non-
permissive cells but also during de novo infection of permissive cells (Donofrio et al., 2004a; Donofrio et al., 
2004b; van Santen, 1993).  
A prior study focused on the results of exogenous expression of BoHV-4 ORF50/Rta, that lead the activation 
of BoHV-4 lytic replication in a non-permissive cell line by over-expression of ORF50/Rta (Donofrio et al., 
2004a), this study was the first attempt to demonstrate the direct role of BoHV -4 ORF50/Rta for the 
progression of the virus into the lytic cycle.  
BoHV-4 IE2 gene was already well characterized in terms of gene structure, transcription and RNA post 
transcriptional processing (van Santen, 1993), but it has not been clearly demonstrated that the expression 
of ORF50/Rta is required for progression to the lytic replication cycle in the context of the viral genome. 
BoHV-4 IE2 promoter was also previously shown, as described above, to be transcriptionally up-regulated in 
bovine endometrial stromal cells (Donofrio et al., 2007a; Donofrio et al., 2008b). To better understand the 
importance of such promoter in the context of viral replication on the endometrial cellular substrate we 
generated pBAC-BoHV-4-U, starting from a uterine virus isolated from a cow affected by post-partum 
metritis (Donofrio 2009). 
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In the second work here presented, we generated several viral mutants targeting specific parts of the IE2 
locus within the BoHV-4 genome, providing the proof of principle that ORF50/Rta has a direct role in 
initiating and progressing BoHV-4 lytic replication. 
Firstly we generated IE2 complemented cell lines, to be able to rescue in trans the defect in IE2 genes in the 
mutants and reconstitute the virus, hypothizing that even in BoHV-4 the IE2 gene should be essential for 
initiation and progression of the viral lytic replication. 
The cell line BEK/IE2, was created expressing the spliced form of the Orf50 gene product, Rta, contained in 
the 3442 bp EcoRI/PstI BoHV-4 genome fragment (van Santen, 1993); an expression cassette was 
engineered to force IE2 expression, inserting a 427 bp sequence containing the hCMV enhancer promoter 
but missing the basic transcriptional apparatus (TATAbox and transcriptional start site), that was dimerized 
in front of the BoHV-4 537 bp IE2 promoter, which was shown to be the minimal promoter size giving the 
maximal signal in a Dual Luciferase reporter assay, and was present at the 5’ end of the fragment; after the 
subcloning into a vector backbone containing a neo resistant cassette for G418 drug selection 
p2xCMVeIE2neo vector was generated. A transient transfection assay and RT-PCR demonstrated that 
p2xCMVeIE2neo was much better expressed then the un-enhanced version, pIE2neo containing only the 
3442 bp EcoRI/PstI BoHV-4 genome fragment. 
BoHV-4 IE2 gene contains also the ORF49 within its intron, that is transcribed in the opposite direction 
respect to ORF50 gene, and was described to cooperate with Rta protein in MuHV-68, facilitating the auto-
activation of Rta and cooperating with Rta in regulating virus replication by downstream actions (Lee et al., 
2007). 
BEK/IE2 cells express the full length Orf50 gene, and it’s in theory possible that both ORF49 and ORF50 are 
expressed. Thus, to exclude the possibility that defect in the expression of ORF 49, present into the IE2 
gene locus, could be responsible or contribute to a replicating defective phenotype, as shown for MHV-68 
(Lee et al., 2007), a new cell line (BEK/ORF50) expressing only the ORF50 ORF was generated.  
The ORF50 spliced transcript that encodes the complete Rta protein was amplified by PCR and subcloned 
into a bi-cistronic vector generating pCMV-ORF50-IRES-neo, used then to generate a stable cell line 
expressing only the ORF50/Rta protein. Both these two cell lines, BEK/IE2 and BEK/ORF50/Rta stably 
expressed ORF50 when tested by RT-PCR; moreover a morphological change, characterized by an increased 
cell sprouting and shrinking, but completely compatible with cell survival and replication, appeared in  
BEK/IE2 and BEK/ORF50 cell lines; such morphological change was probably due to IE2 over-expression, as 
previously observed for MHV-68 ORF50 (Staudt and Dittmer, 2007), but it requires to be further 
investigated to be understood. 
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As a first step in understanding the role of ORF50/Rta expression in promoting BoHV-4 
transcriptional/replication cycle, BoHV-4 IE2 gene promoter was interrupted by site specific insertional 
mutagenesis mediated by homologous recombination into the genome of V.test BoHV-4 and BoHV-4-U 
cloned as bacterial artificial chromosome (BAC) (Warming et al., 2005). 
The first targeting construct, pIE2prKanaGalKIE2pr, contained the KanaGalK 2004 bp DNA staffer double 
selecting cassette (Donofrio et al., 2007b) flanked by two BoHV-4 IE2 gene homologous regions, and was 
inserted between the IE2 putative transcriptional start site and the ATG, the translational start site 
positioned into the IE2 gene first exon (van Santen, 1993)  
This targeting construct was tested by transient transfection assay and RT-PCR and no ORF50/RTA spliced 
transcript could be detected (data not shown).  
BAC recombineering of the targeting cassette in the BAC-BoHV-4-U and BAC-BoHV-4-V.test genome, get 
BAC-BoHV-4-U/IE2pr and BAC-BoHV-4-V.test/IE2pr.  
Also two control parental mutant viruses were generated through the insertion of the same DNA staffer 
into the Timidine kinase ORF of BAC-BoHV-4-U (BAC-BoHV-4-UΔTK) (Donofrio et al., 2009a) and BAC-BoHV-
4-V.test (BAC-BoHV-4-V.testΔTK) (Donofrio et al., 2007b), to verify if the introduction of the DNA staffer 
could be detrimental for virus replication, due to the enlargement of the viral genome size. 
After electroporation in BEK cells or BEK expressing cre of BAC-BoHV-4-V.test/IE2pr DNA, the virus could 
not be reconstituted, as expected.  
To the contrary, BAC-BoHV-4-U/IE2pr could well reconstitute a virus progeny, as well as the control BAC-
BoHV-4-UΔTK, BAC-BoHV-4-V.testΔTK, BAC-BoHV-4-U and BAC-BoHV-4-V.test.  
Surprisingly, even the BoHV-4-U/IE2pr reconstituted progeny virus could still transcribe IE2 gene, rather 
BAC-BoHV-4-V.test/IE2pr could not; moreover when BAC-BoHV-4-V.test/IE2pr DNA, that was unable to 
reconstitute viable virus, was electroporated into BEK/IE2 and BEK/ORF50 complemented cells, viable 
viruses were well reconstituted, connecting BoHV-4-V.test viral reconstitution and replication with IE2 
expression. This is the first proof of principle that the IE2 gene is the master gene switch, involved in 
activating virus replication, in gammaherpesviruses and in BoHV-4, too. 
We had then to explain why the IE2 promoter inactivation strategy gave a non replicating competent 
phenotype for BAC-BoHV-4-V.test but not for BAC-BoHV-4-U. 
We hypothesed several reason to explain this unexpected result: firstly we thought about a technical 
problem or a badly designed strategy and experiments, but all the targeting construct as well as the 
targeted viral genomes were attentively checked by PCR, sequencing, restriction enzyme analysis and 
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southern hybridization and no mistakes were found; secondly we supposed that strain variations in terms 
of IE2 product requirement, could be possible, rendering Rta protein expression indispensable for BAC-
BoHV-4-V.test  strain but not for BAC-BoHV-4-U. 
Taking into account the later hypothesis, another approach to solve the problem was employed, deciding to 
interrupt only the IE2 second exon that contains most of the IE2 ORF, indeed not touching regulatory region 
and the first exon, as well the intron region, coding for Orf49. 
488 bp were then deleted both in BAC-BoHV-4-U and in BAC-BoHV-4-V.test genomes; after transfection in 
permissive cells, the so generated BAC-BoHV-4-UΔORF50 but not BAC-BoHV-4-V.testΔORF50, still was able 
to reconstitute viable viruses; and also the electroporation of BAC-BoHV-4-V.testΔORF50 DNA into BEK/IE2 
and BEK/ORF50 complemented cells rescued well the viral phenotype, as well as the control BAC-BoHV-4-
U, BAC-BoHV-4-V.test, BAC-BoHV-4-UΔTK and BAC-BoHV-4-V.testΔTK DNA.  
Comparing the growth characteristics we found that identical growth kinetics were defined for V.tests ones 
when growth curve was performed on BEK/IE2 cells These growth kinetics data resembled those of a 
MuHV-68 mutant transcribing ORF50 at high level, that showed more quick lytic spread in permissive 
fibroblast cultures (May et al., 2004). Even in this case, the necessity of IE2 gene integrity was shown only 
for BoHV-4-V.test but not for BoHV-4-U.  
We also demonstrated that the full length 1659 bp Orf50 mRNA was still expressed in BAC-BoHV-4-U 
mutants but not in V.tests ones (through RT-PCR analysis); these data begin to support that IE2 gene could 
be duplicated in BoHV-4-U genome  but not in BoHV-4-V.test. 
This hypothesis was confirmed through the generation of a probe spanning the 488bp deleted region 
within the IE2 exon 2, and, as expected, the probe revealed a signal only in the BAC-BoHV-4-U mutants, but 
was absent into BoHV-4-V.test genome. 
We disrupted also the additional gene copy of IE2 gene, present in BAC-BoHV-4-U, through the generation 
of another targeting cassette to exchange the DNA staffer present in the first IE2 locus, with a new 
generated cassette, leading the same homologies region; and then we targeted the second gene copy with 
a different targeting cassette, that lead as homology regions, the 488bp deleted duri ng the first targeting.  
This BoHV-4-U-IE2 double mutant was totally unable to growth, an efficient rescue of the virus was 
achieved only after the transfection of the mutant into the cell lines complemented in trans with Rta 
protein. 
Although the full BoHV-4-U genome sequence would be necessary to finely allocate and define such 
duplication in the contest of the whole genome, this thesis presented the final proof on the essentiality of 
104 
 
IE2 gene for BoHV-4 replication, in agreement with what was found for other gamma herpesviruses like 
MuHV-68 (Pavlova et al., 2003), HHV-8 (Xu et al., 2005) and RRV (Zhou et al., 2010). 
Moreover, the generation of a viral vector, totally unable to growth that requires the ectopic expression of 
Rta protein to be rescued, opened the way to the generation of replication conditional viruses that could be 
important tool to be used as viral vaccine or as oncolityc viruses. 
Such a vector could combine the potential of BoHV-4 as a vector, in terms of absence of oncogenicity, no 
clear correlation with any pathologies, and the possibility to delete up to the 30% of the genome, and to 
manipulate it as a BAC; with the ability to be activated and to replicate only in a defined area, organ or 
tissues, perhaps in a cell-specific manner, through the ectopic expression of Rta protein, guided by an 
inducible promoter or a cell-specific one. 
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